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9List of abbreviations
∆ delta
Ω omega
95%CI 95% confidence interval
ACV active circulation volume
ALI acute lung injury
APCCO arterial pressure based continuous cardiac output measurement
APV arterial pressure variation
ARDS adult respiratory distress syndrome
BP blood pressure
Bpm beats per minute
BSA body surface area
CaO2 arterial oxygen content
CvO2 venous oxygen content
CBV central blood volume
CI cardiac index
CO cardiac output
CO2 carbon dioxide
COTPTD cardiac output measured with TPTD 
COUFP cardiac output measured with UFP
CPB cardiopulmonary bypass
CSA cross sectional area
CVP central venous pressure
DO2 oxygen delivery
DSt down slope time 
EV electrical velocimetry
EVLW extravascular lung water
EVLWI extravascular lung water index
EVLWIG extravascular lung water index gravimetry
EVLWITPDD extravascular lung water index measured with TPDD
EVLWITPTD extravascular lung water index measured with TPTD 
FAP finger arterial pressure
FiO2 inspired oxygen fraction
FR fluid responsiveness
GEDV global end diastolic volume
GEDVI global end diastolic volume index
Hb hemoglobin concentration
HR heart rate
IAP intra-arterial pressure
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ICG indocyanine green
ITBV intra thoracic blood volume
ITBVI intra thoracic blood volume index
ITTV intra thoracic thermal volume
LOA limits of agreement
MAP mean arterial pressure
mmHg millimeters of mercury
MODS multiple organ dysfunction syndrome
MTt mean transit time
NIBD non-invasive blood pressure
OER oxygen extraction ratio
PAC pulmonary artery catheter
PaO2 arterial partial pressure of oxygen
PATD pulmonary artery thermodilution
PEEP positive end expiratory pressure
PBV pulmonary blood volume
PCCO pulse contour cardiac output
PDD pulse dye densitometry
PICU pediatric intensive care unit
PLR passive leg raising
PPV pulse pressure variation
PTV pulmonary thermal volume
PvO2 venous oxygen pressure
SAP systolic arterial pressure
SaO2 arterial oxygen saturation
ScvO2 central venous oxygen saturation
SvO2 mixed venous oxygen saturation
SD standard deviation
SPV systolic pressure variation
SV stroke volume
SVI stroke volume index
SVV stroke volume variation
SVR systemic vascular resistance
TED transesophageal Doppler ultrasound
TEDV total end-diastolic volume 
TPD transpulmonary dilution
TPDD transpulmonary double indicator dilution
TPLD transpulmonary lithium dilution
TPTD transpulmonary thermodilution using ice-cold saline
TPUD transpulmonary ultrasound dilution
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TTE transthoracic echocardiography
UDCO ultrasound dilution cardiac output
UFP ultrasound transit time flow probe
VO2 oxygen consumption
VCO2 carbon dioxide production
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General introduction
Motivation
Pediatric patients admitted to a pediatric intensive care unit (PICU) often need 
hemodynamic monitoring, especially if at risk for hemodynamic instability.[1] The primary 
aim of hemodynamic monitoring is threefold. The first aim is to detect early deterioration 
thereby activating a therapy “trigger”, the second is to choose the most suitable therapy 
aimed at preserving adequate organ perfusion and oxygen supply. The third aim is to guide 
hemodynamic therapy towards a specific end-point, the so called goal directed approach. 
For hemodynamic assessment, doctors generally rely on variables obtained by physical 
examination and routine monitoring including capillary refill time, skin characteristics, 
core-peripheral temperature differences and consciousness in combination with heart 
rate, blood pressure and urine output. However, an apparently sufficient blood pressure 
does not always reflect adequate systemic blood flow. Capillary refill time and skin 
temperature will deviate from normal values depending on ambient temperature.[2] 
Heart rate and blood pressure can be influenced by factors like fever, anxiety and side 
effects of medication. They are indirect clinical markers of systemic blood flow and have 
shown to be unreliable for estimating (changes in) hemodynamic status.[3, 4] 
Why is it so difficult to estimate the hemodynamic status in children? One of the 
explanations is that children use their compensating mechanisms masking circulatory 
failure. Especially young children are able to maintain a relatively normal blood pressure 
for a long time, despite a significant fall in cardiac output. They do so by increasing 
vascular resistance to extreme levels, initially in non-vital organs like the skin. By the time 
pediatric patients become hypotensive, organ failure may already have occurred and the 
resuscitation will be more difficult to stabilize the patient.
Therefore, reliable hemodynamic parameters are needed to reflect blood flow and 
fluid status. Cardiac output measurements, predictors of oxygen dysbalance and fluid 
responsiveness and indicators of fluid overload may contribute to fulfill this need. These 
advanced hemodynamic monitoring parameters may help to identify patients in an 
earlier phase of hemodynamic compromise, may guide and evaluate therapy and may 
prevent irreversible organ failure. 
Physiologic background
The aim of systemic blood flow is to meet the metabolic demands of the tissues and 
ensure adequate tissue oxygenation. Hemodynamics involve complex physiologic 
processes and interactions.[5] For the interpretation of variables monitored, it is essential 
to understand the principles of the circulation and to take into account the physiological 
differences between adults and children. 
1
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Monitoring adequate tissue oxygenation represents the balance between systemic 
oxygen delivery and consumption. In critical illness both the oxygen delivery and 
demand are often deranged.[6] At present, no real-time monitoring tool for use at the 
bedside is available for tracking oxygen transport. Calculations can be made to estimate 
the oxygen delivery and consumption.
The delivery of oxygen to the tissues (DO2) is determined by the product of arterial 
oxygen content (CaO2) and cardiac output (CO):
DO2 = CaO2 x CO
The assessment of total body oxygen consumption (VO2) can be calculated according to 
the product of CO and the difference in arterial-venous oxygen content: 
VO2 = CO x (CaO2 – CvO2)
When the oxygen delivery and oxygen consumption are known, the oxygen extraction 
ratio (OER) can be calculated:
OER =  VO2
 DO2
The formulas may be simplified for practical use by ignoring the amount of oxygen 
dissolved in the blood. Determinants in these calculations are mixed venous oxygen 
saturation (SvO2), arterial oxygen saturation (SaO2), CO and hemoglobin concentration 
(Hb). Of these, advanced hemodynamic monitoring uses (changes in) SvO2 and CO to 
determine the hemodynamic status. 
Advanced hemodynamic monitoring
Cardiac output measurement is feasible in children and provides essential extra 
information on cardiac performance and fluid responsiveness.[7-13] However, despite 
the well-known limitations of physical examination and standard hemodynamic 
measurements, cardiac output is rarely measured in children.[1]
Since the introduction of the pulmonary artery catheter into clinical practice in the 
1970s, an impressive number of medical devices has been developed.[14-16] Clinicians 
may feel somewhat confused by the multiple possibilities. Nevertheless, the perfect 
device still doesn’t exist, being inexpensive, non-invasive, easy to use, accurate, precise, 
reproducible, continuous, applicable for all ages and without complications. The current 
advanced hemodynamic monitoring systems measure at least one or a combination 
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of some of the following variables: cardiac output, continuous arterial blood pressure, 
variations in pressure and/or volumes or blood velocities, cardiac filling pressures and/
or volumes, extravascular lung water and mixed (central) venous oxygen saturation.[8, 
9, 12, 17, 18] In children the applicability of the available devices is limited, depending 
on the technical aspects and size of probes and catheters.[10, 19] Beside these clinical 
limitations, only few validation studies in pediatric patients have been published. One 
of the clinical gold standards used in children are cardiac output monitoring devices 
using the transpulmonary dilution technique.[20, 21] Although validated in children, it 
is still unknown how reliable these hemodynamic estimations are in critically ill pediatric 
patients under various circumstances, while this is the target group for advanced 
hemodynamic monitoring.[22, 23] 
Scientific background
Based on the evidence demonstrated in studies in adult patients, advanced 
hemodynamic monitoring can be used to improve outcome. Cardiac output and various 
other parameters, can be helpful diagnosing and monitoring circulatory failure and 
evaluating the response to the initiated treatment.[18] As previously mentioned, the 
available monitoring devices are still not generally used on pediatric intensive care units, 
partly explained by the unfamiliarity of the clinicians with the devices, unsuitability 
of probes and catheters for infants and small children, lack of pediatric scientific 
evidence and lack of target values for children. However, in the last decade mounting 
evidence from feasibility- and validation-studies show the applicability of several 
monitoring devices in children.[24-30] Still there is a need for more clinical pediatric 
studies supporting the evidence of improving outcome using advanced hemodynamic 
monitoring. Unfortunately, the results of studies in adults cannot be extrapolated to 
pediatric patients. For that, their physiologic responses, compensating mechanisms and 
body proportions are sufficiently different. 
The goal of the present thesis is to demonstrate the feasibility of advanced hemodynamic 
monitoring in children. Cardiac output measurement, using the transpulmonary 
thermodilution technique, is validated in two pediatric animal models as surrogates 
for critically ill children. Extravascular lung water measurement, a relatively new marker 
in clinical practice used for the assessment of fluid overload, is validated against two 
gold standards. Finally, a clinical study in children is included, defining pediatric normal 
reference values of extravascular lung water. 
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Outline of this thesis
This thesis is divided into four parts.
Part I consists of two reviews. In chapter 2 the basic physiological background and 
principles of hemodynamic monitoring in children are summarized. Chapter 3 provides 
an overview of the various available monitoring systems, reviewing the technology and 
their limitations and clinical applications focusing on infants and children. The devices 
are listed in order of degree of invasiveness.
Part II focuses on the use of the transpulmonary thermodilution technique measuring 
cardiac output. In chapter 4 the transpulmonary thermodilution technique is validated 
in a pediatric animal model in the presence of a left-to-right shunt. Chapter 5 is an 
editorial comment discussing the interpretation of the thermodilution curves in the 
presence of a shunt circulation. In chapter 6 the cardiac output measurements using 
the transpulmonary thermodilution method, are validated in a pediatric animal model 
during induction of lung injury.
Part III describes the measurement of extravascular lung water using the transpulmonary 
thermodilution technique. In chapter 7 the results of extravascular lung water measured 
with the transpulmonary thermodilution technique are compared with the two gold 
standards gravimetry and transpulmonary double indicator dilution. In chapter 8 we 
present near normal values of extravascular lung in a heterogeneous pediatric patient 
population.
Part IV consists of chapter 9 and chapter 10 in which the most important findings are 
summarized and discussed in English and Dutch (for laymen), respectively. Conclusions 
are presented together with suggestions for future research.
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Hemodynamic monitoring in children

Advanced hemodynamic monitoring 
in critically ill children
Pediatrics 2011; 128(3): 560-71
Joris Lemson
Anneliese Nusmeier
Johannes G. van der Hoeven
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Abstract
Circulatory shock is an important cause of pediatric morbidity and mortality and 
requires early recognition and prompt institution of adequate treatment protocols. 
Unfortunately, the hemodynamic status of the critically ill child is poorly reflected by 
physical examination, heart rate, blood pressure, or laboratory blood tests. Advanced 
hemodynamic monitoring consists, among others, of measuring cardiac output, 
predicting fluid responsiveness, calculating systemic oxygen delivery in relation to 
oxygen demand, and quantifying (pulmonary) edema. Here we discuss here the 
potential value of these hemodynamic monitoring technologies in relation to pediatric 
physiology.
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Introduction
Circulatory shock is an important cause of pediatric morbidity and mortality.[1] 
Therefore, early recognition of inadequate tissue perfusion and oxygenation followed by 
prompt treatment are most important.[1, 2] In pediatric circulatory shock, cardiac output 
(CO) and blood pressure can be low, normal, or high.[3] Physical examination, although 
essential in the overall assessment, poorly reflects CO, preload status, or the need for 
fluid or other hemodynamic interventions.[4, 5] Moreover, blood pressure and heart rate 
often do not reflect blood flow.[6, 7] Therefore, more reliable pediatric hemodynamic 
parameters are most wanted.
Oxygen delivery to the tissues (DO2) must always outweigh oxygen use (VO2). Therefore, 
the balance between DO2 and VO2 is of vital importance in critically ill patients. The 
main goal of any hemodynamic intervention is to improve DO2 while maintaining an 
adequate perfusion pressure. However, it could be useful to reduce the oxygen need by, 
for example, reducing fever, administering adequate sedation and analgesia, or starting 
mechanical ventilation. Because it is still impossible to quantify the need for oxygen by 
the various tissues or estimate the most adequate level of perfusion pressure, surrogate 
measures are being used. In doing so as an example, a goal directed approach based 
on optimizing venous oxygen saturation (SVO2) might improve outcome in septic adult 
patients.[8]
Advanced hemodynamic monitoring in children seems mandatory to detect inadequate 
tissue perfusion and oxygenation at an early stage, long before it becomes detrimental. In 
contrast, the latest guidelines for treating sepsis in children advise to measure CO only at 
the end of the algorithm, after fluid and vasoactive therapy have already been instituted.
[9] Initial aggressive fluid therapy for pediatric septic shock can be advantageous, but the 
resuscitation should be guided to prevent subsequent overzealous fluid therapy.[10, 11] 
Therefore, advanced hemodynamic monitoring in critically ill children might attribute to 
a lower mortality rate and a shorter intensive care length of stay.
We describe here the potential clinical value of 4 advanced hemodynamic monitoring 
technologies in children. CO measurement and venous oximetry provide important 
insight into the circulatory status and the balance between DO2 and VO2. However, fluid 
responsiveness and the determination of lung water are useful for guiding fluid therapy.
In this review we provide clinicians treating severely ill children physiologic knowledge 
of advanced hemodynamic monitoring. The transitional and neonatal hemodynamic 
physiology has its own unique features, which are beyond the scope of this review. 
29
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Basic hemodynamic physiology
DO2 consists predominantly of the product of CO, arterial oxygen saturation (SaO2), 
and hemoglobin level (Fig 1; Table 1). Under normal conditions, SaO2 is close to 100%. 
Because the body as a whole, under normal conditions, extracts 25% of oxygen from the 
arterial blood, the oxygen saturation of mixed venous blood (SvO2) is ≈75%. VO2 can be 
measured by using calorimetry or estimated indirectly by measuring SvO2, hemoglobin 
level, and CO (Table 1). Under normal conditions, DO2 is much higher than VO2, which 
reflects a wide margin of safety in the supply-to-demand ratio for oxygen. Assuming 
stable hemoglobin and SaO2 levels, the CO is the major determinant of DO2 most of the 
time. However, one should bear in mind that DO2 and VO2 reflect oxygen supply and 
demand of the whole body, whereas important differences between organs might exist, 
depending on the circumstances.
CO is the product of heart rate and cardiac stroke volume (SV). SV depends on preload, 
afterload and contractility (Fig 1). The relation between SV and preload is reflected by the 
Frank- Starling curve (Fig 2A). Blood pressure is the resultant of SV and systemic vascular 
resistance (Table 1 and Figure 1). As a result, a low blood pressure can be caused by a 
low CO, a low systemic vascular resistance, or both. The net driving force of fluid from the 
intravascular space to the interstitium (or vice versa) is guided by Starling’s law (Table 1) 
and reflects the balance between hydrostatic and oncotic pressures in relation to the 
capillary membrane permeability. Also, the amount of lymphatic drainage is important, 
because younger children seem to have a higher capacity to eliminate interstitial fluid.
[12] Therefore, the formation of edema can be caused by several mechanisms. 
In most cases of circulatory shock, either blood pressure and/or CO (thus, DO2) are too 
low, which results in an insufficient perfusion pressure with organ damage and/or an 
unbalance in the oxygen supply-to-demand ratio, which leads to anaerobic metabolism. 
The most frequent causes are hypovolemia, overzealous vasodilation, and cardiac 
dysfunction. The latter consists of 2 components: (1) diminished systolic function with a 
decrease in ejection fraction, an increase in ventricular dimensions, and, subsequently, 
a decrease in SV; and (2) diastolic dysfunction that also results in a decrease in SV.[13]
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Figure 1
Basic hemodynamic relations.
Hb indicates hemoglobin level; HR, heart rate; SVR, systemic vascular resistance.
Table 1 
Several Hemodynamic Calculations
Parameter Formula
SVR 80 x (MAP - CVP) / CO
CaO2 Hb x 1.31 x SaO2 + 0.0031 x PaO2
CvO2 Hb x 1.31 x SvO2 + 0.0031 x PvO2
DO2 CO x CaO2 
VO2 CO x (CaO2 - CvO2)
OER (SaO2 - SvO2) / SaO2
Ω SaO2 / (SaO2 - SvO2)
Jv Kf x ([Pc − Pi] − σ[πc − πi])
PPV (%) (PPmax – PPmin) / [PPmax + PPmin/2] x 100
Units of measure: systemic vascular resistance (SVR), dyn·s·cm-5; CO, L/min; VO2 and DO2, 
mL O2/min; hemoglobin (Hb), g/L; arterial oxygen content (CaO2) and mixed venous oxygen 
content (CvO2), mL O2/L; arterial oxygen saturation (SaO2) and mixed venous oxygen 
saturation (SvO2), fraction of 1.0; pulse-pressure variation (PPV), %; Mean arterial pressure 
(MAP) and central venous pressure (CVP), mmHg; venous oxygen partial pressure (PvO2) 
and arterial oxygen partial pressure (PaO2), mmHg; Ω, oxygen excess factor; Jv, the net fluid 
movement between compartments; Kf, proportionality constant/filtration coefficient; Pc, 
capillary hydrostatic pressure; Pi, interstitial hydrostatic pressure; σ, reflection coefficient; 
πc, capillary oncotic pressure; πi, interstitial oncotic pressure; PPmax and PPmin, maximum and 
minimum pulse pressure, respectively.
DO2 = Sao2 x Hb x CO
SV x HR
Blood pressure = SVR x CO
Afterload
Preload 
Contractility
31
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Figure 2
Cardiac function curves. A, Relation between preload and SV: the Frank-Starling curve. B, 
Relation between preload and extravascular lung water or edema.
Several therapeutic measures might increase DO2. CO can be increased by titrating 
volume therapy with inotropic medication (by increasing cardiac contractility) and 
with vasodilating agents (by decreasing afterload). Vasoconstrictive agents such as 
norepinephrine can be used to increase blood pressure when vascular resistance is 
too low. Fluid restriction and/or diuretics are prescribed to decrease the amount of 
(pulmonary) edema. The optimal intervention clearly depends on the circulatory state. 
Although each of these interventions can be lifesaving, inappropriate use might be 
deleterious. Fluid therapy aims to increase CO through a rise in preload. However, a 
fluid challenge will increase preload and SV only when the heart functions on the steep 
part of the Frank-Starling curve. This situation is called “fluid responsiveness.” When fluid 
is administered on the more horizontal part of the curve, (pulmonary) edema might 
develop (Fig 2B). Also, using high amounts of vasoconstrictive agents in a low-CO state 
caused by decreased myocardial contractility might raise blood pressure at the expense 
of a detrimental further reduction in DO2.
Apart from increasing DO2 it might also be beneficial to decrease VO2. Specifically in 
young children, hyperthermia, increased work of breathing, pain, and anxiousness my 
increase VO2 to levels that cannot be met by DO2. Therefore, mechanical ventilation, 
analgesia, sedation and lowering an increased body temperature are easily applicable 
interventions with a potential beneficial effect.
During human development hemodynamic physiology changes, especially in the first 
years of life. Most important is that oxygen and metabolic demands are higher, show 
less variation, and lack a hypermetabolic response in critical illness compared with older 
children or adults.[14] CO, SV, and ejection fraction (indexed to body proportions) seem 
to decrease with age, and heart rate is higher and blood pressure is lower in young 
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children.[15] The lower blood pressure in conjunction with a relatively higher CO implies 
that young children have a lower systemic vascular resistance.[16] Oxygen saturation of 
arterial and venous blood seems equal at all ages.
The CO of young children is not as strongly dependent on heart rate as was previously 
thought.[17] Many studies in healthy children, in children undergoing cardiac surgery, or 
in critically ill children have revealed that changes in CO are largely caused by changes 
in SV.[6, 7, 16, 18-20] Therefore, heart function in young children complies with general 
hemodynamic physiology (Fig 1). However, cardiac function in young children might be 
characterized by a higher basal contractile state, a greater sensitivity to afterload, and 
higher oxygen demand at higher heart rate or higher preload state.[16, 21]
CO monitoring
CO monitoring allows for the important discrimination between a low CO syndrome and 
a hyperdynamic state, characterized by high CO and low vascular resistance. In case of 
low CO, fluid therapy and/or inotropic drugs should be instituted. In case of high CO with 
concomitant low blood pressure, vasopressors might be instituted. Fluid therapy can be 
guided, ideally, by CO monitoring, because fluids should be stopped when CO does not 
increase (anymore).[22] Also, when administering vasopressors, CO monitoring can warn 
against a decrease in CO. In doing so, overzealous fluid administration and unnecessary 
or even deleterious vasopressor therapy can be avoided. Because hemodynamic profiles 
might differ between critically ill children, determination of CO might guide the clinician 
in the choice of intervention.[3, 23]
In adults, the pulmonary artery catheter is regarded as the clinical gold standard for 
measuring CO. However, because of technical problems and size restraints, the pulmonary 
artery catheter is not practical (and is sometimes impossible) to use in (young) children. 
In the last decade less invasive alternative methods have become available for measuring 
CO in both adults and children. These CO methods are based on multiple techniques 
including Doppler signals, dilution measurements, and bioimpedance methods. In 
general, dilution techniques deliver a reliable CO measurement for children from 3.5 kg 
and above, but all require insertion of central venous and arterial catheters. Less invasive 
methods are often less reliable. At present the transpulmonary thermodilution method 
is considered to be the clinical gold standard for children.[24] The transpulmonary 
thermodilution technology also offers the measurement of global end-diastolic volume, 
reflecting preload, and extravascular lung water (EVLW), which reflects pulmonary 
edema.[25-27] For in-depth technical information, see ref.[28] In general, the bedside 
CO techniques cannot be used in patients with intracardiac and extracardiac shunts. 
However, the transpulmonary thermodilution technology and the modified CO2 Fick 
methods might be feasible in this situation.[29, 30] 
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Nonetheless, in adults there is no evidence that the use of a pulmonary artery catheter 
improves morbidity and/or mortality rates.[31] However, fluid therapy guided by CO 
measurement using esophageal Doppler might improve outcome after major adult 
surgery but not in critically ill patients.[32] Also, CO-guided volume loading in septic 
adults might prevent the increase in lung water.[22] Likewise, the evidence that CO 
monitoring improves outcome in critically ill children is also missing. CO monitoring 
does provide the clinician with important hemodynamic information and provides a 
physiologic value that can be used to determine and guide therapy.[7, 18, 23] Clinical 
studies of CO-guided hemodynamic therapy in children, therefore, are warranted. 
Venous oximetry
According to the Fick principle, total body VO2 equals CO multiplied by the difference 
between arterial and venous oxygen content (Table 1). When VO2, SaO2 and hemoglobin 
levels are relatively constant, a change in CO will cause a change in SvO2. However, this 
relationship is not linear (Table 1); therefore, SvO2, although related to CO, is not the 
same as CO.[33] The most important part of the SvO2–CO curve lies between an SvO2 
value of 60% and 80%.[33] In this steepest part of the curve, a change in SvO2 might 
indicate a significant change in CO. A low SvO2 with a normal SaO2 is almost always a 
sign of low CO in septic adults.[34] In case of a low SaO2 caused by severe pulmonary 
dysfunction or in the presence of intracardiac and extracardiac shunts, SvO2 will be lower 
also. To relate SvO2 to SaO2, the oxygen extraction ratio (OER) is calculated (Table 1). A 
normal OER is ≈0.25. Others prefer to calculate the oxygen excess factor (Ω) (Table 1), 
which is the inverse of the OER and has a normal value of ≈4.[35] A high OER indicates 
a disturbed balance between DO2 and VO2, which could be caused by an increased VO2 
and/or by a decreased DO2 (see basic hemodynamic physiology).
Physiologically, the true SvO2 is closely reflected by the “mixed” SvO2 in the main 
pulmonary artery. SvO2 reflects saturation of the mixed venous blood from the upper 
body, lower body, and the coronary sinus, which requires the use of a pulmonary artery 
catheter. Because this catheter is rarely used in children, ScvO2 measurement with a 
central venous catheter in the superior caval vein is taken instead. ScvO2 measurement 
in the inferior caval vein might provide different results.[36, 37] The ScvO2 reflects merely 
the saturation of venous blood from the upper part of the body (including the brain). 
Under normal conditions, the saturation in the inferior caval vein is higher than that in 
the superior caval vein because of the higher VO2 by the brain compared with that of 
the abdominal organs (especially the kidneys).[36] However, during circulatory shock, 
perfusion of the mesenteric organs decreases more than perfusion of the brain, which 
might cause saturation of the inferior caval vein to decrease. Also, mixing of desaturated 
blood from the coronary sinus might cause an additional decrease in SvO2. As a result, 
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with sepsis or after liver transplantation the ScvO2 can be ≈8% higher than SvO2.[38] 
Both ScvO2 and SvO2 could be equally reliable in determining changes in SvO2 in adults 
and children.[38, 39] However, these values are not interchangeable in all patients with 
septic shock, because ScvO2 and SvO2 do not always change in the same direction[40]; 
this can be explained by variable changes in myocardial, cerebral, or splanchnic VO2 
under different conditions.
Although blood sampling is the most practiced way to determine ScvO2, special venous 
catheters for continuous ScvO2 monitoring are available even for (small) children. They 
replace the need for intermittent sampling and allow for tracking fast changes in ScvO2.
[41] Although continuous ScvO2 monitoring has been validated in children, there have 
been no studies investigating the relation between ScvO2 and CO or clinical condition in 
pediatric patients.[41, 42]
The ScvO2 can be used in 2 ways: (1) relating the absolute ScvO2 value to the OER (eg, 
a low ScvO2 value [<70%] accompanied by a high OER [>0.25] could indicate relatively 
low CO); and (2) changes in ScvO2 might guide hemodynamic therapy, although it is 
difficult in hyperdynamic conditions.[38] In adult patients with sepsis, restoring ScvO2 
to >70% might improve outcome.[8] This might also be true for children with septic 
shock.[43] Unfortunately, studies in septic adults have shown that many patients 
already have a ScvO2 value of >70% at the start of therapy, although they might still 
need hemodynamic improvement.[44] Also, optimizing SvO2 in adult ICU patients did 
not improve outcome.[45]
A complicating factor in interpreting the ScvO2 value is the mitochondrial dysfunction 
that can occur during sepsis. The result is that although oxygen supply to the tissues 
is adequate, the tissues are not able to metabolize oxygen to energy-rich phosphates. 
Although SaO2 and ScvO2 might seem normal or even high, there is still a misbalance 
between VO2 and DO2. Indeed, adult patients with a high ScvO2 level even seem to have 
a higher mortality rate compared with adults with a normal ScvO2.[46]
At present, the additional value of ScvO2 measurement in pediatric clinical practice is 
not clear. Nevertheless, ScvO2 monitoring is already incorporated in the surviving sepsis 
campaign algorithm for both adults and children.[9] If ScvO2 is used, it should preferably 
be combined with CO measurement or markers of insufficient oxygen perfusion such 
as lactate levels. On the one hand lactate has been shown to reflect inadequate organ 
perfusion reliably even when systemic oxygenation seems sufficient for metabolic 
demand, but on the other hand, it lacks the fast changes of ScvO2 that might guide 
treatment.[47] However, a treatment algorithm based on lactate levels has been shown 
to be beneficial in adults.[48]
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Cardiac shunts
A low ScvO2 in children with cardiac shunts can be caused by low systemic blood flow 
(Qs) but also by a low pulmonary blood flow (Qp). In these clinical situations, the OER 
needs to be interpreted together with other hemodynamic parameters.[35] Pediatric 
studies during congenital cardiac surgery have revealed that low ScvO2 predicts the 
occurrence of major adverse events.[20] ScvO2 values of <40% were associated with 
a lower outcome score in neonates after Norwood stage 1 surgery.[20, 49] The peri-
operative use of ScvO2 monitoring is recommended for these patients.[50]
Intermittent or continuous monitoring of ScvO2 in children is recommended when CO 
monitoring is difficult, impossible (cardiac shunts), or not yet available. When using ScvO2 
in cases of shunt, it is advised to calculate the OER and to be cautious with “normal” 
ScvO2 values, because they still might not reflect a normal hemodynamic state.
Fluid responsiveness
The effect of fluid therapy can be determined by measuring CO before and after a 
fluid bolus. When CO (or, more precisely, SV) increases by >10% to 15%, the patient 
is considered fluid responsive. Results from adult and pediatric studies have shown 
that only up to half of the fluid challenges increase SV.[51-53] To avoid unnecessary 
fluid overload, there is a great interest in predicting fluid responsiveness. Both static 
and dynamic parameters are used for this purpose. Examples of static parameters are 
central venous pressure (CVP), heart rate, and global end-diastolic volume index (GEDVI). 
Dynamic values are the result of a physiologic heart-lung interactive process or a special 
maneuver. Examples are arterial pressure variations as a result of mechanical ventilation 
and changes in cardiac SV as a result of a passive leg-raising test.
CVP is often used to guide fluid therapy in both adults and children and is considered to 
reflect cardiac preload. However, CO is, for an important part, determined by the venous 
return to the heart. Venous return itself is determined by CVP, resistance to venous 
return, systemic vascular compliance, venous capacitance, stressed and unstressed 
blood volume, and mean systemic filling pressure.[54] Except for CVP, the other variables 
are difficult or even impossible to measure. Furthermore, the value of CVP is influenced 
by the diastolic compliance of the right ventricle, intra-abdominal pressure, positive 
end expiratory pressure, and forced expiration. Indeed, CVP does not predict fluid 
responsiveness and only poorly reflects preload in adults, children, and pediatric animal 
models.[7, 18, 19, 25, 51, 55, 56]
The other static measure is GEDVI, which is measured by using the transpulmonary 
thermodilution technique incorporated in the PiCCO device (Pulsion, Munich, Germany). 
GEDVI is a virtual blood volume measurement that includes the end-diastolic volumes 
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of left and right atria and ventricles, but it also includes the volume of central veins 
and aorta between the point of injection and the point of detection of the indicator. 
Therefore, GEDVI does not reflect an anatomic volume, which impedes validation.[57] 
However, GEDVI has been shown to be related to preload in adult patients and animals.
[58, 59] A treatment algorithm based on GEDVI might reduce catecholamine use and ICU 
stay in adults after cardiac surgery.[60] Also, GEDVI seems to reflect preload in children.
[7, 25] Results of clinical studies in children showing the value of GEDVI in predicting fluid 
responsiveness are not available, and it is unknown what cutoff values for GEDVI should 
be used, because GEDVI is lower in younger children compared with older children or 
adults.[18, 26, 27, 57, 61]
Dynamic parameters are the result of a temporary change in SV as a consequence of 
a change in the right and/or left ventricular preload or afterload induced by various 
mechanisms. The magnitude of the effect depends on the position of the heart on the 
starling curve. Two phenomena have been studied: arterial pressure variations and the 
passive leg-raising test. 
Arterial pressure variations are mainly studied in relation to mechanical positive-
pressure ventilation. During the breathing cycle the left ventricular filling varies, thus 
influencing SV, and as a result, fluctuations in the arterial pressure curve occur. Figure 
3 shows this phenomenon in a newborn lamb. The explanation is as follows: during 
inspiration lung expansion causes an increase in both pleural and pericardial pressure. 
Subsequently, several phenomena develop simultaneously: (1) transmural pressure 
over the left ventricular wall decreases, thereby diminishing afterload and resulting 
in an immediate increase in left ventricular SV; and (2) at the same time, lung inflation 
squeezes blood from the pulmonary venous side to the left atrium, which enhances 
left ventricular SV. These 2 effects lead to an increase in arterial pressure that is called 
the “Δ up” (Fig 4). (3) The increased alveolar pressure causes an increase in pulmonary 
vascular resistance and thereby increases right ventricle afterload, and as a result, right 
ventricular SV decreases; (4) the increase in pericardial pressure decreases systemic 
venous return, thereby also decreasing right ventricular SV; and (5) the reduced right 
ventricular SV leads, after a few heart beats, to a decrease in left ventricular preload 
and thus left ventricular SV (Fig 5). Effects 3 through 5 lead to a decrease in arterial 
pressure that is called the “Δ down” (Fig 4). 
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Figure 3
Arterial pressure variations in a lamb of 9.2 kg during mechanical ventilation and apnea. 
During inspiration and expiration, the flow in the pulmonary artery and the descending 
aorta fluctuates alternatingly. These fluctuations resolve when ventilation is paused. 
Pao indicates arterial pressure in the aorta; Qao, flow in the descending aorta; Qpa, flow in 
the main pulmonary artery; Paw, airway pressure 
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Figure 4
Arterial pressure variations as a result of mechanical ventilation. A indicates pressure level at 
expiratory hold; 1, Δ up (difference between maximal systolic pressure and pressure level at 
expiratory hold): 2, Δ down (difference between pressure level at expiratory hold and lowest 
systolic pressure); 3, difference between maximal and minimal systolic pressure, which is 
used for calculating systolic pressure variation; a and b, pulse-pressure difference (systolic 
pressure minus diastolic pressure), which is used to calculate pulse-pressure variation.
 
Figure 5
Mechanism of arterial pressure variations. 
LV indicates left ventricle; RV, right ventricle; Ppc, pericardial pressure. 
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The resultant calculation of arterial pressure variations can be performed in multiple 
ways. First, the variation in systolic arterial pressure can be calculated (systolic pressure 
variation). Second, the pulse-pressure variation can be calculated by taking the 
changing difference of systolic minus diastolic pressure. Finally, when a continuous 
arterial pressure wave–based CO device is used, the variation in SV can be calculated. 
Calculations are all based on the same formula (Table 1). Respiratory tidal volume, 
cardiac arrhythmias, and the ratio of the respiratory rate to heart rate all influence the 
magnitude of arterial pressure variations.[62] Although the magnitude of the Δ up seems 
to depend on left ventricular performance, the magnitude of the Δ down is specifically 
influenced by hypovolemia. Therefore, apart from systolic pressure variation and pulse-
pressure variation, Δ down can also be used to establish fluid responsiveness.[63] In 
small children, variation in blood-flow velocity in the aorta using echocardiography can 
serve as a surrogate for arterial pressure variations.[51, 52]
Arterial pressure variations are a reliable indicator of fluid responsiveness in adults.
[53, 64, 65] However, reliability decreases with spontaneous respiration, nonsinus 
rhythm, pulmonary hypertension, right heart failure, low tidal volume, or open-chest 
conditions.[66-69] Also, in children or experimental pediatric animal models, arterial 
pressure variations and variation in blood-flow velocity in the aorta seem to predict fluid 
responsiveness, but specific cutoff values have not been established yet.[6, 19, 51, 52, 
56, 70] The passive leg-raising test is a reliable indicator of fluid responsiveness in adult 
patients regardless of whether it is done during mechanical ventilation or spontaneous 
breathing.[71] However, there are currently no study results from children available. 
In our experience, in small children the passive leg-raising test seems to provide 
limited information, perhaps because of the relatively low blood volume in their legs 
(unpublished data). 
Lung water
Pulmonary edema can be quantified by measuring EVLW. The extravascular fluid of 
the lung can be present in the interstitium and/or the alveolar compartment.[72] 
Alveolar flooding probably occurs after an initial increase of EVLW of ≈100% and is 
enhanced by the disruption of the alveolar membrane.[72, 73] Only when alveolar 
flooding appears will the oxygenation be seriously impaired and clinical signs 
become apparent.[74] Because fluid overload is a risk factor for mortality in critically 
ill adults and children and a restrictive fluid policy might reduce complications after 
major surgery, using a tool for detecting and quantifying fluid overload might be 
advantageous.[11, 75]
EVLW can be measured at the bedside by using the transpulmonary thermodilution 
technique, which is incorporated in the PiCCO device and is indexed to body weight 
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(EVLWI).[61, 76-78] Transpulmonary thermodilution also tracks fast changes in EVLW.[79] 
For the adult population, an EVLWI between 3 and 7 mL/kg is considered normal, and 
levels of > 10 mL/kg are associated with pulmonary edema.[78]
In adults, EVLWI measurement has been validated in many studies[78, 80-83]; in children, 
results of only 1 validation study have been published.[61] EVLWI cannot currently 
be measured reliably in patients with a significant left-to-right or right-to-left shunt. 
Measurement of EVLWI in children or pediatric animal models has revealed higher values 
compared with adult normal values.[7, 18, 25, 26, 61] As a result, the validity of these 
measurements in children has been questioned.[84] There is still no solid explanation 
why EVLW values are higher in young children. There are 3 possible explanations: (1) the 
greater body water content in young children, although this only explains a small part 
of the higher EVLW[85]; (2) the method of calculation of EVLWI[61, 78]; and (3) younger 
children have relatively more lung tissue mass and less air volume compared with older 
children; the larger tissue volume indicates that there is more interstitial tissue in the 
lung and might result in a larger quantity of fluids (eg, lung water).[57] 
In both adults and children EVLWI is related to disease severity and outcome, 
especially when indexed to predicted body weight instead of actual body weight.
[86-88] Furthermore, EVLWI divided by GEDVI might distinguish between pulmonary 
edema caused by increased capillary permeability or increased hydrostatic pressure.
[89] Therefore, EVLWI might be a useful tool for guiding fluid or diuretic therapy. 
Until the results of a currently executed trial are available, there is only circumstantial 
evidence from adults to support this theory (ClinicalTrials.gov, identifier 
NCT00624650).[90, 91] EVLW could be used as a tool for evaluating therapies for 
reducing pulmonary edema.[92]
The clinical value of lung-water estimation in children is unclear. A recent clinical study in 
a general population of critically ill children that compared EVLWI with a chest radiograph 
score of pulmonary edema revealed no correlation between the two. Also, there was 
no correlation between the PaO2/fraction of inspired oxygen ratio or A–a gradient and 
EVLWI or the chest radiograph score. However, EVLWI was indeed significantly higher in 
younger compared with older children.[26]
Discussion
To date, several advanced hemodynamic parameters in critically ill children are available 
for clinical use. Unfortunately, like in adults, evidence that these devices might reduce 
mortality rates is lacking. However, measurement of CO and venous oximetry have been 
adequately validated and could be incorporated in clinical guidelines. Besides the clinical 
use of the mentioned variables, they can also serve a research purpose for studying, for 
example, the effects of various inotropic agents.
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Many pediatric hemodynamic parameters must be interpreted in relation to age.[93, 94] 
Therefore, normal pediatric values should be adapted accordingly. Until normal values 
for these parameters are established, their use is limited to individual changes in relation 
to interventions or their course over time. Furthermore the relation of organ weight 
and, among others, blood volume with body weight or body surface area changes with 
human growth, which might have important consequences for indexing hemodynamic 
parameters such as lung water or CO.[57] Also, many technologies are not adapted for 
use in children or are still insufficiently validated. Because the pediatric market is less 
commercially interesting, it remains uncertain if these problems will be solved in the 
near future.
Because fluid therapy is the mainstay of hemodynamic treatment in critically ill children, 
the determination of fluid responsiveness seems to be essential.[2, 9] For the majority of 
critically ill children in shock, the initial approach will remain the prompt administration 
of fluid up to 40 mL/ kg.[10, 95] Hereafter, predicting fluid responsiveness could prevent 
fluid overload and its deleterious effects.[11] Therefore, the value of static and dynamic 
parameters in children should be elucidated in the near future.
One should bear in mind that hemodynamic monitoring by itself will never be of 
benefit to critically ill children. The advantageous effects must be the result of correct 
interpretation of monitoring results coupled with a treatment strategy that is beneficial.
[96] As long as it is unknown what the precise effects of certain vasoactive drugs on 
critically ill children are, advanced monitoring will not achieve its maximum beneficial 
effect. However, advanced hemodynamic monitoring is indispensable for evaluating 
these drugs.
Figure 6 serves as an illustration of the interpretation of hemodynamic variables with 
subsequent treatment actions. Other algorithms might also be possible, and some 
patients have both low CO and low blood pressure. Therefore, it is debatable what 
treatment options should be used first. This algorithm can also be used repeatedly 
as long as circulatory conditions require it. Because hemodynamic parameters 
reflect cardiac function and/or blood flow to the whole body, monitoring of specific 
organ oxygenation or microcirculation could be useful. Therefore, 2 technologies 
might become useful in the near future. Near infrared spectroscopy (NIRS) provides 
the clinician with a quantification of tissue oxygenation in the brain or muscle.
[97] More experimentally, microcirculation can be quantified in buccal mucosa by 
using orthogonal polarization spectral imaging or side-stream dark-field imaging.
[98] Because many hemodynamic strategies aim to improve tissue oxygenation, 
both technologies seem rational. However, because these techniques only measure 
microcirculation or oxygenation in a specific organ or part of the body, it is likely 
that they will supplement advanced hemodynamic monitoring but not replace it 
completely.
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Conclusion
Advanced hemodynamic monitoring in pediatric patients is feasible, and many important 
parameters of the circulation can be quantified, which might result in more rational and 
effective hemodynamic treatment protocols. 
Figure 6
Example of a hemodynamic treatment protocol. Note that a low ScvO2 could be replaced by 
a high OER in cases of a low SaO2 (as in right-to-left shunts). Also, the algorithm can be used 
repeatedly as long as there is a need for hemodynamic intervention. PLR indicates Passive 
Leg raising.
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Abstract
Cardiac output (CO) measurement is becoming increasingly important in the field of 
pediatric intensive care medicine and pediatric anesthesia. In the past few decades, 
various new technologies have been developed for the measurement of CO. Some of 
these methods are applicable to pediatric patients and some are already being used 
in children. The devices and methods have their advantages and limitations and, 
therefore, it is difficult for the clinician to decide which technique should be used. This 
article focuses on the currently available minimally invasive and noninvasive monitoring 
devices for CO measurement in children. A brief explanation of the technical aspects 
of each method and clinical use will be followed by the knowledge, gained from infant 
animal and clinical pediatric studies. The goal of this article is to give an update of the 
various CO measurement technologies in children.
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Introduction
Cardiac output (CO) measurement is the cornerstone of advanced hemodynamic 
monitoring and provides invaluable information for the circulatory management 
of critically ill patients. Measurement of CO at the bedside in adults started with the 
introduction of the pulmonary artery catheter (PAC) in 1967.[1] With the PAC, CO can be 
measured by employing the thermodilution technique, but it requires an invasive right-
heart catheterization. The technical aspects and the risks involved make the PAC less 
applicable for children and unsuitable for neonates and young children. As a result, CO 
monitoring and concomitant hemodynamic management evolved strongly in adults, 
while the development in children lagged behind. 
During the last decade more technologies have become available for measurement of 
CO and additional hemodynamic variables. Since the newer methods do not require 
the same degree of invasiveness as the PAC they are called less or minimally invasive. 
However, some of these minimally invasive technologies still need arterial and central 
venous catheters, but by also using these catheters for standard treatment and 
pressure measuring purposes, one has two birds with one stone. The new technologies 
have replaced the need for usage of the invasive PAC for almost all, except some 
specific, clinical indications, such as pulmonary hypertension. Examples of these 
newer technologies are several types of transpulmonary dilution techniques, Doppler 
measurements and arterial pressure curve-based CO estimates. These new devices are 
in part also suitable for measuring CO in young children, first studied a decade ago.[2, 3] 
As a result, hemodynamic monitoring in children is now slowly evolving in the pediatric 
critical care and anesthesia arena. 
One of the problems for the pediatric intensivist and anesthesiologist is to decide 
which technique should be used in pediatric patients.[4, 5] Not all methods are properly 
validated in children, and conclusions of studies, reviews and editorials concerning adult 
hemodynamic monitoring cannot be extrapolated to pediatric patients.[6-13] 
This article gives an update on available technologies of minimally invasive and 
noninvasive CO monitoring in pediatric patients.
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Clinical importance of measuring CO
Cardiac output is the amount of blood pumped by the heart every minute, expressed in 
liters per minute. It is the product of cardiac stroke volume and heart rate. Stroke volume 
is determined by preload, contractility and afterload. Given that children vary widely 
in weight and height, CO is normally indexed to body surface area (l/min/m2), but can 
also be indexed to body weight (l/min/kg). Indexing of CO enables clinicians to compare 
measured CO values between individuals and to established normal values. 
According to Ohms law, blood pressure is related to CO and systemic vascular resistance. 
Therefore, a low blood pressure is the result of a low CO, a low peripheral resistance or both. 
Since blood pressure is essential for the perfusion of organs and tissues, it is maintained 
by several regulating systems in the body, the most important being the baroreflex. 
While blood pressure is important as the driving perfusion pressure, CO is important for 
delivering oxygen to the tissues. This oxygen delivery is reflected by the multiplication 
of CO, hemoglobin level and oxygen saturation. When indicated, CO can be increased by 
various measures, for instance volume therapy to increase preload, vasoactive medication 
to increase contractility and vasodilating agents to decrease systemic vascular resistance. 
Clinical estimation of CO, although still frequently practiced, poorly correlates with the 
true value of CO.[14, 15] Measurement of CO is, therefore, imperative to determine the 
hemodynamic status of the patient, to initiate the appropriate therapy, to follow the 
patient’s response to therapy and, thereby, to prevent organ dysfunction.
 
How to interpret studies comparing different CO techniques
The number of studies validating CO measurement in children is limited and almost 
all include small numbers of patients or animals. Additionally, the methodology varies 
between several studies. To clarify the differences between these studies, we will briefly 
mention two general aspects of the methods used: which reference method is used and 
how the results are analyzed. 
When validating a CO technique, the new technology should be compared with a gold 
standard reference technique. This reference technique should be accurate in measuring 
true values, should have a small variability and should provide reproducible results. 
Finally, the reference method itself should not influence the method being tested. 
To our knowledge, the best in vivo method of measuring CO is the use of ultrasound 
transit-time flow probes. These flow probes should preferably be positioned around the 
pulmonary artery, since positioning the probe around the ascending aorta will result 
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in a CO value not including flow to the coronary arteries.[16] Ultrasound flow probes 
have a documented variability less than 10%, provide real-time continuous CO values 
and do not need calibration. Measured values closely resemble true CO.[17-19] Flow 
probes, being highly invasive, are normally only feasible in animal models. Therefore, 
when studying CO measurements in humans, other less reliable methods are used for 
validation. Comparing CO measuring devices using a less reliable reference method can 
therefore lead to erroneous results.
The clinical standard in adults for measuring CO is the pulmonary artery thermodilution 
(PATD) technique. In pediatric patients, methods such as the Fick technique and 
transpulmonary thermodilution (TPTD) have been regarded as sufficiently precise and 
accurate to act as a clinical gold standard.[3, 20, 21] 
The appropriate statistical analysis for comparing two measurement technologies 
is well described but not always sufficiently practiced. Correlation coefficient and 
regression analyses are inappropriate statistical techniques for comparing two methods 
measuring the same physiological variable, such as CO. In 1986 Bland and Altman 
proposed a new statistical method.[22] This method delivers graphical information in 
which the difference between the two methods is plotted against the mean values of 
the two methods. Using this statistical analysis, the agreement between two methods is 
quantified by calculating bias, limits of agreement and percentage error. The bias is the 
mean difference between the two methods, while the limits of agreement are calculated 
by multiplying the standard deviation of the difference between the methods by 1.96. 
The limits of agreement reflect the boundaries between 95% of all measurement values 
that are positioned in the plot.
Additionally, Critchley and Critchley recommended using the percentage error to 
compensate for the relationship between the magnitude of CO measurements and the 
size of the error, especially important for pediatric patients, who have lower absolute CO 
values compared with adults.[23] 
The percentage error can be calculated by taking the percentage of the limits of 
agreement in relation to the mean CO measurement value of the reference technique. 
The percentage error can be used as cutoff value for accepting a new technique. 
The basis of this approach is that, in order to accept the new technology, the level of 
accuracy and precision should be at least equal to the reference technique. They suggest 
acceptance of a new method judged against the ±20% precision of the reference 
method and consequently accept the percentage of error of agreement between the 
new and the reference technique of up to ±30%. This shows that the precision of the 
reference technique is extremely important when assessing the combined error of the 
two. Therefore, the precision of the reference method should always be mentioned and 
any validation study should start with a definition of acceptable percentage error (using 
the error-gram of Critchley and Critchley) prior to the data analyses.[23, 24] 
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By using the method proposed by Critchley and Critchley in pediatric studies there 
might be an important drawback. The percentage error is calculated by using the 
mean of a range of absolute CO values. When the limits of agreement (e.g., the errors 
in measurement) are proportional to the mean CO value, the percentage error will be 
comparable between high and low CO samples. For instance, in comparing a pediatric 
and an adult study validating the transpulmonary thermodilution technique, the mean 
CO value was 2.55 l/min in the pediatric study and 8.8 l/min in the adult study. The 
limits of agreement were 0.49 l/min in the pediatric and 2.2 l/min in the adult study.[3, 
25] Thus, the percentage error was even smaller in the pediatric study. However, due 
to technical reasons, errors in the measurement may also have an absolute character 
and may not solely be proportional to the measured value. In these cases, the limits 
of agreement would be relatively larger compared with the mean value, resulting in a 
larger percentage error in subjects with lesser weight or lesser size.
Besides analyzing the accuracy of a new technique to reflect absolute values of CO, the 
ability to track directional changes should be carefully studied.[26] This is becoming more 
important since changes in CO as a result of therapeutic interventions are frequently 
considered more valuable than single measurements. 
Indicator dilution methods
Indicator dilution methods are based on measuring the change of concentration over 
time of an indicator at a point downstream following a venous injection. In doing so, 
the flow is inversely proportional to the area under the concentration–time curve for the 
indicator as shown in the Stewart–Hamilton equation: 
Flow = mass of indicator / ∫C(t) x dt
Indicator dilution methods, regardless of what indicator is used, have to fulfill the following 
conditions: constant blood flow, no or minimal loss of indicator between injection and 
detection point, complete mixing of the indicator with blood and the indicator must 
pass the detection point only once.[27] Almost all indicator dilution methods require a 
central venous catheter and an arterial catheter. Sequential injections of the indicator are 
performed as soon as the dilution curve is back to baseline. This prevents recirculation 
bias between separate measurements. During a single thermodilution, the dilution curve 
is interrupted at the downslope part based upon a specific algorithm to prevent the 
effects of recirculation.[28] Subsequently, the curve is extrapolated from the interrupted 
point to the baseline in order to calculate the area under the curve (AUC).[29, 30]
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Transpulmonary thermodilution CO
The TPTD technique uses thermal energy as an indicator. In contrast to PATD, the 
transpulmonary approach uses a large (mostly femoral) systemic artery in which the 
temperature change is detected. Since TPTD does not require the insertion of the 
pulmonary artery catheter, this method is considered ‘less invasive’. Moreover, no extra 
catheters have to be inserted because this special thermistor-equipped arterial catheter 
can also be used as an arterial catheter for continuous blood pressure measurement 
and blood sample drawing. A central venous catheter for the injection of an ice-cold 
indicator is needed, but is often already employed in patients where CO monitoring is 
indicated. The minimum size of the thermistor tipped arterial catheter is 3-French, which 
makes it accessible for infants weighing as little as 3.5 kg.[31, 32] Furthermore, a special 
device is needed to compute the measured values pulse-contour CO (pulse-induced 
contour CO; PiCCO™) (Table 1). 
Several pediatric or juvenile animal studies showed TPTD to be a reliable technique for CO 
measurement. Lemson et al. validated TPTD CO measurements, with ultrasound perivascular 
flow probes serving as the standard reference, under various hemodynamic conditions.[20] 
The study was performed in newborn lambs as a surrogate for infants. CO measurement was 
also reliable in a low CO state with a percentage error of ±14.7%. Besides measuring absolute 
values, the TPTD method was also reliably capable of tracking changes in CO. Ruperez et 
al. compared TPTD with PATD in juvenile animals and demonstrated moderate agreement 
(percentage error of ±33%).[33] Clinical pediatric studies demonstrated the mean of a series 
of three TPTD measurements, spread randomly over the respiratory cycle, to be a reliable 
and validated method for estimating CO in children.[34] Pauli et al. used the direct Fick 
method as the clinical reference standard and found a percentage error of ±11%. Other 
pediatric clinical studies used the indirect Fick method (indirect calorimetry) and PATD as a 
reference method for CO measurements.[2, 3] They demonstrated acceptable agreement 
(Table 2). In addition, these studies confirmed that TPTD slightly overestimates CO. In 
conclusion, the TPTD appears to be accurate and can be considered as a reference standard 
for CO measurement in children.[21] In the presence of cardiac shunts, the PiCCOplus 
device is capable of detecting and quantifying right-to-left shunts (Pulsion Company. 
PiCCO operational manual, software version 7.0, part 8.4.5. 2005). However, validation of 
this method has not been published and the method has not been incorporated in the 
successor of this device. Studies on the reliability of thermodilution CO measurement in the 
presence of left-to-right shunts are not conclusive.[35, 36] 
Besides CO measurement, the TPTD technique also allows for assessment of global end 
diastolic volume and extravascular lung water. Global end diastolic volume is related 
to preload and extravascular lung water is a quantification of pulmonary edema.[37, 
38] The results of intrathoracic and intracardiac volumes and extravascular lung water 
volume in juvenile animals and children are different from adult reference values.[39, 40] 
Further studies are needed to define normal values in the pediatric range and clarify the 
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clinical value of these measurements.[39-42] When using the PiCCO device, additional 
continuous CO measurement is possible using pulse contour analysis (see later).
When using the TPTD technology some points are of importance. A femoral venous 
catheter can be used for indicator injection.[27, 39, 43] However, the use of venous and 
arterial femoral catheters on the same side of the body and of the same length should be 
avoided. Local extravascular distribution of the thermal indicator can reach the arterial 
thermistor before the temperature change by blood does. This phenomenon is called 
‘crosstalk’ and is blood-flow dependent.[44, 45] Finally, the absolute values of CO are 
always slightly, but consistently, overestimated because of temperature loss.
Lithium dilution CO
The transpulmonary lithium dilution CO method (TPLD) uses an isotonic solution of 
lithium chloride (LiCl) as the indicator and requires a venous and arterial catheter, usually 
already in place, and a specially developed lithium sensor.[46] After venous injection 
of LiCl, arterial blood is withdrawn by means of a mechanical device through a lithium 
sensor, and CO is derived from the lithium concentration–time curve. Each measurement 
requires approximately 3 ml of blood. The sensor consists of a lithium-selective electrode. 
When the lithium-selective membrane is in contact with blood, the voltage across it is 
related to plasma lithium concentration following the Nernst equation together with a 
correction for plasma sodium concentration. The TPLD technique is incorporated in the 
lithium dilution CO (LiDCO™) device (see Table 1).
There is currently one study in pediatric patients validating TPLD CO measurements. 
Using TPTD as the reference technique, the results demonstrate its safety and feasibility 
in patients who weigh as little as 2.6 kg. From the data the percentage error could be 
recalculated, which was quite acceptable (±32%) with a percentage of the bias of 5%.[47] 
The TPLD method does not require a special arterial or venous catheter. Like the PiCCO, 
the LiDCO device offers the advantage of continuously monitoring CO using an arterial 
pressure-based CO technique (see later). Several points should be considered. Each 
measurement takes approximately 3 ml of blood, which is a significant amount for small 
infants. Since the mean of two to three measurements is needed, this would take up to 
10 ml of blood loss for each CO measurement, which is not acceptable for small children. 
TPLD cannot be used in the presence of some non-depolarizing neuromuscular blocking 
agents and the baseline lithium level at the start of the measurement should not exceed 
0.2 mEq/l.[48] The current intravenous LiCl dose recommendation for adults is 0.15 
mmol for every single CO measurement, with a maximum cumulative dose of 3 mmol. 
The dose used in children for a single CO measurement is 0.002–0.009 mmol/kg, which 
has no known pharmacological effect.[48, 49] In some countries, the use of LiCl as an 
indicator is prohibited by law, and the device has not yet acquired a US FDA registration 
for children weighing less than 40 kg.
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Pulse dye densitometry
With pulsed dye densitometry, intermittent CO measurements can be obtained at the 
bedside by using a finger or nose clip device and a dye densitogram analyzer (DDG2001 
analyzer, see table 1). 
Table 1
Devices for measuring cardiac output in children
+ and - symbols represent the degree of invasiveness or reliability (e.g., +++ = reliable or 
invasive, - = not invasive or less reliable).
AC = arterial catheter; APCCO = arterial pressure based continuous cardiac output; CVC = 
central venous catheter; PDD = pulse dye densitrometry; PVC = peripheral venous catheter; 
TPTD = transpulmonary thermodilution; TPUD = transpulmonary ultrasounddilution.
Name 
(Manufacturer)
Technology Invasiveness Equipment Reliability 
in children
Remarks
PiCCO 
(Pulsion, Munich, 
Germany)
TPTD +
APCCO
+++ special 
AC + CVC
+++ Multiple hemodynamic
parameters, continuous, 
gold standard in children
LidCO 
(LidCO, London, 
UK)
TPLD + 
APCCO
++ AC + CVC
or PVC
+++ Continuous, requires 
injection of lithium, 
not for children < 40 kg
DDG 
2001 analyzer (Nihon
Kohden, Tokyo, Japan)
PDD +/- PVC
Finger/
nose clip
? Non-invasive, intermittent, 
no validation in children
COstatus 
(Transonic, Ithaca, USA)
TPUD +++ AC + CVC ? Intermittent, 
no validation in children
Flowtrac/Vigileo
Edwards  Lifesciences,
Irvine, USA)
APCCO + AC ? Continuous, calibration 
not possible. 
No validation in children
MostCare 
(Vytech, Padova, Italy)
APCCO + AC +/- Continuous, 
calibration not possible 
CardioQP 
(Deltex, Chichester, 
UK )
Oesophageal 
doppler
+/- oesopagus 
probe
+/- No intravascular 
catheters needed. 
difficult in small children
USCOM 
(Uscom, Sydney, 
Australia)
Trans-
cutaneous
Doppler
- external 
doppler
probe
+/- Non-invasive, intermittent,
operator dependent
NICO2 
(Respironics, Paris,
France)
CO2 
Fick 
rebreathing
+/- endo-
tracheal 
tube
? Non-invasive, only in 
intubated patients with 
Tv > 300 ml
Aesculon 
(Osypka medical,
Berlin, Germany)
Electrical
impedance
cardiometry
- surface
electrodes
+/- Non-invasive, continuous
NICOM 
(Cheetah Medical, 
Tel Aviv, Israel)
bioreactance - surface
electrodes
? Non-invasive, continuous
Nexfin 
(BMEYE, Amsterdam,  
Netherlands)
APCCO - finger cuff ? Non-invasive, also measures
continuous blood pressure, 
no calibration incorporated, 
not for small children
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This technique is based on a dye (indocyanine green) dilution technique with a 
transcutaneous signal detection adapted from pulse oximetry.[50] In contrast to the 
conventional dye dilution method, this technique does not require blood sampling 
after the venous injection of indocyanine green. CO and circulating blood volume can 
be calculated by analyzing the pulsatile change in indocyanine green concentration in 
the arterial blood by placing a probe over arterial vessels. Appropriate signal detection 
is mandatory and high heart rate, poor peripheral circulation, interstitial edema and 
movement artifacts negatively influence this. 
Studies in adults are limited, and recent data regarding reproducibility and validity of the 
pulsed dye densitometry method are conflicting.[51-53] Although the first (experimental) 
studies in pediatric animals and patients applying blood volume and CO measurements 
are published, the technique has not been validated.[54-57] The applicability in clinical 
practice is, therefore, as yet unknown.
Ultrasound dilution method
The ultrasound dilution technology was first introduced in adult patients during 
hemodialysis and is still under development. The method uses an extracorporeal 
arterial–venous tubing loop, connected to existing intravascular central venous 
and arterial catheters, in which the indicator is injected. A roller pump provides a 
constant blood flow through the loop and the system needs to be primed once at the 
beginning of every series of CO measurements. Normal isotonic saline, heated to body 
temperature, is used as the indicator. The difference of velocity of ultrasound between 
blood and isotonic saline induces a decrease in ultrasound velocity, which is used to 
obtain a dilution curve.[58] The average of two to three consecutive injections spread 
randomly over the respiratory cycle is advised for obtaining an accurate value of CO.[59] 
The volume of the injectate is 0.5 ml/kg, with a maximum of 30 ml. Operator errors are 
reduced because flow sensors measure exactly the injectate volume, whereas dilution 
sensors in the arterial part measure ultrasound velocity. 
The technique was accurate and precise in the CO range of less than 1.5 l/min in a piglet 
study.[59] The first data of pediatric use are available, but more human studies are 
needed to further assess the reliability of this method in various clinical situations for 
infants and children.[60]
The use of a nontoxic, low volume and warmed injectate makes it attractive for infants 
and children, as well as for patients who are at risk for fluid overload. As with the TPTD 
technique, this method also provides static hemodynamic variables, such as central 
blood volume, total end-diastolic volume and active circulation volume, for all of which 
the clinical utility has yet to be evaluated.
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Arterial pressure-based CO measurement
Arterial pressure-based continuous CO measurement (APCCO) converts the arterial 
pressure wave into CO. It is based upon the principle that the stroke volume of one 
heartbeat generates a corresponding arterial pressure wave. Using an APCCO method, 
the pressure wave is converted back into stroke volume. 
Several different algorithms for converting the pressure waveform to stroke volume exist; 
different methods are also employed for taking the mean value of several heartbeats 
and for converting stroke volume to CO.[61] Several facts regarding the APCCO 
systems for use in children are of importance. First, the pressure waveform is largely 
dependent on the Windkessel function of the aorta. This function is influenced by the 
aortic compliance, which changes over time due to patient-related factors, but also by 
changes in blood pressure itself. Second, the arterial pressure waveform changes from 
central (aorta) to peripheral (radial) positions. In general, the systolic pressure increases 
and the diastolic pressure decreases going downstream, while the mean pressure 
remains the same as a result of the reflection of the arterial waveform. This effect is also 
dependent on patient-related (static) factors, such as age and medication (dynamic), 
by influencing vascular tone. Third, these systems have to rely on an optimal arterial 
pressure waveform. Therefore, an optimal arterial pressure transducing system has to 
be used with low compliant tubing, fast-reacting pressure heads and careful calibration. 
Especially in small children, kinking of catheters, damped waveforms and movement 
artifacts often exist due to the small size of the arterial catheters in these patients. 
Fourth, cardiac rhythm disturbances will influence these systems. Fifth, all algorithms 
used are designed for adults and do not address specific vascular properties that are 
applicable to a growing and developing vascular system.[62] Owing to these variables, it 
is challenging to measure CO reliably by only converting an arterial waveform to volume 
without knowing the individual patient-related factors.
The available APCCO systems are PiCCO, PulseCO (LiDCO), FloTrac/Vigileo™ system, 
pressure recording analytical method (PRAM; MostCare®) and Nexfin (formerly 
Modelflow) (Table 1). They all use their own specific algorithms and methods for 
converting the pressure wave to volume. Pulse-contour and pulse CO use a second CO 
technique for calibration. The FloTrac/Vigileo system uses a stored database of many 
patients as reference for calibration. The other systems (PRAM, Nexfin) are independent 
of patient characteristics or calibration. The systems incorporating a second calibrating 
CO measuring technique have the advantage over other methods that they also 
provide volumetric data, which may be helpful in targeting fluid therapy. However, the 
techniques used for calibration have their own (technical) limitations.
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Pulse-contour
The pulse-contour analysis of the PiCCO system requires an initial calibration using TPTD. 
Furthermore, periodic recalibration is necessary on a regular basis, at least every 8 h, or 
more frequently when patient-related factors change.[63, 64] 
Lopez-Herce et al. studied the correlation between CO measured by TPTD and PiCCO in an 
infant animal model.[65] Based on the correlation coefficient, the authors concluded that 
there was a good agreement, but on recalculating the percentage error (±63%) the method 
should have been rejected. Piehl et al. demonstrated in a piglet hemorrhagic shock model a 
percentage error of 11% between PiCCO and PATD under stable hemodynamic conditions.
[66] On the other hand, PiCCO’s utility in the setting of rapidly changing hemodynamics 
was limited unless recalibration with TPTD was frequently performed.
A study in pediatric cardiac surgery patients showed no good agreement (percentage 
error ±54%) between CO measured by TPTD compared with PiCCO.[67] Part of the 
explanation is found in their study population. Some patients had intracardiac shunts 
and valvular diseases, which makes both CO measurement techniques unreliable. 
However, the weak agreement persisted even after the congenital defects were 
corrected. From another pediatric study, the results for accuracy and precision cannot 
be reliably recalculated.[68] 
In our opinion, the pulse-contour analysis algorithm has to been refined, especially for 
use in pediatric patients and in changing hemodynamic conditions. The small patient size 
with small absolute CO values, very high heart rates, abrupt changes in blood pressure 
and the greater compliance of the child’s aorta, affects the accuracy and precision of 
PiCCO analysis. Therefore, using the PiCCO system in children, the continuous pulse-
contour system can be used as a rough estimate of CO. However, important therapeutic 
decisions should be based on the more reliable TPTD CO measurements.
PulseCO
The PulseCO method, incorporated in the LiDCO device, converts the arterial waveform 
to a nominal stroke volume using a pressure-volume transformation.[48] By using the 
entire pressure waveform rather than just the systolic portion of the curve, the PulseCO 
system incorporates the influence of peripheral resistance and the reflected wave from 
the periphery. The CO estimations are periodically calibrated by the TPLD technique, 
comparable to the pulse-contour method. 
The method has been validated in a pediatric study comparing pulse CO against PATD 
under hemodynamically stable conditions.[69] This resulted in very precise (percentage 
error of 8.8%) and accurate (relative bias 6%) measurements. The method seems 
promising, but further studies under various hemodynamic conditions are warranted. 
Like the PiCCO system, the accuracy and precision are dependent on the frequency 
of recalibration. Also with this method, we would like to advise that important clinical 
decisions are based upon the more reliable TPLD technique.
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FloTrac/Vigileo system
The FloTrac/Vigileo system is a CO-monitoring system based on analysis of the systemic 
arterial pressure wave, which does not require calibration. The stroke volume is derived 
by the application of a proprietary algorithm, using the patient’s vascular resistance 
and arterial compliance based on sex, height, weight and age, and the pulse pressure 
waveform characteristics.[70] The pulsatility is derived from continuous analysis of the 
shape of the arterial pressure waveform. The technique involves determination of the 
area under the arterial pressure curve, thus quantifying the relationship between the 
amount of blood flow and the pressure wave associated with it. This relationship can vary 
widely from one individual to another, but also in a single individual as clinical conditions 
change. By using the aforementioned system, the second-generation operating FloTrac/
Vigileo system recalculates its calibration constant every 60 s and does not provide a 
beat-to-beat CO result. 
Contradictory results have been obtained in adult, hemodynamically unstable patients.
[71-73] However, the algorithm has been modified, which may improve the reliability 
of the device.[74] Arterial wave artifacts, aortic regurgitation and an irregular pulse 
influence the measurements unfavorably. As far as we know, no pediatric or infant 
animal studies have been published using this method.
PRAM
The pressure recording analytical method analyzes the systemic arterial pressure 
waveform morphology.[75] The results of this beat-to-beat analysis allow for 
determination of the stroke volume, which provides CO by multiplying stroke volume by 
heart rate. This recently developed method has been studied in children by Calamandrei 
et al.[76] The PRAM CO measurements were compared with transthoracic Doppler 
echocardiographic measurements. Recalculation of their data shows a percentage error 
of 20.3%. The method may be valuable in pediatric patients, but more clinical validation 
studies are warranted.
Ultrasound techniques
Transthoracic echocardiography
Transthoracic echocardiographic assessment of CO can be divided into volumetric and 
Doppler-based methods.[77, 78] Using volumetric measurements of the left ventricular 
volume performed at the end systolic and end diastolic phase, the stroke volume (end-
diastolic minus end-systolic volume), and hence the stroke volume, can be estimated.[79]
The two main limitations of this volumetric method are resolution and geometry.[80] The 
resolution of echocardiography is approximately 1 mm.[77] But a variation of 1 mm in the 
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size of the ventricle radius of an infant heart can influence the stroke volume estimation 
to an important extent. The geometric limitations rely on the assumptions of circular 
or elliptical shape of the ventricles and on the uniform contractions of the ventricles. In 
clinical practice, this is often not the case.
Doppler-based methods require accurate measurement of the pulmonary or aortic valve 
annulus and the velocity profile of systolic flow through the valve.[81] The velocity–time 
integral is known as stroke distance, which is the distance that a column of blood will 
travel along the aorta in one cardiac cycle. Stroke distance can be converted to stroke 
volume, and hence CO. The major difficulty is the measurement of the aortic dimensions 
for the calculation of the cross-sectional area. This may cause large variations in CO data 
between the reference method and Doppler echocardiography.[82]
Both these techniques require training in echocardiography, which makes it less 
useful to many intensive care unit practitioners. Another problem is the need for 
the constant realignment of handheld probes. On the other hand, transthoracic 
echocardiography supplies a vast amount of functional, morphological and thus 
diagnostic information, including indices of diastolic dysfunction, regional wall 
abnormalities, valve regurgitation, pericardial effusion, chamber dilatation, cardiac 
chamber interdependence, systemic and pulmonary blood flow (Qp/Qs ratio), superior 
caval vein flow (neonates) and organ flow.
Lu et al. evaluated the accuracy, reproducibility and efficacy of various methods of 
volumetric echocardiographic assessment of left ventricular indices in children. In 
this study, M-mode, 2D and 3D echocardiographic algorithms were compared with 
cardiac magnetic resonance measurements. The 3D echocardiography was superior 
to the other methods in accuracy and reproducibility for quantification of the LV 
indices in children.[80] Chew et al. published a 20-year literature review for Doppler CO 
measurement in children, focusing on its reliability, bias and precision in comparison to 
standard reference methods such as thermodilution, dye dilution and Fick techniques.
[82] They concluded that Doppler CO measurements are reasonably precise, with a 
percentage error of ±30% and a percentage bias of less than 10% (range: -37–16%) 
in the majority of studies. However these results are operator and thus experience 
dependent.
Echocardiographic estimation of CO in the intensive care unit has several limitations, 
such as technical problems, examiner variability and costs. Furthermore, transthoracic 
echocardiography is, by definition, a non-continuous measure of cardiac function 
and filling status, and not useful as a trend monitor over hours and days. As such, 
echocardiography cannot be considered to be a CO monitoring device. However, it is 
has become an indispensable diagnostic tool for critically ill adults and children in many 
intensive care units.
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Transesophageal Doppler ultrasound method
The transesophageal Doppler ultrasound technique (TED) measures the descending 
aortic blood velocity. The Doppler probe is positioned in the esophagus at the 
midthoracic level and placed in the direction of flow in a blind fashion and is 
subsequently adjusted to obtain the optimal Doppler signal.[83] Murdoch and Tibby 
derived blood flow velocity in mechanically ventilated children in the descending 
aorta without the need for direct aortic cross-sectional area measurement, which 
is a major source of error of Doppler flow measurement.[84, 85] They used signal 
minute distance as a surrogate for CO, which is a time–velocity integral multiplied 
by heart rate. Compared with the TPTD technique, in both studies the signal minute 
distance was able to track changes in CO under various hemodynamic conditions. This 
property makes TED a very useful method for guiding fluid management in children.
[86] However, percentage error could not be recalculated from their data for CO 
measurements. Mohan et al. studied tracking changes in CO with suprasternal Doppler 
ultrasound and TED in children.[87] Their data support that TED seems to be a clinically 
useful tool in monitoring trends in CO. Chew et al. reviewed several pediatric studies of 
ultrasound Doppler CO measurement, and concluded that transesophageal Doppler 
measurements seem to be more reproducible than transthoracic echocardiography, 
with an interobserver repeatability of 2.5–8% and an intraobserver repeatability of 
±3%.[82] Schubert et al. compared TED (CardioQP™; see Table 1) with transthoracic 
echocardiography for CO measurement in postcardiac surgery infants and children.
[88] TED seemed to underestimate CO and recalculation of the percentage error 
resulted in an unacceptably high value of ±78%. The Working Group on Noninvasive 
Haemodynamic Monitoring in Pediatrics compared the CardioQP™ esophageal 
Doppler technique in children during heart catheterization with the PATD method.
[89] They conclude that CO values cannot be reliable measured with the CardioQP™ 
calculating a percentage error of ±54%.
Technical aspects, such as probe size, fixation and patient tolerance, are limitations for 
the use of TED. With the provision of special pediatric probes, the technique seems safe 
for children and infants.[88] On the other hand, in small children it is difficult to position 
the Doppler probe optimally and, owing to its size, the probe cannot be left in place for 
a long period of time in small children. Furthermore, the nasogastric tube can negatively 
influence the quality of the obtained signal. The absolute CO measurements should not 
be interpreted, as they almost always underestimate the true value. This can be explained 
by the assumption that the insonation angle (the angle between the ultrasound beam 
and the aortic blood flow) is supposed to be approximately the same as the fixed angle 
between the probe and the transducer. Even small deviations of the actual from the 
assumed angle will result in erroneous velocity calculations, because of the nonlinear 
character of the cosine function in the Doppler equation.[90]
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Continuous wave Doppler ultrasound 
The ultrasonic CO monitor (USCOM) (see Table 1) is a new, easy to handle portable 
apparatus for measuring CO. It provides a transcutaneous CO measurement based 
upon continuous wave Doppler ultrasound. The Doppler flow is measured using a 
handheld probe positioned on the thorax. A nomogram, based on the subject’s height, 
incorporated into the software, estimates the valve cross-sectional area, so that the CO 
can be calculated from the measured flow across the aortic or pulmonary valve.[91-94]
The reliability found in animal studies compared with ultrasound flow probes around the 
ascending aorta were acceptable, with a percentage error of 13%.[95] It has been used 
in adults, as well as in children and neonates, for assessment of serial CO measurements 
and changes in CO. The only validation study in children has been performed by Knirsch 
et al. against the PATD.[91] With a percentage error of ±36%, they concluded that the 
USCOM does not reliably represent absolute CO measurements compared with PATD. 
A pilot study in healthy newborns and preterm neonates showed a good inter-operator 
(rater) agreement.[92] The study of Phillips et al., comparing USCOM versus 2D echo 
Doppler in 37 preterm neonates, showed good agreement between the two intermittent 
CO measurement methods.[96]
The USCOM CO measurements are rather dependent on the skills of the operator 
and on the quality of the Doppler flow signal. The nomogram-based estimates of the 
cross-sectional area of the aorta and pulmonary values are bound to introduce some 
systematic error into the measurement of CO in the clinical setting. The validity of this 
technique requires further studies. Its clinical use seems especially beneficial in settings 
of emergencies for a quick and global estimation of CO.
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Fick principle technique
The direct oxygen Fick method is a gold standard for the measurement of CO. The Fick 
equation relates CO to oxygen consumption and the arterial–venous oxygen content 
difference[3, 97, 98]:
CO = VO2/(CaO2–CvO2) 
where VO2 is oxygen consumption; CaO2 is arterial oxygen content; and CvO2 is mixed 
venous oxygen content. However, this method requires the precise and simultaneous 
measurement of VO2 (using calorimetry), hemoglobin level and arterial and mixed 
venous oxygen saturation. This renders the method not practical for bedside 
measurement. 
The equation may also be modified using carbon dioxide (CO2) elimination and the 
difference between the venous and arterial CO2 blood content. The NICO2TM monitor 
(see Table 1), designed for CO measurement, utilizes the indirect Fick principle for CO2, 
based on a partial rebreathing method, which obviates the need to measure CO2 in the 
blood stream.[99-101] However, this technique needs further adjustments for use in 
younger children and is dependent on the assumed amount of pulmonary shunt.[99, 
102] One of the major disadvantages of this Fick derived method is that the measurement 
of CO requires a period of steady state. Furthermore, its use is restricted because of the 
many potential technical problems, such as sampling, air leak, high inspiratory oxygen 
concentrations and death space. Currently, it can only be used in patients ventilated with 
tidal volumes more than 300 ml. Consequently, the technique is often not applicable in 
critically ill patients who require extreme ventilatory conditions, using high fractions of 
inspired oxygen. The technique will also fail in conditions that affect the intra alveolar 
distribution of the gas, for instance in the presence of severe interstitial or obstructive 
lung disease.[12]
Besides the rebreathing CO2 Fick method, a modified CO2 Fick method is also applicable 
in children. Like the oxygen Fick method, it requires arterial and central venous blood 
sampling. Instead of determination of VO2, VCO2 measurement is necessary. VCO2 can 
be measured using volumetric capnography. Although reliable, this technique is still 
complicated and shares many disadvantages with the oxygen Fick method, but it has 
the advantage of being validated in small subjects.[103] 
Bio-impedance techniques
The noninvasive thoracic bio-impedance technique for measuring CO was introduced 
more than 40 years ago with impedance cardiography.[104] In the last decades two 
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successors of the impedance cardiography technology have been developed: electrical 
velocimetry (EV) and bioreactance.
The first method relates the maximum rate of change of thoracic electrical impedance 
to peak aortic blood acceleration, and derives the mean aortic blood velocity using a 
transformation.[105] This technique measures changes in the transthoracic impedance 
during cardiac ejection caused by volumetric changes of the aorta and by conductivity 
changes of the blood in the aorta. The basic equation of the algorithm, in contrast to 
former approaches, focuses on the compartment with the greatest contributing factor 
to conductivity changes, being the blood in the aorta. Minor changes in high-resistance 
low-conductivity compartments, such as the lung, gas and surrounding tissues, are 
neglected. This technique requires four disposable surface electrodes, two placed at the 
left side of the neck and two placed on the left lateral side of the thorax at the level of 
the xiphoid process. The device emits a small sinusoidal, low current (2 mA) with high 
frequency (50 kHz) through two electrodes on both sides. The other two electrodes 
record the thoracic electrical bio-impedance (Z). Changes of the basic impedance are 
averaged over ten cardiac cycles. The first study to validate EV in an infant-simulated 
model, was a piglet study comparing CO measurements of EV with TPTD under 
various hemodynamic conditions.[106] Although the EV method could track changes 
of more than 15% in CO, the percentage error was markedly higher (83%), which they 
attributed to the morphology differences between humans and piglets. Four human 
studies have been published in pediatric patients since the commercial availability of 
the Aesculon® (see Table 1). Tomaske et al. compared EV with PATD in pediatric patients 
with congenital heart disease without shunts, under hemodynamic stable conditions.
[107] They could not assess reliable CO measurements with EV and found a percentage 
error of ±44%. Recently, the same group published a similar study, this time comparing 
CO measurements of EV with transthoracic echocardiographic Doppler flow.[108] Again, 
agreement between the two methods was low. Two other clinical studies also showed 
an unacceptable percentage error.[88, 109]
Although the EV method is potentially attractive, being noninvasive, continuous and easily 
applicable, at this stage it cannot be used in clinical practice for reliable measurement of 
absolute CO values in children. New approaches for optimizing electrode position on the 
patient’s surface have been suggested for improvement.
Bioreactance, the second technique, is the analysis of the variation in the frequency 
spectra of a delivered oscillating current that occurs when the current traverses the 
thoracic cavity. This is different from the traditional bioimpedance technique that 
analyses only the changes in signal amplitude. Although promising results in adults have 
been published, there are currently no pediatric data available.[91, 110-112]
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Noninvasive continuous finger arterial pressure 
& CO monitoring
Blood pressure and CO can be obtained using a continuous, noninvasive, finger arterial 
pressure measurement technique. This method requires an inflatable finger cuff that 
incorporates a photoplethysmographic sensor, a rapid-reacting pneumatic servo system 
and a special device (Nexfin; see Table 1). This method is based upon the vascular clamp 
principle of Penaz and is the successor of the former Finapres device.[113-115]
In short, the plethysmographic signal drives the servo system in a way that the finger 
arterial wall is constantly kept unloaded. Thereby, the cuff pressure is a reflection of the 
finger arterial pressure. After application of a software algorithm, a brachial pressure 
curve is generated.[116] The blood pressure measurement is reliable and complies 
with the Association for the Advancement of Medical Instrumentation standards in 
adults[117-119]. In children, a beta-type device has been shown to be feasible and 
accurate in measuring blood pressure.[120-122] 
The Nexfin device incorporates an APCCO method that can be applied to the arterial 
waveform from the finger artery. Patient parameters (weight, length, gender, age) are 
needed to track changes in CO more reliable. Using a separate calibration method is 
possible but is not required. This continuous noninvasive CO method has only been 
studied in adults so far, and has shown been to be reasonably accurate.[123-127] At 
present, only finger cuffs for children from 6 to 8 years of age are commercially available. 
Application for younger children will be available in the future.
Expert commentary
The ideal CO monitor should be accurate, reproducible, continuous, noninvasive, easy 
to apply, operator-independent, cost effective and should have a rapid response time 
(beat-to-beat) (4). Unfortunately, no such technique exists for CO measurement in either 
pediatric or adult practice. 
In this article, we discussed the available CO monitoring devices that are currently 
available and, in part, applicable in pediatric patients. The choice is mainly determined 
by the clinical indication and situation. Thereafter, the balance between invasiveness, 
risks, instrumentation, user expertise and additional parameters that can be collected, 
together with cost, will finally be decisive. In choosing a device the physician should 
consider the following three questions: is a reliable absolute measurement of CO 
required or is tracking changes more appropriate? In the first case a more invasive 
approach is required. In the latter, a continuous technique should be applied. Is an 
invasive measurement feasible or does the clinical situation require noninvasiveness? 
When noninvasiveness is required, the physician should be aware that the obtained 
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results are often less reproducible. Are other hemodynamic measurements also required 
(such as extravascular lung water or arterial pressure variations)? 
In clinical practice, invasive dilution techniques should be considered for hemodynamic 
monitoring of septic and other (postoperative) circulatory compromised pediatric 
patients during pediatric intensive care unit treatment. The CO value may help the 
clinician to guide inotropic, vasopressor or fluid therapy. In the setting of perioperative 
hemodynamic monitoring, continuous CO measurement, such as an APCCO method or 
TED, is probably more convenient. Tracking changes in these situations is particularly 
informative and in some systems there is no need for intermittent recalibrations. 
Noninvasive methods, such as echocardiography and other ultrasound techniques, 
can be very useful in the first phase of treatment of an acute patient, because it can be 
available quickly and can guide the direction of treatment in the first phase. Depending 
on the severity of the circulatory insufficiency, continuous and more invasive monitoring 
should be considered thereafter.
In general, a more invasive technique produces a more reliable absolute measurement. 
Most importantly, the physician should have the knowledge of the technical background 
and pitfalls that are associated with the use of the chosen technology. 
Five-year view
Data from adult studies cannot be extrapolated to small children. More research is 
needed to further adapt algorithms and technologies for the pediatric population. 
Unfortunately, industrial interest is generally directed towards adult critical care medicine 
and anesthesiology. Besides that, technical difficulties and ethical constraints to perform 
clinical validation studies in children also play a role. We believe that the combination of 
transthoracic echocardiography and a fast and continuous CO monitoring technology 
(with or without calibration) will be the most ideal combination in the near future. 
With every new device comes the need for validation and evaluation of its usefulness 
in the clinical setting. In this regard there is a growing need for standardized validation 
methods for CO monitoring tools. 
Besides validation studies, randomized trials of CO guided hemodynamic therapy should 
demonstrate whether CO monitoring is a useful adjunct to the existing clinical arsenal 
with respect to morbidity and mortality in critically ill children. 
Key issues
•  Measurement of cardiac output (CO) is imperative to determine the hemodynamic 
status of the patient, to initiate the appropriate therapy, to subsequently follow 
the patient’s response to instituted therapies and thereby trying to prevent organ 
dysfunction. 
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• In the last decade, more technologies have become available for measurement of 
CO, in part applicable in pediatric patients. As a result hemodynamic monitoring in 
children is now slowly evolving in the pediatric critical care and anesthesia area.
•  The ideal CO monitor does not exist.
•  The choice of CO measuring device in children is mainly determined by the clinical 
indication and situation. Thereafter, the balance between invasiveness, risks, 
instrumentation, user expertise, additional parameters that can be collected and 
costs will finally be decisive.
• More research is needed to further adapt algorithms and technologies for the pediatric 
population. 
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Abstract
Background 
The transpulmonary thermodilution technique for measuring cardiac output has never 
been validated in the presence of a left-to-right shunt.
Methods
In this experimental, pediatric animal model nine lambs with a surgically constructed 
aorta-pulmonary left-to-right shunt were studied under various hemodynamic 
conditions. Cardiac output was measured with closed and open shunt using the 
transpulmonary thermodilution technique (COTPTD) with central venous injections of 
ice-cold saline. An ultrasound transit time perivascular flow probe around the main 
pulmonary artery served as the standard reference measurement (COMPA).
Results
Seven lambs were eligible for further analysis. Mean weight was 6.6 kg (± SD 1.6). The 
mean COMPA was 1.21 l/min (range 0.61 – 2.06 l/min) with closed and 0.93 l/min (range 
0.48 – 1.45 l/min) with open shunt. The open shunt resulted in a mean Qp/Qs ratio of 
1.8 (range 1.6 – 2.4). The bias between the two CO methods was 0.17 l/min (limits of 
agreement (LOA) ± 0.27 l/min) with closed shunt and 0.14 l/min (LOA ± 0.32 l/min) with 
open shunt. The percentage errors were 22% with closed shunt and 34% with open 
shunt. The correlation between the two methods was r= 0.93 (p<0.001) with closed 
shunt and r=0.86 (p<0.001) with open shunt. The correlation between the two methods 
in tracking changes of CO (Δ CO) during the whole experiment was r = 0.94 (p<0.0001).
Conclusions 
The transpulmonary thermodilution technique is a feasible method of measuring cardiac 
output in pediatric animals with a left-to-right shunt.
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Introduction
Clinical hemodynamic assessment in critically ill children is considered unreliable.[1] 
Therefore, several invasive and non-invasive methods of measuring CO are increasingly 
applied in infants and children.[2, 3] Of these the transpulmonary thermodilution (TPTD) 
technique is considered the gold standard.[4-7]
TPTD measures CO by analyzing the thermodilution curve in the femoral artery after 
injection of ice-cold saline in a central vein. However, in the presence of congenital 
intra- and/or extra-cardiac shunts, the TPTD method is considered inaccurate. The 
systemic blood flow in the presence of a shunt is usually evaluated by clinical signs 
and intermittent echocardiography.[8-10] Heart catheterization using oximetry (Fick’s 
principle) and several other methods accurate detect, localize and quantify left-to-right 
shunts.[11-15] However, a continuous bedside CO measurement, reliable in a shunt 
circulation seems not available.
The transpulmonary thermodilution method may, however, be more reliable in case of 
a left-to-right shunt than previously considered. In general, indicator dilution methods 
have to fulfill four conditions: 1) steady blood flow, 2) no or minimal loss of indicator 
between injection and detection point, 3) complete mixing of the indicator with blood, 
and 4) the indicator must pass the detection point only once.[16] In the presence of 
a left-to-right shunt, CO measurement using the TPTD technique, may meet all these 
conditions. 
We evaluated the reliability of the TPTD technique in a pediatric animal model with 
a surgically constructed aorta-pulmonary left-to-right shunt. Measurements were 
performed under various hemodynamic conditions of hemorrhagic shock with open 
and closed shunt and resuscitation with closed shunt. We also studied the possibility to 
track changes in the CO. 
Methods
General. This experiment was performed in accordance with Dutch national legislation 
concerning guidelines for the care and use of laboratory animals and was approved 
by the local ethics committee on animal research of the Radboud University Nijmegen 
Medical Centre (RUNMC Licence number RU-DEC 2008-117; CDL-projectnumber 
33047). Nine lambs were studied under general anesthesia. Premedication consisted 
of the intramuscular administration of midazolam 2 mg/kg and ketamine 10 mg/
kg and intravenous administration of propofol 2 mg/kg. General anesthesia was 
maintained using inhalation of isoflurane 1-1.5 volume% and continuous intravenous 
administration of sufentanil 20 µg/kg/hr, midazolam 0.2 mg/kg/hr, ketamine 10 mg/
kg/hr, and pancuronium 0.05 mg/kg/hr after a loading dose of 0.05 mg/kg. During 
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the experiment continuous intravenous glucose 10% 2 ml/kg/hr was administered. 
The lambs were orotracheally intubated using a 5 to 6 mm (inner diameter) cuffed 
endotracheal tube (Kruse, Marslev,Denmark). The lungs were mechanically ventilated 
in a pressure-controlled mode using tidal volumes of approximately 10 ml/kg (Datex-
Ohmeda anesthesia machine). Normocapnia, guided by capnography with the CO2SMO 
Plus Respiratory Profile Monitor (Model 8100, Respironics, Pittsburgh, USA), was achieved 
by adjusting the respiratory frequency to maintain an end-tidal CO2 tension between 30 
and 41 torr (4.0–5.5 kPa). A servo-controlled heating mattress and an external heating 
lamp were used to maintain rectal temperature between 38 and 40°C. At the start of the 
shunt construction, anticoagulation therapy was instituted with unfractioned heparin 
with a loading dose of 100 IU/kg and a continuous intravenous infusion of 50 IU/kg/hr. 
At the end of the experiment, the animals were sacrificed.
Instrumentation. Immediately after induction of anesthesia the animals received a 
femoral artery catheter (3Fr 7 cm, PV2013L07,Pulsion, Germany), a femoral central venous 
catheter (5Fr 2lumen 13 cm, Arrow, Germany) and a Pediasat Oximetry Catheter (4,5F 5 
cm, Edwards Lifesience LLC, USA) positioned in the external jugular vein with the tip 
positioned in the superior vena cava. All intravascular catheters were inserted by surgical 
cut-down. A left-sided thoracotomy was performed and the remains of the native ductus 
arteriosus were ligated. A 4 to 6 mm pediatric shunt (Gore-Tex® Vascular Grafts, Gore 
Medical, USA) was constructed between the descending aorta and the left pulmonary 
artery. Ultrasound transit time perivascular flow probes (PAX series, Transonic Systems, 
Ithaca, NY) were placed around the main pulmonary artery (QMPA, probe 10 mm) to 
measure reference cardiac output (COMPA). Two 8 mm flow probes were positioned around 
the descending aorta, proximal (Qpre) and distal (Qpost) of the aorta-pulmonary shunt. The 
flow probes were checked for zero flow value directly postmortem. Ultrasound transit 
time flow probes use a two-way ultrasound technique. By calculating the difference 
between transit times upstream and downstream, the blood flow is measured. Care was 
taken to avoid air within the flow probe by applying sufficient quantities of acoustic gel. 
During the whole experiment the thorax was left open enabling opening and closure of 
the shunt with a clip.
Transpulmonary Thermodilution. Transpulmonary thermodilution cardiac output 
(COTPTD) was measured by injecting ice-cold saline into the jugular venous catheter. 
Temperature changes were detected by the thermistor tipped catheter inserted in 
the femoral artery connected to a commercially available device (PiCCOplus, software 
version 6.0, Pulsion, Munich, Germany). We used the mean value of three bolus injections 
of 3 ml of ice-cold (<10°C) saline. The venous injection point was not in proximity to the 
arterial femoral catheter thermistor tip, thereby avoiding the cross-talk phenomenon 
in case of low cardiac output.[17, 18] Measurements were stored on a computer using 
specially designed software (PiCCO-Volef Data Acquisition version 6.0, Pulsion, Munich, 
Germany). Before a series of thermodilution measurements, the central venous catheter 
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was flushed with 1–2 ml of ice-cold saline. Afterwards, each thermodilution measurement 
was visually inspected to assure that it was technically correct.
Other Measurements. We measured invasive arterial pressure and central venous 
pressure, electrocardiogram, heart rate, arterial oxygen saturation, end-tidal CO2, 
respiratory frequency, tidal volume, airway pressure, and body core temperature. During 
COTPTD measurement, all other hemodynamic variables, including COMPA, were recorded 
simultaneously with a 200-Hz sampling rate using a computer system with special 
biomedical registration software (Poly, Inspektor Research Systems, Amsterdam, The 
Netherlands). The exact time span of the thermodilution measurement was marked 
in the registration. The difference between COTPTD and COMPA was calculated using the 
mean value of three consecutive TPTD measurements and the mean value of COMPA 
measurements over the same three periods. To analyze whether changes in COMPA are 
adequately reflected by changes in COTPTD, we included all measurements over the entire 
experiment. 
For technical reasons, direct measurement of the shunt flow is not possible, therefore 
shunt flow was calculated as the difference between Qpre and Qpost. 
The Qp/Qs ratio was calculated using the following equation:
Qp/Qs = (QMPA + (Qpre - Qpost)) / QMPA
In open shunt conditions we only included measurements with a Qp/Qs ratio of > 1.5.
Protocol. The CO measurements were performed during three phases of the experiment 
as shown in figure 1. The aorta-pulmonary shunt was alternately opened and closed with 
a clip. The hemorrhage was performed by three periods of withdrawal of blood from 
the venous catheter to obtain a decrease in mean arterial blood pressure of 10 mmHg 
each step. After the hemorrhagic phase, the shunt remained closed and the animals 
were resuscitated with three fluid challenges of 20 ml/kg of either homologous whole 
blood transfusion or hydroxyethyl starch HES 130/0.4 6% (VoluvenTM), depending 
on the hemoglobin content of the blood, analyzed after each volume loading. Blood 
transfusions were stopped as soon as the initial hemoglobin content was reached.
In case of serious hemodynamic insufficiency at the time of the experiment a continuous 
infusion of epinephrine was administered to prevent the animal from dying.
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Figure 1
Protocol of the 3 phases of the experiment. Cardiac output is measured with alternately open 
(not padded arrow) and closed shunt (solid broad arrow).
Statistical analysis. Comparison between absolute values of COTPTD and COMPA and 
changes in CO was performed using correlation statistics (Pearson correlation) after 
confirming normal distribution of the data. In addition, data were analyzed using the 
method described by Bland and Altman.[19] As the number of measurements per 
animal did not vary (1x12, 6x13) we did not correct for the repeated measurements. The 
difference between the two methods (bias) was calculated by subtracting the value of 
COMPA from COTPTD. The bias was plotted against the mean CO ([COMPA + COTPTD]/2). The 
limits of agreement (LOA) were calculated by multiplying the standard deviation (SD) 
of the bias with 1.96. The percentage error was calculated using the following formula: 
(1.96 x SD of the bias)/mean QMPA x 100%, using mean QMPA as being the reference.[20] 
The coefficient of variance (CV) of the CO is calculated by dividing the SD of the mean by 
the mean of all the CO measurements of each technique and lamb separately. The results 
are expressed as percentages (=100% x SD/mean). Calculations and data management 
were performed using Excel for Windows (Office 2007, Microsoft, Seattle, WA). Statistical 
calculations were performed with MedCalc (Med-Calc Software, Mariakerke, Belgium).
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Table 1
Characteristics, hemodynamic parameters and procedures of each lamb separately.
lamb weight age shuntsize
Mean
shuntflow mean
Mean
COMPA
Mean
COMPA
Mean
MAP total  
nr (kg) (days) (mm) (l/min) Qp/Qs
Closed 
shunt
Open
shunt (mmHg)
blood
withdrawal
    Ratio (range) (l/min) (l/min) (range) (ml/kg)
1 3.5 12 4 0.7 1.9 (1.7-2.1) 0.87 0.80 46 (36-54) 21
2 6.2 5 6 0.6 1.6 (1.3-1.8) 1.23 0.98 40 (29-53) 21
3 8.7 10 6 0.9 1.7 (1.6-1.8) 1.65 1.31 44 (35-58) 22
4 6.4 11 6 0.6 2.0 (1.4-2.4) 1.06 0.67 34 (25-51) 17
5 7.3 28 6 0.7 1.6 (1.3-1.8) 1.49 1.19 43 (32-54) 15
6 7.7 28 6 0.6 1.6 (1.4-1.9) 1.15 1.00 55 (115-47) 14
7 6.4 29 6 0.8 2.4 (2.1-2.6) 0.93 0.61 46 (33-53) 22
Table 2
Coefficient of variation in cardiac output (CO) measurements of each lamb separately. 
Lamb
mean CO
TPTD
SD 
TPTD CV TPTD
mean CO
MPA SD MPA CV MPA
(number) (l/min) (%) (l/min) (%)
1 0.90 0.05 5 0.84 0.01 1
2 1.19 0.08 7 1.13 0.01 1
3 1.65 0.12 7 1.52 0.02 1
4 0.98 0.07 8 0.91 0.01 1
5 1.51 0.09 6 1.37 0.01 1
6 1.50 0.18 12 1.09 0.02 2
7 1.06 0.08 8 0.81 0.01 1
Mean CO TPTD resp. MPA= mean cardiac output of all transpulmonary thermodilution resp. 
main pulmonary artery measurements; SD TPTD resp. MPA = standard deviation of the mean 
CO TPTD resp. MPA; CV TPTD resp. MPA = coefficient of variation (100 x SD/mean) of the TPTD 
resp. MPA measurements expressed in percentages. 
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Results
One lamb died during the surgical procedure due to an intractable bleeding before the 
first measurement was performed. In another lamb the aorta-pulmonary shunt was 
insufficient with a maximum Qp/Qs ratio of 1.2. Data from this lamb were excluded from 
the study. As a result seven lambs with a mean body weight of 6.6 kg (± SD 1.6) and a 
mean age of 17.6 days (± SD 10.3) were included. The mean COMPA with a closed shunt 
was 1.21 l/min (range 0.61 – 2.06 l/min) and with an open shunt 0.93 l/min (range 0.48 
– 1.45 l/min). Hemodynamic data for each individual lamb are shown in table 1. The 
open shunt resulted in a mean Qp/Qs ratio of 1.8 (range 1.6 – 2.4) with a mean aorta-
pulmonary shunt flow of 0.7 l/min (range 0.6 – 0.9 l/min).
Calculations of the coefficient of variance (CV) are shown for each technique per lamb in 
table 2. The median CV for the TPTD technique and flow probe (MPA) respectively is 6% 
(min. 0% and max. 33%) respectively 1% (min. 0% and max. 6%). An example of a change 
in the thermodilution curve induced by opening the shunt is depicted in figure 2. The 
shunt opening induced a Qp/Qs ratio of 1.8. The measurement results are shown in table 
3. The increase in mean transit time (MTt) was almost half the increase in down slope 
time (DSt): 52% and 92% respectively. The influence of the Qp/Qs ratio on the change 
in MTt and DSt is depicted in figure 3. The inverse correlation between the percentage 
changes of Qp/Qs and CO is shown in the same figure (r = -0.84; p<0.0001).
Differences between the COTPTD and the COMPA with a closed and open shunt are shown in 
figure 4a and 4b respectively. The higher number of paired CO measurements in Figure 
4b is explained by the fact that during the resuscitation phase the shunt remained 
closed. The mean bias was 0.17 l/min (LOA ± 0.27 l/min) with the shunt closed and 0.14 
l/min (LOA  ± 0.32 l/min) with an open shunt. The bias was not influenced by epinephrine 
administration or the magnitude of the Qp/Qs ratio (not shown). The Spearman’s 
coefficient of rank correlation (rho) between the shunt ratio (Qp/Qs) and the difference 
between CO values by the two techniques was -0.2 (95%CI -0.392 to 0.00646; p = 0.057). 
The percentage errors were 22% with a closed shunt and 34% with an open shunt. The 
correlation coefficient between the two methods was 0.93 (p<0.001) with a closed shunt 
and r = 0.86 (p<0.001) with an open shunt.
The correlation between the two methods in tracking changes in CO (Δ CO) for the whole 
experiment was r = 0.94 (p<0.0001)(figure 5). 
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Figure 2 
Transpulmonary thermodilution curves of lamb 1 with a closed and open shunt during stable 
hemodynamics. 
 
Table 3
The absolute values of two single TPTD measurements with a closed and open shunt in lamb 
1, graphically illustrated in figure 2. 
shunt
COTPTD
 (l/min)
MTt
(sec)
DSt 
(sec)
EVLW
(ml)
GEDV
(ml)
MAP
(mmHg)
closed 0.96 8.9 4.8 61 65 55
open 0.83 13.5 9.2 113 59 46
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Figure 3
The percentage change in Qp/Qs ratio compared to the percentage change in mean transit 
time (MTt)(solid circle) and down slope time (DSt)(open square) with an open and closed 
shunt. The linear correlation is r=0.95 (p<0.001) for the MTt and r=0.96 (p<0.0001) for the 
DSt. The inverse correlation between the percentage change of Qp/Qs and CO (open triangle) 
is r = -0.84 (p<0.0001).  
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Figure 4a
Bland Altman plots with closed (4a) and open shunt (4b).
Figure 4b
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Figure 5
Correlation between changes in COTPTD and changes in COMPA for the whole experiment with 
sequential open and closed shunt.
 
Discussion
For the first time we demonstrate that the transpulmonary thermodilution cardiac 
output measurement is feasible in the presence of a significant left-to-right shunt. There 
was a significant correlation r = 0.94 (p<0.0001) between the two methods in tracking 
changes of CO including the results over the whole experiment. The experiment order 
made it impossible to separate the results for tracking changes of CO merely in the open 
situation.
The precision of TPTD for measuring CO with a closed shunt is in agreement with earlier 
studies from our group with a percentage error well within the acceptable limits of 
30% as described by Critchley and Critchley.[4, 20] However, the percentage error for 
measuring CO with an open shunt was significantly larger (34 versus 22%). This can be 
explained by the lower cardiac output with an open shunt condition and the increased 
limits of agreement. Probably the shunt flow itself may cause this measurement error. 
The longer passage time of the thermal indicator in the extra circuit may cause a loss 
of indicator by diffusion into the surrounding tissue resulting in an overestimation of 
the CO.
The calculations of CV of the CO measurements show more deviations with the TPTD 
method compared to the flow probe (MPA) technique (table 2). The low CV values of 
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our reference technique (flow probe) confirm assessment of CO measurements in stable 
conditions. The measurements by the TPTD method fluctuated more during the same 
time-interval, which explains the difference in agreement between the two methods, 
although it is not possible to deduce from these calculations, which measurement 
contains the true value.
We used the flow through the main pulmonary artery as the reference value of the 
systemic blood flow. We consider this the only valid reference method, since shunt flow 
entered the pulmonary circulation distal to the measurement site and it also includes 
the coronary blood flow. The descending aortic blood flow distal from the shunt does 
not represent systemic blood flow, as it excludes the blood going to the upper part of 
the body and the coronaries.
COTPTD measurement in the presence of a left-to-right shunt has, to our knowledge, not 
been validated before although the technique was described in several case reports.
[21, 22] Silove et al. measured systemic CO by thermal (room temperature) dilution 
technique in pediatric patients with a left-to-right shunt and compared the results with 
the reference Fick method.[23] Measuring the output of the left and right ventricles 
separately, the issue of recirculation was circumvented. The relation between the outputs 
of the two ventricles correlated closely to the Qp/Qs ratio based on the Fick method.
A left-to-right shunt prolongs the indicator pathway by recirculation. Broadbent et 
al. described in 1954 the typical alterations in the peripheral (= transpulmonary) dye 
dilution curve of a centrally located left-to-right shunt in 16 subjects with a patent 
ductus arteriosus.[24] They showed a decrease in the maximal dye concentration and a 
prolongation of the disappearance time of the curve. We confirmed these findings in our 
experiment (Figure 3).
The distortion of the TPTD curve can also be quantified by calculating the mean transit 
time (MTt) and down slope time (DSt) as shown in table 3. MTt is the time interval between 
the moment of injection and time of appearance of half of the amount of the injectate at 
the detector and DSt describes the extrapolated decay of the curve. Dye dilution studies 
showed a relation between the concentration curve and presence and magnitude of a 
shunt.[24, 25] As shown in figure 3, our study revealed a significant correlation between 
Qp/Qs and changes in MTt and DSt. Therefore, MTt and DSt related to cardiac output 
may be useful for quantifying the magnitude of the shunt.
The presence of a shunt also effects the measurement of the global end diastolic 
volume (GEDV) and extravascular lung water (EVLW). Since DSt increases with greater 
magnitude compared to MTt, the pulmonary thermal volume (PTV) will increase more 
than the intrathoracic thermal volume (ITTV). Therefore, GEDV will decrease and extra 
vascular lung water (EVLW) will increase. This has been confirmed in clinical patients.[22] 
These results show that in cases of a left-to-right shunt, volumetric variables like GEDV 
and EVLW are inaccurate.
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The commonly used techniques for CO evaluation in the presence of a left-to-right shunt 
are arterial and venous oximetry and transthoracic echocardiography. Unfortunately 
these techniques are either invasive, or need trained and experienced performers. 
Recent studies of other (non-invasive) methods like the modified carbon dioxide Fick 
method and electric velocimetry show promising results but need further research.[26, 
27] In our opinion, the TPTD method is a valuable alternative. Although, the precision is 
less with an open shunt, the ability to track changes in CO is clinically acceptable. 
Our study has several limitations. First we only studied a limited number of animals. 
Second, although this experiment was carefully controlled, we cannot be sure that the 
model adequately reflects the human situation. Third, it was not possible to close the 
shunt consistently for 100% in all animals, which is of minor importance for our study. Still 
we can’t rule out that the measurements in the closed shunt situation were influenced 
by residual shunt flow, although the results of TPTD for measuring CO with a closed 
shunt correlated well with the reference method and were in agreement with earlier 
studies from our group. Fourth, we introduced an uncertain amount of inaccurateness 
by using a syringe of 10 ml to determine 3 ml injections. It is advisable to choose the 
size of syringes to the volume amount of indicator. Fifth, the experiment required the 
frequent opening and closing of the shunt. As a result is was not possible to study 
consecutive hemodynamic changes (following fluid therapy for instance) with the shunt 
left open. Sixth, this model resembles the situation with a patent ductus arteriosus with 
a unidirectional left-to-right blood flow. In case of a bi-directional or mainly right-to-left 
shunt blood flow these results will be different.
In conclusion, our study shows that cardiac output measurement using the 
transpulmonary thermodilution technique is feasible in the presence of a centrally 
located left-to-right shunt. However, volumetric values like GEDV and EVLW are strongly 
influenced by and dependent on the amount of shunt flow. 
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Appendix
Calculation of EVLW and GEDV
Intrathoracic thermal volume (ITTV)  =  CO x MTt x 1000 / 60 [ml]
Pulmonary thermal volume (PTV)  =  CO x DSt x 1000 / 60 [ml]
Global end diastolic volume (GEDV)  =  ITTV – PTV [ml]
Intrathoracic blood volume (ITBV)  =  GEDV x 1,25 [ml]
Extra vascular lung water (EVLW)  =  ITTV – ITBV [ml]
 
4

Interpretation of the transpulmonary
thermodilution curve in the presence
of a left-to-right shunt
Intensive Care medicine 2011; 37(3): 550-1
Anneliese Nusmeier
Johannes G. van der Hoeven
Joris Lemson
5
 
103
Abstract original article
Transpulmonary thermodilution curves for detection of shunt.
Giraud R, Siegenthaler N, Park C, Beutler S, Bendjelid K
The transpulmonary thermodilution (TPTD) with integrated invasive arterial pulse 
contour analysis monitoring system operates via a single thermal indicator technique 
to determine extravascular lung water (EVLW), cardiac output (CO) and volumetric 
variables. The impact of intracardiac shunt on volumetric variables derived from the 
TPTD curve has not previously been studied. The present two case reports, describe the 
impact of ventricular septal defect (VSD) and aorto cava fistula (ACF) on the TPTD curve 
and EVLW measurements in critically ill patients monitored with TPTD.
This report describes two cases of systemic-venous circulation shunt generating 
early recirculation of thermal indicator with overestimation of EVLW. Haemodynamic 
measurements in the first patient showed a CO at 4.8 l/min with an increased extravascular 
lung water indexed value (EVLWI, 31.7 ml/kg), despite absence of hypoxaemia (FiO2 
30%) and normal lungs on chest ray. Because, of these conflicting monitoring results, 
a transthoracic echocardiography was performed that displayed an apical VSD with a 
gradient measured at 30 mmHg. After surgical repair of the VSD, CO was 5.7 l/min and 
EVLWI decreased to 14.3 ml/kg. The second case describes a diagnostic dilemma in a 
hemodynamic instable patient with abdominal pain. Haemodynamic measurements 
showed decreased global end diastolic volume (GEDV) and increased EVLWI value, 
despite absence of hypoxaemia. The thermodilution curve was characterized by an 
early recirculation of the cold indicator which resulted in premature flattening of the 
descending portion of the curve, indicating a left-to-right shunt. Additional examinations 
showed an aorto-cava fistula related to an aortic aneurysm at the level of the bifurcation 
of the aorta.
In conclusion, in the case of recirculation of thermal indicator, the observed overestimated 
EVLW in absence of gas exchanges abnormality could be an indicator suggesting the 
search for a circulatory shunt.
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To the editor
In a recent article by Giraud et al. the effect of a left-to-right shunt on the transpulmonary 
thermodilution (TPTD) curve and the subsequent calculation of extravascular lung water 
(EVLW) and intra thoracic blood volume (ITBV) is described.[1] The authors conclude that 
a left-to-right shunt generates recirculation of thermal indicator, which induces a change 
in the dilution curve. Although we support their observation their explanation may lead 
to confusion.
The transpulmonary thermodilution method must fulfill the following conditions: 
1) constant blood flow, 2) no or minimal loss of indicator between injection and 
detection point, 3) complete mixing of the indicator with blood, and 4) the indicator 
must pass the detection point only once.[2] To satisfy condition 4, the dilution curve 
is interrupted at the down slope part based upon a specific algorithm to prevent the 
effects of recirculation.[3] Subsequently the curve is extrapolated from the interrupted 
point to the baseline in order to calculate the area under the curve.[4] 
The cases described by Giraud et al. both had a left-to-right shunt (ventricular septal 
defect (VSD) and aorto-cava fistula (ACF). The (pulmonary) “recirculation” that occurs in 
a left-to-right shunt is an extra “short” circuit. The observed TPTD curve is the result of a 
delay in delivery of the indicator to the systemic circulation and will subsequently show 
a lower initial peak, followed by a slow re-approximation to the baseline.
Unfortunately the authors do not provide the values of the mean transit time (MTt) and 
downslope time (DSt), but these numbers are easily deduced from Figure 1 on page 1084. 
The recalculations are explained in table 1 and show that the left-to-right shunt induces 
an increase of both time intervals. The increase of the DSt (51%) is twice the increment 
of the MTt (25%). Recirculation of the indicator passing the detecting point for a second 
time is excluded by the fact that true recirculation will not occur before approximately 
60 seconds (≈ 2*MTt in the normal situation). This is long after the interruption of the 
down slope part. 
Increment of the DSt and, to a lesser extent, of the MTt can also be observed in the 
presence of a large volume of lung water. Both situations are the consequence of delayed 
delivery of indicator to the systemic circulation. In conclusion it can be stated that a left-
to-right shunt induces an increase in DSt and, to a lesser extend MTt as a consequence of 
delayed delivery of indicator to the systemic circulation, due to the presence of an extra 
circuit. This phenomenon should not be confused with true recirculation.
 
105
Table 1
Recalculations case 1
Case 1 VSD present VSD closed
CO 4.79 5.68
ITBVI 857 1334
EVLWI 31.7 14.3
BSA 1.8 1.8
weight 75 75
   
Calculations   
ITBV (ml) 1542.6 2401.2
EVLW (ml) 2377.5 1072.5
GEDV (ml) 1234.1 1921.0
ITTV (ml) 3920.1 3473.7
MTt (sec) 49.1 36.7
PTV (ml) 2686.0 1552.7
DSt (sec) 33.6 16.4
  
Formulas  
ITTV  =  CO * MTt * 1000 / 60
PTV  =  CO * DSt * 1000 / 60
GEDV  =  ITTV - PTV 
ITBV  =  GEDV * 1,25 
EVLW  =  ITTV - ITBV 
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Abstract
Background
The transpulmonary thermodilution (TPTD) technique is widely used in clinical practice 
for measuring cardiac output (CO). This study was designed to investigate the influence 
of various amounts of pulmonary edema on the reliability of CO measurements by the 
TPTD method.
Methods
In 11 newborn lambs pulmonary edema was induced using a surfactant washout 
technique. Serial CO measurements using TPTD (COTPTD) were performed at various 
amounts of lung water. Simultaneously, CO was measured by an ultrasound flow probe 
around the main pulmonary artery (COMPA) and used as the standard reference. CO was 
divided by the body surface area to calculate cardiac index (CI). Data were analysed 
using correlational statistics and Bland-Altman analysis.
Results
One lamb died prematurely. A total of 56 measurements in 10 lambs were analysed with a 
median CIMPA of 2.95 (IQR 1.04) litres min
-1 m-2. Mean percentage increase in extravascular 
lung water (EVLW) between the start and the end of the study was 126.4 % (SD ± 40.4). 
Comparison of the two CO methods showed a mean bias CI of -0.16 litres min-1 m-2 
(limits of agreement (LOA) ±0.73 litres min-1 m-2) and a percentage error of 23.8%. 
Intraclass correlation coefficients were 0.91 (95% CI 0.81-0.95) for absolute agreement 
and 0.92 (95% CI 0.87-0.95) for consistency. Acceptable agreement was confirmed 
by a tolerability-agreement ratio of 0.39. The within-subject correlation between the 
amount of EVLWI and the bias between the two methods was not significant (-0.02; 
p = 0.91). 
Conclusions
Cardiac output measurements by the transpulmonary thermodilution technique over 
a wide range of CI values are not affected by the presence of high EVLWI. The slight 
underestimation of the CO is independent of the amount of pulmonary edema. 
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Introduction
Cardiac output (CO) is measured reliably in newborn animals and children using the 
transpulmonary thermodilution (TPTD) technique.[1, 2] Furthermore, this technology 
can be used at the bedside to measure cardiac volumes and to quantify the amount of 
pulmonary edema, expressed as extravascular lung water (EVLW).[3-5] However, both in 
adults and in children, the TPTD method slightly overestimates the true CO value.[6-8] 
Loss of indicator because of the longer distance of the thermal indicator traversing the 
heart, lungs and great vessels is suggested as an explanation of the difference in the CO 
when comparing pulmonary artery with (transpulmonary) femoral artery thermodilution. 
In addition, there may be other factors that negatively influence the reliability of the 
TPTD technique. These include indicator loss because of low blood flow or the presence 
of a left-to-right shunt.[9-11] However, the effect of pulmonary edema on the reliability 
of CO measurements is only scarcely studied. Theoretically, an increased loss of indicator 
in the presence of a high amount of pulmonary edema may occur because a thermal 
indicator diffuses much more easily through water than through air. Consequently, 
more temperature will be lost into the surrounding tissues. Only a few studies in adults 
analysed the dependency of CO measurements on the amount of lung edema.[9, 12, 
13] However, as infants and young children have a much higher EVLW indexed to body 
weight (EVLWI) than adults, the impact of these increased amounts of lung edema may 
be more pronounced.[14-16] Pediatric studies are, to our knowledge, not available. 
Therefore this newborn animal experiment was designed to investigate the influence of 
various levels of pulmonary edema on the reliability of CO measurements.
Methods
General. This experiment was performed in accordance with Dutch legislation concerning 
guidelines for the care and use of laboratory animals and was approved by the local 
ethics committee on animal research of the Radboud University Nijmegen Medical 
Centre (RUNMC Licence number RU-DEC 2010-034; CDL-project number 33078). Eleven 
lambs were studied under general anaesthesia. Premedication consisted of the i.m. 
administration of midazolam (0.2 mg kg-1), ketamine (10 mg kg-1) and i.v. administration 
of propofol (2 mg kg-1). General anaesthesia was maintained using inhalation of 
isoflurane (1-1.5 vol%) and the continuous i.v. administration of sufentanyl (20 µg kg-1 
hr-1), midazolam (0.2 mg kg-1 hr-1), ketamine (10 mg kg-1 hr-1), and pancuronium (0.02 mg 
kg-1 hr-1) after a loading dose of 0.05 mg kg-1. The depth of anaesthesia was repeatedly 
assessed by pain stimuli and clinical parameters such as heart rate, spontaneous 
ventilation, and elevated arterial pressure. The depth of anaesthesia was adjusted 
when necessary. During the experiment, continuous i.v. dextrose 10% 2 ml kg-1 hr-1 
113
was administered. The lambs were intubated orotracheally using a 4 to 6 mm (inner 
diameter) cuffed tracheal tube (Kruse, Marslev, Denmark). The lungs were mechanically 
ventilated in a pressure-controlled mode using tidal volumes of approximately 10 ml 
kg-1 (Datex-Ohmeda anaesthesia machine) and an inspiratory-to-expiratory ratio of 
1:2. Normocapnia, guided by capnography with the CO2SMO Plus Respiratory Profile 
Monitor (Model 8100, Respironics, Pittsburgh, USA), was achieved by adjusting the 
minute volume ventilation to maintain an end-tidal CO2 tension between 4.0 and 5.5 
kPa. Impaired oxygenation was treated by adjusting the positive end expiratory pressure 
(PEEP) and the fraction of inspired oxygen (FiO2) to maintain the oxygen saturation > 
95%. A servo-controlled heating mattress and an external heating lamp were used to 
maintain core temperature between 38 and 40°C. At the end of the experiment, the 
animals were killed with pentobarbital (150 mg kg-1 i.v.).
Instrumentation. Immediately after induction of anaesthesia a thermal-dye-dilution 
probe (PV2023, Pulsion, Germany) equipped with a thermistor for detection of changes 
in blood temperature and a fiber optic to detect plasma levels of green dye, was inserted 
in the femoral artery. In the contra lateral femoral vein a central venous catheter (5Fr, 
2lumen, 13 cm, Arrow, Germany) was inserted for the administration of fluid and drugs. 
At the same site a femoral artery catheter (20 Ga, single lumen, 12 cm, Arrow, Germany) 
was introduced for arterial pressure monitoring and blood sampling. All intravascular 
catheters were inserted by a surgical cut-down technique. A left-sided thoracotomy was 
performed and the remains of a native ductus arteriosus were ligated. An ultrasound 
transit time perivascular flow probe (10 or 12 mm) (PAX series, Transonic Systems, 
Ithaca, NY) was placed around the main pulmonary artery to measure reference CO 
(COMPA). The flow probe signal was checked for zero flow values directly postmortem. 
Ultrasound transit time flow probes use a two-way ultrasound technique. By calculating 
the difference between transit times upstream and downstream, the blood flow (QMPA) 
is measured. Care was taken to avoid air within the flow probe by applying sufficient 
quantities of acoustic gel. After the placement of the flow probe the thorax was closed. 
The animals were positioned either supine or lying on the right side throughout the 
experiment. 
Pulmonary edema was induced using a surfactant washout lavage model.[17] In short, 
lambs underwent repetitive saline lavages (10-35 ml kg-1 lavage-1 37°C NaCl 0.9%) of the 
lung in order to induce surfactant depletion and provoke acute lung injury (ALI). Before 
the lavages the lambs were pre-oxygenated using an FiO2 of 1.0. After the lavages, 
the animals were stabilized for 30 minutes before measurements of ventilatory and 
hemodynamic parameters and blood gases were obtained. Between lavages the PEEP 
and minute volume ventilation were increased to maintain oxygen saturation and end-
tidal CO2 within the normal range.
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Transpulmonary thermodilution. Transpulmonary thermodilution CO (COTPTD) was 
measured by rapid injection of 5 ml ice-cold saline (NaCl 0,9%) into the femoral venous 
catheter. Changes in temperature were detected by the thermistor connected to a COLD 
monitor (Pulsion, Munich, Germany). The theoretical background of measuring CO by 
analysis of the dilution curves and calculation using the Steward Hamilton equation is 
described elsewhere. [18] Besides CO, blood volumes and extravascular lung water can 
be calculated from the measurement of the mean transit time (Mts) and downslope time 
(Dst) of the dilution curves.[5, 19] Before a series of thermodilution measurements, the 
central venous catheter was flushed with 1–2 ml of ice-cold saline. Each thermodilution 
curve was visually inspected for artefacts or signs of an inadequate measurement. We 
used the mean value of three bolus injections of 5 ml of ice-cold (<10°C) saline.
Other Measurements. We measured invasive arterial pressure and central venous 
pressure, continuous electrocardiogram, heart rate, arterial oxygen saturation, end-tidal 
CO2, respiratory frequency, tidal volume, airway pressures, and body core temperature. 
During the thermodilution measurements, all other hemodynamic variables, including 
COMPA, were recorded simultaneously with a 200-Hz sampling rate using a computer 
system with special biomedical registration software (Poly, Inspektor Research Systems, 
Amsterdam, The Netherlands). The exact time span of the dilution measurement was 
marked in the registration system. The reference CO was calculated using the mean 
value of COMPA measurements over the same three periods as the mean value of three 
consecutive TPTD measurements. 
Protocol. After instrumentation, baseline measurements of CO (TPTD and COMPA) 
respiratory and hemodynamic parameters and blood gases were obtained. Repetitive 
saline lavage procedures were performed in either one or two subsequent sessions 
of 10-30 ml kg-1, depending on the recovery of the lambs during the procedure. After 
each lavage procedure, a pause of 30 minutes was instituted for cardiorespiratory 
stabilization, followed by repeated measurements of the above-mentioned parameters. 
A blood transfusion was administered if the hemoglobin (Hb) was < 3.5 mmol litre-1. 
Dobutamine or epinephrine was administered when indicated.
Statistical analysis. The CO values were indexed (CI) to body surface area (BSA). The BSA 
of the lambs was calculated using the following formula: BSA = weight2/3 x 0.121.[20] 
The statistical variability in the CO during the measurement periods is expressed as the 
coefficient of variance (CV). This is calculated by dividing the standard deviation (SD) of 
the mean by the mean of the COMPA results during each separate measurement period. 
The results are expressed as percentages (=100% x SD/mean). We defined a CV of ≤ 5 % as 
acceptable for reliable COTPTD measurements. Intraclass correlation coefficients, using the 
two-way mixed model, were calculated for consistency and absolute agreement between 
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the CO measurement methods. In addition, data were analysed using the method described 
by Bland and Altman.[21] The difference between the two methods (bias) was calculated 
by subtracting the value of CIMPA from CITPTD. The bias was plotted against the mean CI 
({CITPTD + CIMPA}/2). The limits of agreement (LOA) were calculated by multiplying the SD of 
the bias with 1.96. The percentage error was calculated using the following formula: {(1.96 
x SD of the bias)/mean CIMPA} x 100%, using mean CIMPA as the reference.[22] As the number 
of measurements per animal varied, we corrected for the repeated measurements.[23] The 
strength of agreement was also calculated by the agreement-tolerability-interval ratio, 
with acceptable agreement defined as a ratio <1.[24] The tolerability interval is estimated 
from the 95% range of the observed CI data. The agreement interval is calculated from 
the range of the LOA. Differences between the bias of low/high CI (</≥ 3.0 litres min-1 m-2), 
lowest/highest quartile of EVLWI groups and low/high (</≥ 8cmH2O) PEEP were analysed 
by the Mann-Whitney test. Differences between the LOA were analysed by comparison of 
standard deviations test (F-test). Differences between the start and final results of EVLWI, 
PaO2/FiO2 ratio and PEEP were analysed by the Wilcoxon signed-rank test. The percentage 
bias of the COTPTD compared with the reference CO is calculated by (bias/mean COMPA) x 
100%. Within-subject correlation statistics were used in the comparison of PEEP, EWLWI 
and PaO2/FiO2 ratio with the bias by analysis of covariance for repeated measurements.
[25] Calculations and data management were performed using Excel for Windows (Office 
2007, Microsoft, Seattle, WA). Statistical calculations were performed with MedCalc (Med-
Calc Software, Mariakerke, Belgium).
Table 1
Lamb Weight Age Total 
lavages
CO
measurements
Mean COMPA
(±SD)
Mean CIMPA 
(±SD)
(kg) (days) (ml kg-1) (n) (litres min-1) (litres min-1 m-2)
1 8.1 21 125 7 1.89 (0.13) 3.86 (0.27)
2 7.4 21 303 5 1.06 (0.29) 2.31 (0.63)
3 4.1 7 293 6 1.00 (0.09) 3.24 (0.29)
4 7.4 14 68 2 2.48 (0.81) 5.39 (1.77)
5 10.2 17 294 6 2.06 (0.49) 3.62 (0.86)
6 9.4 18 191 4 2.05 (0.14) 3.81 (0.26)
7 died excluded excluded
8 8 15 420 8 1.01 (0.26) 2.08 (0.54)
9 9.9 16 242 3 1.61 (0.25) 2.89 (0.45)
10 11.5 19 184 7 1.82 (0.25) 2.95 (0.40)
11 12.3 22 98 8 1.61 (0.23) 2.50 (0.36)
Characteristics of the lambs.
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Results
One lamb died soon after the first lavage before reliable CO measurements could be 
performed. Ten lambs with an age between 1 and 3 weeks and with a median weight 
of 8.8 kg (interquartile range IQR 2.8) were studied. The characteristics of the lambs are 
shown in table 1. The pulmonary lavages and high ventilator pressures induced cardio 
respiratory instability in all animals. We excluded four CO measurements, each from a 
different lamb, because of CV > 5%. 
A total of 56 measurements were analyzed with a median COMPA of 1.63 (IQR 0.71) l min
-1 and 
CIMPA of 2.95 (IQR 1.04) litres min
-1 m-2. Intraclass correlation coefficients were 0.91 (95% CI 
0.81-0.95) for absolute agreement and 0.92 (95% CI 0.87-0.95) for consistency. Differences 
between the two CO methods are shown in the Bland-Altman plot (Figure 1). The mean 
bias of the CI was -0.16 litres min-1 m-2 (LOA ±0.73 litres min-1 m-2). The percentage error was 
23.8%. Correction for unequal repeated measurements per lamb revealed LOA in the same 
range (± 0.75 litres min-1 m-2) and a percentage error of 24.4%. The tolerability interval was 
1.7 – 5.4 litres min-1 m-2 and the agreement-tolerability-interval ratio revealed 0.39.
Separate analysis of the lower and higher CI measurements showed comparable 
percentage errors 22% (CI < 3.0 litres min-1 m-2; n=28; mean bias -0.06 (LOA ± 0.51) L min-1 
m-2) and 23% (CI ≥ 3.0 litres min-1 m-2; n=28; mean bias -0.27 (LOA ± 0.85) litres min-1 m-2). 
We subsequently determined the bias and level of agreement of the CI measurements 
for different amounts of EVLWI and showed a mean bias of -0.28 (LOA ± 0.57) litres min-1 
m-2 and percentage error of 16.1% in the lowest quartile of EVLWI versus -0.27 (LOA ± 
0.33) litres min-1 m-2 and percentage error of 21.8% in the highest quartile of EVLWI. 
Differences in the bias and LOA were significant in the low/high CI (p=0.014 and p=0.008) 
groups, but not in the low/high EVLWI (p=0.75 and p=0.84) groups.
The initial median EVLWI was 16.0 ml kg-1 (IQR 3.8), which increased after multiple lung 
lavage procedures to a final median EVLWI of 34.3 ml kg-1 (IQR 9.1). The mean percentage 
increase of EVLWI between the start and the end of the study was 126.4 % (SD ± 40.4). The 
increment of EVLWI worsened oxygenation. The median PaO2/FiO2 ratio decreased from 
403 (IQR173) to 73 (IQR 54). The median PEEP had to be increased during the experiment 
from 5 cmH2O (IQR 0) up to 16 cmH2O (IQR 10). The differences in these parameters between 
the start and final measurements were analysed by the Wilcoxon signed-rank test (all p 
= 0.02) and are shown in figure 2abc. The overall COTPTD measurements underestimated 
slightly the CO with 6%, increasing up to 7% bias in the highest (> 30 ml kg-1) EVLWI values.
When we compared the bias and LOA between the two CO measurements during low 
PEEP (n=22) and high PEEP (n=32), these differences were not statistically significant 
(p=0.98 and p=0.11). The within-subject correlations between the amount of EVLWI, 
PaO2/FiO2 ratio, or the PEEP and the bias between the two CO measurement methods 
were r = -0.02 (p = 0.91), r = 0.09 (p = 0.56) and r = 0.10 (p = 0.5) respectively and are 
illustrated in figures 3abc. 
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Figure 1
Bland-Altman plot comparing the cardiac index values by the TPTD method (CITPTD) and the 
peri-vascular flow probe around the main pulmonary artery (CIMPA). 
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Figure 2abc
Wilcoxon signed-rank test plot comparing the change in indexed extra vascular lung water 
(EVLWI; ml kg-1) (a), PaO2/fiO2 ratio (b) and PEEP (cmH2O) (c) from the start to the end of the 
experiment for each lamb separately.
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Figure 3 abc. 
Scatter plots of the bias of CI measurements by the TPTD method (CITPTD) and the peri-vascular 
flow probe around the main pulmonary artery (CIMPA) on the y-axis and EVLWI (a)(within-
subject r = -0.02), PaO2/FiO2 ratio (b)(within-subject r = 0.09) and PEEP (c)(within-subject r = 
0.10) on the x-axis.
 
6
120
Discussion
In this newborn animal model the TPTD method accurately measured CO in the presence 
of severe pulmonary edema (increase more than 125%). The bias and LOA were small 
and the percentage error around 24% is within the range of acceptance.[22] The high 
intraclass correlation coefficient and the low ( < 0.5) agreement-tolerability-interval 
ratio, taking the reference range of the observed data of the study as tolerability interval 
into account, support the acceptable strength of agreement and imply the EVLWI to be 
irrelevant in this study.[24] The initial EVLWI values in our pediatric animal model were 
higher than normal indexed EVLW values known from adult studies, but in agreement 
with the high EVLWI found in young children.[14-16, 26] Our results show no important 
dependency of the bias between the two CO methods and the amount of EVLW, but 
rather a scatter of differences that need to be considered.
It has been estimated that with the TPTD method up to 9% of the thermal indicator may 
be lost during passage through the pulmonary circulation.[27] In critically ill pediatric 
patients without pulmonary edema, TPTD overestimates the CO up to 4.4% compared 
with pulmonary artery thermodilution.[6] This is in agreement with adult studies.[6-
10, 28] Our results didn’t show overestimation of the COTPTD. An explanation for this 
discrepancy could be that, in contrast to others, we used an ultrasound flow probe as 
reference method, which is not influenced by other factors. Most human studies use 
the pulmonary artery thermodilution as the reference method, which is influenced by 
the traversing distance of the indicator and the transient effect of ice water on the heart 
rate.[29, 30]
Only a few adult studies focus on the influence of pulmonary edema on the reliability 
of CO measurements using the TPTD technique. A retrospective study in adult surgical 
intensive care patients showed no dependency of the bias between TPTD and pulmonary 
artery thermodilution CO measurements on the amount of pulmonary edema.[12] In 
this study however, the amount of EVLWI was relatively low (mean 9.1 (SD ± 5.8 ml kg-1) 
compared with the much higher EVLWI values in children. Another adult study in ARDS 
patients with a high mean EVLWI of 20.2 ml kg-1 showed the same results.[13] This may be 
explained by re-entry of the lost cold thermal indicator into the flowing blood. An older 
study found a decrease in thermal loss as EVLW accumulates with a negative correlation 
between the bias and the EVLW.[9] The measured values of EVLWI in this adult study 
ranged from 1.9 up to 27.5 ml kg-1. In our study, the EVLWI values ranged from 12.8 up 
to 60.2 ml kg-1. In agreement with the latter study, our results also show a slight (6%) 
underestimation of the mean COTPTD.
These findings suggest that in the presence of severe pulmonary edema, other factors 
compensate for the possible loss of the thermal indicator. Factors governing the 
temperature exchange between blood and interstitial fluid are the velocity of diffusion 
of the cold indicator, the surface area for exchange, the volume of the interstitial fluid 
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into which cold diffuses, and the flow of blood, which determines the time during which 
temperature exchange must occur.[31] So, as a result of perfusion alterations induced by 
pulmonary edema, PEEP or both, the surface area for exchange is reduced compensating 
thermal indicator loss in edematous lung tissue. However, our study couldn’t demonstrate 
an effect of PEEP level on the bias between CO measurements. Blood flow alteration is 
another factor influencing the loss of thermal indicator. High CO states may not allow 
sufficient time for equilibration with the extra vascular fluids and therefore less thermal 
indicator may be lossed.[9] On the other hand, low CO values result in more indicator 
loss at lower flow rates.[32, 33] This influence of the blood flow on the bias is confirmed 
in our study comparing low with high CO values. However, fractionally the error margin 
of the measurements remains the same. The higher the CO the wider the LOA and vice 
versa, resulting in comparable percentage errors in the high and low CO values.
Limitations
Despite variable hemodynamic circumstances, we included only measurements during 
stable blood flow. We corrected for the unequal and repeated CO measurements per 
lamb. Our animals were either lying supine or on their right side, which could influence 
the distribution of pulmonary edema, atelectases, and ventilation-perfusion mismatch 
and may have influenced our measurements in the comparison between the animals. 
We had no clinical indication to assume intracardiac shunting. We used a common model 
to induce EVLW increment with well-described pathophysiological and morphological 
characteristics.[17, 34, 35] However this surfactant depletion model does not share 
all features of ALI/ARDS in humans. Finally, the difference in normal values of EVLWI 
between children and adults may not be real but the result of a difference in age-related 
changes in the ratio of lung weight to body weight ratio.[36]
Conclusions
Haemodynamic monitoring plays a crucial role in the treatment of critically ill patients. 
Especially patients with capillary leakage and ALI require tight fluid management avoiding 
risk of overzealous fluid administration while maintaining sufficient intravascular volume 
status. The transpulmonary thermodilution technique provides reliable CO monitoring 
over a wide range of clinical conditions. This study shows that the CO measurements are 
not affected by severe pulmonary edema. 
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Abstract
Background 
The measurement of extravascular lung water (EVLW) using the transpulmonary 
thermodilution (TPTD) technique enables the bedside quantification of the amount 
of pulmonary edema. Children have higher indexed values of EVLW (EVLWI) compared 
to adults. TPTD measurements of EVLW in children have not yet been validated. The 
purpose of this study was to validate the EVLW measurements with the TPTD method 
over a wide range of lung water values in a pediatric animal model.
Methods 
In eleven lambs pulmonary edema was induced using a surfactant washout model. 
Between the lavages, EVLWI was estimated using transpulmonary single (TPTD) and 
double (TPDD) indicator dilution. Two additional lambs were used to estimate EVLWI in 
lungs without pulmonary edema. The final EVLWI results were compared with the EVLWI 
estimations by post-mortem gravimetry (EVLWIG). The results were analysed using both 
correlation and Bland Altman statistics.
Results 
EVLWITPTD correlated significantly with either EVLWIG (r
2=0.87) and with EVLWITPDD 
(r2=0.96). The mean bias with EVLWIG was 12.2 ml kg-1 (limits of agreement (LOA) ± 10.9 
ml kg-1) and with EVLWITPDD 2.4 ml kg
-1 (LOA ± 3.8 ml kg-1). The percentage errors were 
41% and 14%, respectively. The bias became more positive when the mean of EVLWITPTD 
and EVLWIG increased (r
2 =0.72 (p=0.003)).
Conclusions 
EVLWITPTD was significantly correlated to the post-mortem gravimetric gold standard, 
although a significant overestimation was demonstrated with increasing pulmonary 
edema.
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Introduction 
The measurement of extravascular lung water (EVLW) enables the bedside quantification 
of pulmonary edema. Therefore monitoring of EVLW is increasingly used as a parameter 
for diagnosis and treatment of critically ill adults with acute lung injury (ALI). EVLW 
measurement may allow the clinician to optimize fluid management and prevent further 
impairment of pulmonary function. In adults, mortality is closely related to the amount 
of EVLW.[1-6] Only a few studies have investigated the value of extravascular lung water 
measurement in children.[7, 8] Interestingly, these reports showed consistently higher 
normal EVLW values when indexed to bodyweight, specifically in young children. In 
pediatric patients the use of lung water measurement to guide fluid therapy seems 
to have a positive effect on outcome as well, but is not yet integrated in therapeutic 
guidelines.[9, 10]
Measurement of EVLW has been studied for many years. The gold standard reference 
method is gravimetry.[11-13] The gravimetric method compares the wet and dry weight 
of the lungs and corrects for the amount of blood. Unfortunately it is only feasible post 
mortem. 
Among the clinical methods, the most frequently used at the bedside is the 
transpulmonary indicator dilution technique. The transpulmonary double indicator 
dilution (TPDD) technique, using ice-cold indocyanin green (ICG), has been validated 
against the reference gravimetric method and is widely accepted as the clinical gold 
standard.[14-17] The difference between the mean transit times of both indicators is 
used to calculate the extravascular lung water (see Appendix 1). The system is no longer 
commercially available.
Meanwhile, a single transpulmonary thermodilution (TPTD) technique has been 
developed for the routine bedside estimation of EVLW in patients (PiCCO (Pulsion, 
Germany) (see Appendix 1).[18] This system is a reliable bedside method to measure 
EVLW in young children without clinical signs of pulmonary edema.[7] However, TPTD 
estimation of EVLW may be influenced by regional lung perfusion, type of lung injury 
and amount of EVLW.[19-22] Children have higher indexed values of EVLW compared to 
adults, up to more than 30 ml kg-1. TPTD measurements of EVLW in these patients has 
not yet been validated.
The purpose of this study was twofold. First, we aimed to validate EVLW measurements 
with TPTD (using PiCCO) against gravimetry over a wide range of lung water values 
in a pediatric animal model. Second, since sequential gravimetric measurements are 
impossible, we compared subsequent TPTD with TPDD measurements in the same 
animal model in order to test the ability of the TPTD measurements to track changes in 
EVLWI.
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Methods
General. This experiment was performed in accordance with Dutch legislation 
concerning guidelines for the care and use of laboratory animals and was approved 
by the local ethics committee on animal research of the Radboud University Nijmegen 
Medical Centre (RUNMC Licence number RU-DEC 2010-034; CDL-projectnumber 33078). 
Thirteen lambs under general anaesthesia were studied. Premedication consisted of 
the intramuscular administration of midazolam (0.2 mg kg-1), ketamine (10 mg kg-1) and 
intravenous administration of propofol (2 mg kg-1). General anaesthesia was maintained 
using inhalation of isoflurane (1-1.5 volume%) and the continuous intravenous 
administration of sufentanil (20 µg kg-1 hr-1), midazolam (0.2 mg kg-1 hr-1), ketamine 
(10 mg kg-1 hr-1), and pancuronium (0.02 mg kg-1 hr-1) after a loading dose of 0.05 mg 
kg-1. The depth of anaesthesia was repeatedly assessed by pain stimuli and clinical 
parameters such as heart rate, spontaneous ventilation or arterial blood pressure and 
was adjusted when necessary. During the experiment continuous intravenous dextrose 
10% 2 ml kg-1 hr-1 was administered. The lambs were intubated orotracheally using a 
4 to 6 mm (inner diameter) cuffed endotracheal tube (Kruse, Marslev, Denmark). The 
lungs were mechanically ventilated in a pressure-controlled mode using tidal volumes 
of approximately 10 ml kg-1 (Datex-Ohmeda anaesthesia machine) and an inspiratory-
to-expiratory ratio of 1:2. Normocapnia, guided by capnography with the CO2SMO Plus 
Respiratory Profile Monitor (Model 8100, Respironics, Pittsburgh, USA), was achieved 
by adjusting the minute volume ventilation to maintain an end-tidal CO2 between 30 
and 41 torr (4.0–5.5 kPa). Impaired oxygenation was treated by adjusting the positive 
end expiratory pressure (PEEP) and the fraction of inspired oxygen (FiO2) to maintain the 
oxygen saturation > 95%. A servo-controlled heating mattress and an external heating 
lamp were used to maintain core temperature between 38-40°C. At the end of the 
experiment, the animals were killed with pentobarbital (150 mg kg-1 i.v.).
Instrumentation. Immediately after induction of anaesthesia a thermal-dye-dilution 
probe (Pulsiocath PV2023, 3 Fr, Pulsion, Germany) equipped with a thermistor for 
detection of changes in blood temperature and a fiber optic to detect changes in ICG 
concentrations in the blood was placed in the lower abdominal aorta via the femoral 
artery. In the contralateral femoral vein a central venous catheter (5Fr, 2lumen, 13 cm, 
Arrow, Germany) was inserted for the administration of fluid and drugs. At the same site 
a femoral artery catheter (20 Ga, single lumen, 12 cm, Arrow, Germany) was introduced 
for arterial blood pressure monitoring and blood sampling. All intravascular catheters 
were inserted by a surgical cut-down technique. 
Acute lung injury was induced using a surfactant washout model resulting in pulmonary 
edema.[23] In short, 11 lambs underwent repetitive saline lavages (10-35 ml kg-1 lavage-1 
37°C NaCl 0.9%) of the lung in order to induce surfactant depletion and provoke acute 
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lung injury (ALI). Prior to the lavages the lambs were pre-oxygenated using a FiO2 of 1.0. 
After the lavages, the animals were stabilized for 30 minutes. Between lavages the PEEP 
and minute volume ventilation were adjusted to maintain oxygen saturation and end-
tidal CO2 within the target range. To include also the EVLWI measurements of minimal 
injured lungs, in 2 additional lambs no lavages were performed and only baseline 
measurements were performed before they were killed.
TPDD measurements were performed by rapid injection of 5 ml ice-cold (<10°C) ICG 
injectate (1 mg ml-1 in glucose 5%) into the femoral venous catheter with the catheter 
tip close to the right atrium. Changes in both temperature and ICG concentration were 
detected by the thermal-dye-dilution probe connected to a COLD monitor (Pulsion, 
Munich, Germany). In the last three animal experiments the COLD system was defective. 
Alternatively, a thermistor tipped arterial catheter (3Fr, 7 cm, PV2013L07, Pulsion, 
Germany) connected to a PiCCOplus monitor (software version 6.0, Pulsion, Munich, 
Germany) was used, with which EVLWI can be estimated only by the TPTD technique. 
TPTD measurements were performed by rapid injection of 5 ml ice-cold saline (NaCl 
0,9%) into the femoral venous catheter with the catheter tip close to the right atrium. 
Cardiac output (CO), blood volumes and EVLWI can be calculated from the analysis of 
the dilution curves and measurement of the mean transit time (MTt) and downslope 
time (DSt) (Appendix 1).[18, 24, 25] Before a series of measurements was performed, the 
central venous catheter was flushed with 1–2 ml of ice-cold saline. Each dilution curve 
was visually inspected for artifacts or other signs of inadequate measurement. EVLWI 
was determined by the average of three consecutive EVLWI measurements by TPDD/
TPTD.
Gravimetric technique. Immediately prior to killing the animal, a 50 ml sample of central 
venous blood was obtained. Subsequently, a median sternotomy was performed 
and the lungs were removed and drained passively. The gross weight of each lung, 
with its residual blood, was determined. The lungs were homogenized with an equal 
weight of water to induce hemolysis using a commercial blender and homogenizer. 
The homogenate was centrifuged at 6000 rpm for 1 hour at 4°C to separate a clear 
supernatant. Haematocrit from whole blood and haemoglobin from whole blood and 
lung supernatant were measured. The wet and dry weights of the samples of blood, 
homogenate and supernatant were determined before and after 4 days incubation in a 
heat chamber at 70°C until the weight stabilized. Postmortem EVLWI was calculated by 
the formulas as previously described (see Appendix 2).[11-13]
Determination of the relationship between ITBV and GEDV. To establish the relation 
between ITBV and GEDV, we used the TPDD technique to determine the ITBV, which is 
the calculation of the distribution volume of the non-diffusible indicator ICG (equation 
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6 in Appendix 1). From the same data, the results of the thermal indicator dilution curve 
were used in the calculation of the GEDV (equations 1 till 3 in Appendix 1).
Protocol. After the instrumentation, baseline dilution measurements, respiratory 
parameters and blood gases were obtained. Repetitive saline lavage procedures were 
performed in either one or two subsequent sessions of 10-30 ml kg-1, depending on the 
recovery of the lambs during the procedure. Halfway and final measurements of the 
above mentioned parameters were repeated after a post-lavage stabilization period. We 
also included two lambs without lung lavage to measure EVLWI in minimal injured lungs. 
In all lambs postmortem EVLWI measurements were performed by gravimetry (EVLWIG). 
A blood transfusion was administered if the haemoglobin concentration was < 3.5 mmol 
l-1. Dobutamine or epinephrine was administered when indicated.
Statistical analysis. The EVLW values were indexed (EVLWI) to actual bodyweight (kg). 
Variables were summarized as frequencies for categorical data, means and standard 
deviations for continuous normally distributed variables, or medians and interquartile 
ranges otherwise. Correlation between EVLWITPTD, EVLWITPDD and EVLWIG was tested by 
Spearmans’s coefficient of rank correlation. Data were compared using the method 
described by Bland and Altman.[26] The difference between two methods (bias) was 
calculated by subtracting the reference value of EVLWI (either gravimetry or TPDD) from 
EVLWITPTD. The bias was plotted against the mean EVLWI ({EVLWITPTD + EVLWI(TPDD or G)}/2). 
The limits of agreement (LOA) were calculated by multiplying the standard deviation 
(SD) of the bias with 1.96. The percentage error was calculated using the following 
formula: {(1.96 x SD of the bias)/mean EVLWI(TPDD or G)} x 100%.[27] Comparisons between 
the bias of EVLWI between TPTD and the two reference methods, and final PEEP, final 
PaO2/fiO2 ratio, age, mean EVLWI and CO were analysed by Spearmans’s coefficient of 
rank correlation. Changes in consecutive EVLWI measurements by TPTD and TPDD were 
calculated by subtracting the preceding from the succeeding result. Comparison of 
these changes in EVLWI was analysed by Spearmans’s coefficient of rank correlation. 
The relationship between GEDV and ITBV, expressed as the linear regression equation 
ITBV = a x GEDV + b (Appendix 2), was analysed using the EVLWITPDD results. Additionally, 
the EVLWITPDD results were separated into two subgroups (EVLWITPDD < / > 20 ml kg
-1) to 
demonstrate the influence of the amount of EVLWITPDD on the coefficients a and b.
Calculations and data management were performed using Excel for Windows (Office 
2007, Microsoft, Seattle, WA). Statistical calculations were performed with MedCalc 
(Med-Calc Software, Mariakerke, Belgium).
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Table 1. 
Characteristics and extravascular lung water index (EVLWI) results of the lambs.
Lamb Weight Age Total 
lavage 
volume
Initial 
EVLWI 
TPTD
Final 
EVLWI 
TPTD
Final 
EVLWI 
TPDD
EVLWI 
G
PEEP final PaO2/
FiO2 
final
(kg) (days) (ml kg-1) (ml kg-1) (ml kg-1) (ml kg-1) (ml kg-1) (mmHg)
1 8.1 21 125 13.8 17.7 15.8 15.1 7 143
2 7.4 21 303 14.5 NA NA 19.4 18 93
3 4.1 7 293 19.5 42.6 38.6 28.5 10 122
4 7.4 14 68 16.0 NA NA 18.8 10 53
5 10.2 17 294 12.8 30.1 29.9 17.1 20 78
6 9.4 18 191 15.1 33.8 34.1 20.1 20 68
7 7.1 14 135 19.1 NA NA 16.5 16 7
8 8.0 15 420 16.2 31.3 30.4 21.5 25 98
9 9.9 16 242 24.0 NA NA 18.2 20 35
10 11.5 19 184 16.0 53.5 49.1 29.8 15 41
11 12.3 22 98 14.7 37.3 NA 24.3 15 44
12 5.6 4 0 24.2 24.2 NA 13.3 5 NA
13 6.7 4 0 21.4 21.4 NA 11.8 5 NA
(EVLWI = extravascular lung water index by either transpulmonary thermodilution (TPTD), 
or transpulmonary double indicator dilution (TPDD) or gravimetry (G), PEEP = positive end 
expiratory pressure, PaO2/FiO2 ratio = ratio between arterial partial pressure of oxygen and 
inspired oxygen fraction, NA = not available)
Results
Thirteen newborn lambs with a postnatal age between 4 and 21 days and a mean 
weight of 8.3 kg (range 4.1 – 12.3 kg) were studied. The characteristics and results of the 
EVLWI measurements of the lambs are shown in Table 1. Four lambs (lambs 2,4,7,9) died 
during or after a lavage session before reliable final EVLWTPTD measurements could be 
performed, leaving 9 lambs to compare EVLWITPTD with EVLWIG. Only 10 lambs could be 
used comparing EVLWITPTD with EVLWITPDD as the COLD device was out of order in the last 
three experiments.
A total of 25 measurements were analysed comparing EVLWITPTD versus EVLWITPDD with a 
median EVLWITPDD of 24.0 (IQR 20.7) ml kg
-1. For the comparison of EVLWITPTD with EVLWIG 9 
measurements were analysed with a median EVLWIG of 20.1 (IQR 10.7) ml kg
-1. In the lambs 
undergoing saline lavages, the initial median EVLWITPTD was 16.0 ml kg
-1 (IQR 5.3), which 
increased after multiple lung lavage procedures to a final median EVLWITPTD of 31.3 ml kg
-1 
(IQR 14.6). The increase of EVLWI worsened oxygenation as illustrated in Table 1 by a final 
median PaO2/FiO2 ratio of 73 (IQR 54) and a final median PEEP level of 16.5 cmH2O (IQR 10).
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Figure 1ab
Spearman rank correlation between extravascular lung water index by transpulmonary 
thermodilution (EVLWITPTD) versus gravimetry (EVLWIG)(a), and EVLWITPTD versus 
transpulmonary double indicator dilution (EVLWITPDD)(b). ∙∙∙∙∙ line of identity
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Figure 2ab 
Bland Altman plot comparing extravascular lung water index measurements by the 
transpulmonary thermodilution (EVLWITPTD) with gravimetry (EVLWIG)(a) and transpulmonary 
double indicator dilution (EVLWITPDD)(b).  = linear regression line with regression 
coefficient r2
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Figures 1a and 1b illustrate the correlation between EVLWITPTD and EVLWIG (r2=0.87, 
p<0.0002, 95% CI 0.71-0.99) and between EVLWITPTD and EVLWITPDD (r
2=0.96, p=<0.0001, 
95% CI 0.95-0.99), respectively. Differences between EVLWITPTD and the two reference 
methods are shown in the Bland-Altman plots (Figures 2a and 2b). The mean bias with 
EVLWIG was 12.2 ml kg
-1 (LOA ± 10.9 ml kg-1) and with EVLWITPDD was 2.4 ml kg
-1 (LOA ± 
3.8 ml kg-1). The percentage errors were 41% and 14%, respectively. The bias between 
EVLWITPTD and EVLWIG was not related to the final PEEP (r
2 = 0.09 (p = 0.44)), final PaO2/
FiO2 ratio (r
2 = 0.14 (p = 0.3)) or age (r2 = 0.008 (p = 0.8). The bias became more positive 
when the mean EVLWI of both techniques increased (r2 =0.72 (p=0.003))(Figure 2a). 
The bias between the EVLWITPTD and EVLWITPDD did not correlate with the amount of 
mean EVLWI (r2 = 0.14 (p = 0.06)) (Figure 2b). Bias of EVLWI between TPTD and the two 
reference methods was not influenced by cardiac output (r2 =  0.2; p = 0.23 (G) and r2 = 
0.02; p=0.4(TPDD), respectively). The correlation of change in EVLWI (Δ EVLWI) between 
consecutive measurements by TPTD and TPDD is shown in Figure 3.
The coefficients a and b in the regression analysis of the relationship between GEDV and 
ITBV diverge depending on the data used, either all or the two subgroups of EVLWITPDD 
< / > 20 ml kg-1 (Table 2, Figure 4). 
Figure 3
Spearman rank correlation between the change in extravascular lung water index (Δ EVLWI) 
of transpulmonary thermodilution (TPTD) and transpulmonary double indicator dilution 
(TPDD) method (p < 0.001).  = linear regression line with regression coefficient r2.
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Figure 4
Linear regression analysis of the relationship between intrathoracic blood volume (ITBV) and 
global end-diastolic volume (GEDV): ---- linear regression line of  EVLWI < 20 ml kg-1; 
linear regression line of   EVLWI > 20 ml kg-1; ∙∙∙∙∙ line of identity
Table 2
The regression equation ITBV = a x GEDV + b, with a and b as coefficients derived from linear 
regression analysis using different TPDD data: either all or in subgroups EVLWI < or > 20 ml 
kg-1. * = p < 0.001.
TPDD data n a b r2 95%CI for slope 95%CI for y intercept
All 25 1.24 21 0.81* 0.98-1.50 14 – 57
EVLWI < 20 ml kg-1 11 1.46 -2 0.81* 0.93-1.99 -76 – 71
EVLWI > 20 ml kg-1 14 1.14 29 0.85* 0.84 – 1.44 -12 – 70
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Discussion
Our results show that the EVLWI measurements using the TPTD technique are closely 
related to both the gravimetric method and the TPDD technique. However, EVLWITPTD 
seems to overestimate lung water considerably compared to EVLWIG. 
Comparing EVLWITPTD versus EVLWIG. Our results are consistent with other experimental 
studies in which the EVLWITPTD overestimates gravimetric estimates of EVLWI.[28-31] 
This is explained by equilibration of the thermal indicator with dry lung mass and non-
pulmonary structures such as the hilar vessels and mediastinum.[28, 29, 31] Overall, 
studies using gravimetry as reference method show good linear correlations with TPTD.
[28-31] In agreement with a recent study in humans and a validation study in immature 
pigs, the overestimation is more pronounced with higher EVLWI measurement values.
[30, 32] However, opposite results were found in an experimental study with sheep.[33]
Comparing EVLWITPTD versus EVLWITPDD. Our results showed a good accuracy and precision 
over the whole range of pulmonary edema, which is in agreement with previous 
reports comparing EVLWITPTD measurements with TPDD as reference technique.[7, 18] 
Clinical studies in adults show, that in patients with high EVLWI (> 12 ml kg-1), the TPTD 
technique tends to underestimate lung edema in contrast to the low to normal range 
(<7 ml kg-1), where there is an overestimation.[18, 22] This may partly be explained from 
the deviations of the coefficients in various amounts of pulmonary edema in equation 
4 (Appendix 1) from the default setting in the PiCCO device, as elucidated in the next 
paragraph. Our results show the same trend in Figure 2b. 
Changes in EVLWITPTD closely relate to changes in EVLWITPDD, which makes EVLWITPTD 
suitable for trend monitoring of pulmonary edema (Figure 3).
Relationship GEDV and ITBV. Using the TPTD method it is assumed that GEDV has a constant 
and predictable relationship to ITBV, even in the presence of several physiological 
derangements seen in critical ill patients, which might introduce a potential error. With 
the TPTD technique, ITBV and EVLW are not obtained directly, but are derived from the 
measurements of CO, ITTV and PTV using equations 1 till 5 in Appendix 1. The PiCCO 
device uses a simplified formula, namely ITBV = 1.25 x GEDV (equation 4 in Appendix 1), 
to estimate ITBV and hence EVLW. This formula is based on a study in adult patients.[18] 
The coefficients in this linear regression analysis vary among different lung conditions 
and species.[28, 29, 31, 34-37] Coefficient ‘a’ calculated from our results of the whole 
experiment was 1.24, which is close to the PiCCO default setting, and is exactly the same 
as the results from a pediatric study.[7] Nevertheless, it is too premature to conclude, 
that age does not influence the estimation of EVLWITPTD. 
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Factors influencing EVLW measurements using dilution techniques. We clearly demonstrate 
the influence of the amount of lung water on dilution derived EVLW measurements. We 
showed a changing relation between GEDV and ITBV depending on the amount of EVLW 
(Figure 4, Table 2). In other studies this influence is explained by reduced pulmonary 
blood flow and hence underestimation of the EVLWITPTD in edematous lung areas 
compared to EVLWITPDD.[22, 38] 
From both experimental and clinical studies, various other factors have been analysed 
that influence the estimations of EVLWI with the indicator dilution method, including 
PEEP and cardiac output.[22, 39-41] Overall, these studies illustrate the limitation of the 
dilution techniques, as they are vulnerable to perfusion variations.[19-21] In our study, 
there was no relationship between the final PEEP levels, PaO2/FiO2 ratio or cardiac output 
and the bias of EVLWI, although our experiment was not designed to study the influence 
of these factors.
Limitations
We used an experimental pediatric animal model. The relationship between ITBV and 
GEDV is species dependent and requires reconsideration when applied to humans.[34] 
The type of lung injury does affect the EVLW measurements.[35, 38] The results of this 
surfactant washout model cannot be applied to all other types of acute lung injury, as it 
doesn’t share all features of acute lung injury or acute respiratory distress syndrome in 
humans.[23] Some of the lambs were treated with epinephrine, which may have affected 
the measurements. 
Conclusions
In conclusion, the EVLWITPTD was significantly correlated to the post-mortem gravimetric 
gold standard although a significant overestimation was demonstrated, specifically in 
the higher lung water range. Secondly, changes in EVLWITPTD closely relate to changes 
in EVLWITPDD, which makes EVLWITPTD suitable for trend monitoring of pulmonary edema.
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Appendix 1
Transpulmonary thermodilution (TPTD)
Analysis of the TPTD curve yields the cardiac output (CO), the mean transit time of the 
indicator (MTt), and the exponential downslope  time of the curve (DSt).
Multiplication of the CO by the MTt gives the volume in which this thermal thermal 
indicator is dissolved, i.e., the intrathoracic thermal volume (ITTV).
 1. ITTV = CO x MTt (ml)
Multiplication of the CO by the DSt gives the largest individual mixing volume in a series 
of indicator dilution mixing chambers, i.e., the pulmonary thermal volume (PTV).
 2. PTV = CO x DSt (ml)
Subtraction of the PTV from the ITTV reflects a volume that represents the global end-
diastolic volume (GEDV), i.e., the sum of the diastolic volumes of the right and left heart.
 3. GEDV = ITTV – PTV (ml)
There is a linear relationship assumed between intrathoracic blood volume (ITBV) and 
global end-diastolic volume (GEDV) and used as a default setting in the PiCCO[18]: 
 4. ITBV = (1.25 x GEDV) – 28.4 (ml)
  (PiCCO uses the simplified formula: ITBV = (1.25 x GEDV))
The differences between the ITTV and ITBV yield an estimate of extravascular lung water 
(EVLW):
 5. EVLW = ITTV – ITBV
Transpulmonary double indicator dilution (TPDD)
In the double indicator dilution technique two different indicators are injected 
simultaneously, using cold indocyanine green (ICG). While the cold equilibrates with the 
extra vascular space, the dye is rapidly bound to proteins and remains intravascularly. 
The distribution volume of the cold yields the ITTV, the distribution volume of the dye 
yields the intrathoracic blood volume (ITBV). Multiplying the CO by the MTt of the strictly 
plasma bound indocyanin green (ICG) equals the ITBV:
 6. ITBVTPDD = CO x MTtICG
The difference of the thermal and blood volume is the extravascular lung water. 
 7. EVLW = ITTVTPTD - ITBVTPDD
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Appendix 2
Formulas used in the gravimetric calculation of EVLW
[1]  Fws = Wws - Wds
 Wws
[2]  Fwh = Wwh - Wdh
 Wwh
[3]  Qr =  Qh  x  Hbs  x  Fwh  x  Hct
 Hbb Fws
[4]   Qb = Qr + {Qr(1-Hct)}
  Hct
[5]   Fwb = Wwb - Wdb
 Wwb
[6]   EVLW = Qh x Fwh – Qb x Fwb – Qwt
EVLW extravascular lung water
Fw  fraction water
b  blood
h  homogenate
s  supernatant
Hct  haematocrit
Hb  haemoglobin concentration
EVLW extravascular lung water
Ww  wet weight
Wd  dry weight
Q  weight
Qwt   weight of added water
Qb  residual blood content in lungs
Qr   red cell mass of lung
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Abstract
Introduction
Extravascular lung water (EVLW) can be measured at the bedside using the 
transpulmonary thermodilution method and reflects the amount of pulmonary edema. 
In children unusual high body weight indexed EVLW (EVLWI) have been described, 
which seems to be related to growth and development. Lack of age related normal 
values makes the interpretation and clinical use of this parameter impracticable at the 
pediatric intensive care unit (PICU). Goal of this study was to define “near normal” values 
of EVLWI in children.
Methods
This international multi-centre study prospectively collected EVLW measurements from 
children admitted to a PICU after resolution of their illness. The obtained values were 
indexed to predicted body weight and to height and subsequently related to age. 
Results
58 children with heterogeneous PICU admission diagnoses were included in this study. 
EVLW indexed to predicted body weight correlated with age (r2 = 0.7) and could be 
categorized in three age groups that consisted of significantly different median EVLWI 
values (5-95 percentile) < 1 year 10-35 ml/kg, 1-5 year 7-22 ml/kg and 5-17 year 6-12 ml/
kg. EVLW indexed to height did not correlate to age and resulted in an age-independent 
“near normal” value of < 200 ml/m.
Conclusions 
Younger children have higher “near normal” values of EVLW indexed to predicted body 
weight. Age categorized normal EVLWI values are presented for clinical use. Furthermore 
we suggest to index EVLW to height, which seems to be age-independent. 
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Introduction
Extravascular lung water (EVLW) can be measured at the bedside using the 
transpulmonary thermodilution method incorporated in the PiCCO device (Pulsion, 
Munich, Germany). EVLW reflects the amount of pulmonary edema with acceptable 
accuracy, predicts mortality in both adults and children and can be used to guide fluid 
therapy.[1-7]
EVLW is traditionally indexed using body weight (EVLWI, ml/kg). For the adult population 
values below 10 ml/kg are considered normal. Unusual high values of EVLWI have been 
described in young children.[8, 9] Since EVLW is related to lung mass the reason for these 
high values of EVLWI are in part explained by the changing relation between lung mass 
and body weight during human growth and development, specifically in the first years 
of life. In the young, the ratio of lung mass (and thus the amount of lung water) to body 
weight is higher.[10] Up to now, there are still no age related normal values available 
making the interpretation and clinical use of this parameter impracticable in pediatric 
patients.[11]
Adult studies have shown that indexing EVLW to predicted body weight produces a 
more physiological and useful value.[7, 12] Others suggest that indexing EVLW to height 
is superior to the aforementioned weight-based methods.[13]
This study was designed to collect EVLW values measured by the PiCCO system from 
children, admitted to a PICU after resolution of their illness. The obtained values were 
used to define age related “near normal” values of indexed lung water in children.
Methods
In this prospective study EVLW values were collected from routinely performed PiCCO 
measurements near the end of PICU treatment. Since this study was strictly observational, 
the medical ethical committee of the Radboud University Nijmegen Medical Centre 
waived the need for informed consent in concordance with Dutch legislation. Data 
were collected by PICU’s in Tunis (Tunisia), Rome (Italy), Santa Barbara (USA), Hamburg 
(Germany) and Nijmegen (The Netherlands).
We included children (0 tot 18 years) admitted to a PICU and connected to a PiCCO 
monitor for hemodynamic monitoring. EVLW values were eligible for the study if they 
were measured under stable hemodynamic condition and after resolution of the acute 
illness. Breathing was either spontaneous or with minimal supportive ventilation 
(pressure support max 10 cmH2O or likewise, PEEP =< 5 cmH2O and FiO2 =< 40%). 
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Patients were hemodynamically stable including normal sinus rhythm, normal blood 
pressure, normal renal function and either no or minimal vasoactive support (dopamine 
or dobutamine ≤ 5 ug/kg/min, epinephrine or nor-epinephrine < 0,1 ug/kg/min and 
milrinone <0,25 ug/kg/min or enoximone < 10 ug/kg/min). 
Exclusion criteria were clinical signs of (pulmonary) edema or increased work of breathing 
and an abnormal chest x-ray. Additionally, measurements in the presence of an intra- or 
extra-cardiac left-to-right or right-to-left shunt were excluded as well as measurements 
with technical defects or abnormal thermodilution curves.
The PiCCO system requires a central venous catheter and a special thermistor equipped 
arterial catheter inserted in the femoral artery. The three main recorded parameters are 
cardiac output (CO), global end-diastolic blood volume (GEDV) which reflects preload, 
and extravascular lung water (EVLW). The technical background of the PiCCO system 
and the calculation of the various hemodynamic parameters have been described in 
detail elsewhere.[11] The mean value of multiple (at least 3) measurements was taken. 
Measurements were performed using various PiCCO devices (PiCCOplus, PiCCO2 or 
PiCCO module for use with HP/Philips monitoring system). Other recorded data included 
among others, heart rate, blood pressure, central venous pressure (CVP), respiratory rate, 
saturation and blood gas results. Apart from a basic description of the hemodynamic 
status,  some of these results were used to determine, the patient had values consistent 
with a patient in a normal hemodynamic state or resolution of illness.
Predicted body weight based upon height was calculated using published WHO data 
that reflect the ideal body weight of children ranging from birth to 18 years.[14] Body 
surface area (BSA) was calculated by the Haycock method using actual weight.[15] CO 
and GEDV were indexed using BSA (CI = CO/BSA [l/min/m2]; GEDVI = GEDV / BSA [ml/
m2]). EVLW was indexed either using predicted body weight (EVLWI = EVLW / weight [ml/
kg]) or height (EVLWIh = EVLW / height [ml/m]).
All data were tested for normality. In case of normal distribution a t-test (or when 
appropriate ANOVA) was used, otherwise Mann Whitney U testing was performed. A 
p-value < 0.05 was considered significant. Normal values were constructed using the 5 
to 95 percentile values.
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Table 1
Patient data (n = 58)
Median value (range)
Age (year) 4 (0.04 - 17)
Weight (kg) 19 (3.7 - 80)
Predicted body weight (kg) 18.6 (3.1 – 77.4)
Length of stay PICU (days) 7 (2 - 21)
BSA (m2) 0.77 (0.23 – 1.96)
FiO2 (%) 30 (21 - 40)
PaO2 (mmHg) 98.1 (62.3 - 204)
SaO2 (%) 97 (92 - 100)
PaO2/FiO2 (mmHg) 395 (171 - 661)
PaCO2 (mmHg) 35.6 (21 – 45)
A-a gradient (mmHg) 34 (0-174)
pH 7.44 (7.33 – 7.60)
PEEP (cmH2O) 5 (4-5)
HR (bpm) 110 (62 - 169)
MAP (mmHg) 78 (48 - 131)
Respiratory rate (resp/min) 21 (11 - 46)
CO (l/min) 3.48 (0.56 – 10.9)
CI (l/min/m2) 4.61 (2.15 – 13.91)
SV (ml) 34.13 (6.44 – 100.48)
SVI (ml/m2) 40.23 (20.4 – 98.1)
GEDV (ml) 348 (70 - 1120)
GEDVI (ml/m2) 479 (186 - 772)
EVLW (ml) 216 (71 - 544)
EVLWI (ml/kg) 10.3 (4.7 – 34.6)
BSA  =  body surface area
MAP  =  mean arterial pressure
CO  =  cardiac output
CI  =  cardiac index = CO/BSA
SV  =  stroke volume
SVI  =  stroke volume index = SV/BSA
GEDV  =  Global end diastolic volume
GEDVI  =  global end diastolic volume index = GEDV / BSA
EVLW  =  Extra vascular lungwater
EVLWI  =  Extra vascular lungwater index = EVLW / body weight
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Results
58 children were included in this study of which 42 were breathing spontaneously while 
16 were being mechanically ventilated. Admission diagnoses were heterogeneous 
and included among others sepsis (14 children), pulmonary infection (12 children), 
Trauma (10 children), neurological disorders (5 children), organ transplant (4 children) 
and various other diseases (14 children). Patient characteristics are depicted in table 1. 
The mean body mass index (BMI) was 16.9 (SD 3.4, range 11.7 to 27.7) kg/m2. Only four 
children had a BMI value above 22 kg/m2.
Figure 1 shows the relation between EVLW and weight. Figure 2 shows the relation 
between age and EVLW indexed to predicted body weight. Figures 3ab reflect EVLW 
indexed to either predicted body weight or height divided per age group.
There were no differences between mechanically ventilated or spontaneous breathing 
children with regard to PaO2/FiO2 ratio, EVLWI, CI or GEDVI (data not shown). There were 
also no differences between boys and girls with respect to age, weight, height, CI, GEDVI 
or EVLWI. We couldn’t demonstrate any influence of the site of the central venous line 
(internal jugular, subclavian or femoral vein) on the results of the PiCCO measurements 
concerning CO, EVLW and GEDV.
The additional results of the PiCCO measurements, GEDVI and CI, are shown in Table 2. 
There were no differences between the CI values in the different age categories. However, 
the GEDVI values of the youngest age group were lower compared to the oldest group (p 
< 0.05). The median value of EVLWIh for the entire cohort was 200 ml/m (5-95 percentile 
125-315 ml/m).
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Figure 1 
The relation between EVLW and weight
 
Figure 2
The relation between age and EVLW indexed to predicted body weight 
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Figures 3a 
reflect EVLW indexed to predicted body weight divided per age group
 
Figures 3b 
reflect EVLW indexed to height divided per age group
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Table 2
Measurement results (median and 5-95 percentile) of EVLWI, GEDV and CI categorized in 
three age groups
Age (year) EVLWI [ml/kg] 
Median 
(5-95 percentile)
EVLWIh [ml/m] 
Median 
(5-95 percentile)
GEDVI [ml/m2] 
Median 
(5-95 percentile)
CI  [l/min/m2] 
Median
(5-95 percentile)
0 – 1 23 (10 – 34) 198 (142-313) 420 (270-510) 4.7 (2.2-13.7)
1 – 5 13 (7 – 22) 175 (127-316) 510 (260-680) 4.5 (2.6-6.2)
5 - 17 7 (6 – 12) 234 (142-313) 515 (340-690) 4.6 (2.7-6.7)
All 10 (6-26) 201 (124-315) 476 (305-701) 4.6 (2.5-6.6)
Discussion
Our study confirms that young children have higher values of indexed lung water 
compared to older children or adults. The collected data enable, for the first time, the 
design of age related normal values for EVLWI.
High levels of lung water in young children have been described in the past and our results 
are in conjunction with these results.[4, 9, 16] However these studies reflect critically ill 
children with predominant pulmonary abnormalities and frequently severe edema. This 
is the first study to describe measurements after these pulmonary abnormalities have 
been resolved, and therefore the results can be regarded as “near normal”. 
We propose the following “near normal” values in children based upon predicted 
body weight. For children under one year of age EVLWI values below 34 ml/kg can be 
considered normal. For children between 1 and 5 years normal values are below 22 ml/
kg. Between 5 and 17 years levels should be below 12 ml/kg. Above 17 years adult values 
(< 10 ml/kg) should be used. 
In a former study, we explained the high lung water values in children by the altered 
relation between body weight and lung mass of children compared to adults[10]. Also, 
the relation between GEDV and intra thoracic blood volume (ITBV) is not constant in 
all ages, and may vary even among individuals and species [17]. Yet the PiCCO system 
assumes a constant relationship and uses an adult-based calculation algorithm of EVLW 
values.[18, 19] 
In general, indexing requires a linear (and 1:1) relation between the physiologic variable 
and the indexing parameter over an age range from newborns to adults. The question 
157
is, which body parameter is most suitable for indexing hemodynamic variables. Several 
adult studies have shown predicted body weight to be superior over actual body weight 
in predicting severity of illness.[12, 13, 20] For that reason we primarily choose to use 
that same method in our study. Besides, in the software versions of the newer PiCCO2 
devices predicted body weight is used for indexing EVLW in both adults and children. 
However, with regard to lung mass, it seems that height is the most suitable parameter 
since lung volume is importantly related to height. [21] Recent studies in adults suggest 
that height seems to be superior to weight as indexing variable.[13, 22] Our study results 
confirm that indexing to height might be more useful compared to the default indexing 
to predicted body weight, which makes age-dependent adjustments unnecessary. Our 
study results suggest normal values of EVLWIh below 315 ml/m.
In the present study CO indexed to BSA was age independent, which suggests the 
possibility of extrapolating adult normal values to children. In contrast, GEDVI appears 
to be age dependent and in accordance to an earlier study, lower in young children [10].
There are several limitations to our study. First data were collected at various PICU’s and 
with various PiCCO devices without a uniform treatment protocol. On the other hand 
the PiCCO measurements were routinely performed as advised by the manufacturer. 
Furthermore we collected absolute values to prevent indexing differences based upon 
various algorithms incorporated in the subsequent software versions of the PiCCO 
devices. Second the sample size is small. Third, the children were primarily selected 
based on a normal pulmonary condition and not on normal preload and cardiac output 
conditions. Therefore CI and GEDVI values from this study may not be entirely interpreted 
as normal. Fourth, we cannot rule out underlying pulmonary pathology, as no additional 
pulmonary examinations were included. On the other hand, the presented oxygenation 
and respiratory variables point to a near normal pulmonary condition. Therefore, the 
values of EVLWI should be interpreted as “near” normal. Unfortunately measurements of 
healthy children will ethically not be possible or at least very difficult to perform due to 
the invasive nature of these measurements. 
Conclusion
We conclude that in younger children, even after resolution of critical illness, values 
of predicted body weight indexed extravascular lung water are higher compared 
to published adult values. We present age related normal EVLWI values for possible 
clinical use. Furthermore we advise to index EVLW to height, which seems to be age-
independent.
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General discussion
Circulatory failure is a life-threatening condition that is associated with tissue 
hypoperfusion and cellular hypoxia leading to organ dysfunction.[1] The optimal 
method of guiding therapy with the use of hemodynamic monitoring in these critically 
ill children is still under discussion. Assessment of the hemodynamic state is often not 
based on a single measurement but a continuous evaluation of oxygenation, cardiac 
function and volume status over time during disease progression. In this chapter we will 
discuss the role of advanced hemodynamic monitoring in critically ill children in clinical 
practice.
 
Figure 1
Principle hemodynamic determinants
The main component of interest in monitoring the hemodynamic status is the oxygen 
balance. Figure 1 shows the physiological determinants of hemodynamics. The oxygen 
delivery, the product of cardiac output (CO) and O2 blood content, must satisfy the O2 
consumption to keep a positive O2 balance in the body and prevent tissue hypoxia. 
Blood flow or CO, necessary for oxygen transport, depends on the interplay of heart rate, 
preload, contractility and afterload. Advanced hemodynamic monitoring quantifies 
the components pertaining to oxygen balance. These measurements help to evaluate 
adequacy of the circulation and can be used as end-points in guiding therapies. Physical 
examination and routine hemodynamic variables, such as blood pressure and heart rate, 
play only a minor role in hemodynamic management of critically ill patients as they are 
unreliable estimating (changes in) cardiac output.[2, 3]. 
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End-points
The recommendations of the pediatric sepsis guidelines, based on adult studies, direct 
the intensive care hemodynamic support to goals of central venous oxygen saturation 
(ScvO2) ≥ 70% and cardiac index (CI) between 3.3 and 6.0 L/min/m
2 after the initial 
resuscitation of septic shock.[4, 5] These and other advanced hemodynamic end-points 
will be discussed in the next paragraph.
Oxygen balance related end-points
The balance of oxygen delivery and consumption can be assessed by measuring the 
oxygen extraction ratio (OER) as described in chapter 2 of this thesis. Monitoring of the 
mixed venous oxygen saturation (SvO2) is used as a surrogate for the balance between 
systemic oxygen delivery (DO2) and consumption (VO2). The relationship between DO2 
and VO2 is biphasic as shown in Figure 2. The VO2 is independent of oxygen delivery over 
the upper range of DO2 due to the body’s ability to increase the OER. This is reflected by 
a decrease in SvO2. However, VO2 will become dependent on DO2 when the enhanced 
OER fails to compensate for the decreased DO2. Below the point of critical DO2 (DO2crit), 
oxygen demands exceed oxygen availability. At this point VO2 falls, anaerobic metabolism 
ensues and lactate accumulates in the blood. The DO2crit changes in parallel to changes in 
oxygen requirements. The associated critical OER, which is approximately 70%, remains 
constant regardless of changes in oxygen demand or cause of the inadequate DO2.[6, 7] 
A significant elevated OER is an indicator of (impending) inadequate tissue oxygenation. 
Figure 2
Schematic relationship of oxygen delivery (DO2) and oxygen consumption (VO2), mixed venous 
oxygen saturation (SvO2), oxygen extraction ratio (OER) and lactate concentration in the blood.
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Mixed venous oximetry is often not available as placement of a pulmonary arterial 
catheter is difficult in neonates and infants. Alternatively, central venous oxygen 
saturation (ScvO2) is monitored in or nearby the right atrium. The agreement between 
SvO2 and ScvO2 has been investigated in numerous studies with controversial 
conclusions.[8-12] Sampling from the superior vena cava reflects the venous blood 
from the upper part of the body and neglects venous blood from the lower body. The 
opposite applies to the inferior vena cava. In general, all the organs have different OER 
and consequently different regional venous oxygen saturations. In normal conditions, 
the lower body extracts less oxygen than the upper body, which is reflected by a 
higher inferior vena cava oxygen saturation. However, septic shock and other critically 
ill settings will change regional ratios of oxygen supply to demand. This effects the 
ScvO2 values depending on the sampling site and effects the relationship between 
SvO2 and ScvO2, which differs from normal conditions. This makes the interpretation 
of ScvO2 in critical conditions more complex. Furthermore, a drop in ScvO2 does not 
necessarily mean that tissue hypoxia occurs. Only when the VO2 becomes dependent 
on DO2, indicating an oxygen debt, the corresponding ScvO2 reflects inadequate tissue 
oxygenation. To make it even more complex, also an elevated (>70%) ScvO2 may be 
indicative of inadequate oxygenation, as a result of impairment of oxygen extraction. 
A beneficial effect of fluid administration on VO2 in potential fluid responders, seems 
to be more reliable predicted by lactate than ScvO2.[13] Right-to-left shunting will 
influence the absolute values of arterial and venous oximetry. This will however not 
be of influence of the calculation and interpretation of the OER. In conclusion, ScvO2 
should not be used as an individual marker in the assessment of tissue oxygenation but 
combined with other variables.[14]
Anaerobic markers like serum lactate levels and the respiratory quotient (CO2 production 
(VCO2)/ O2 consumption (VO2) ratio) are elevated once aerobic metabolism cannot be 
maintained.[15] Therefore lactic acidosis may, at an advanced stage of circulatory failure, 
indicate inadequate DO2 leading to impaired oxygen utilization. Under conditions of 
tissue hypoxia the total VCO2 should be less reduced than VO2, as CO2  is also produced 
under anaerobic conditions. Thus the VCO2/VO2 ratio, equal to the veno-arterial CO2 
tension difference/arteriovenous O2 content difference ratio, will be increased. These 
two anaerobic metabolism markers can be used to diagnose global tissue hypoxia and 
to monitor whether therapy will reduce oxygen debt assessed by an increase in VO2. A 
possible advantage of the respiratory quotient above lactate would be, that it is a pure 
marker of anaerobic metabolism, as lactate levels may also be elevated as a result of 
impaired clearance.[16] Lactate clearance (> 10%) seems to have prognostic value and 
may be a potential goal in early sepsis resuscitation.[17, 18] However, future studies 
are needed to prove that targeting these indicators of anaerobic metabolism improves 
outcome. It seems logical that targeting therapy by achieving a rapid decline of lactate 
levels will benefit patient in shock. On the other hand an increased lactate level is a non-
9
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specific indication of tissue hypoxia. It does not guide the clinician into what specific 
therapy (e.g. fluids, vaso-active drugs etc) is most beneficial.
In summary, from the available oxygen balance related parameters, serum lactate levels 
may be used as a prognostic marker in critically ill patients. Furthermore, ScvO2 and OER 
can be considered as therapeutic end-points in critically ill children. 
Cardiac output related end-points
Blood flow, responsible for the transport of oxygen, can be quantified by measuring CO. 
An outline of all the modalities for CO measurements in children is described in chapter 
3 of this thesis. In general, more invasive measurements of CO are more reliable. CO as 
an end-point to guide therapy can be used either to target normal values or to monitor 
changes over time. The first option is only useful if a reliably estimate of CO can be 
obtained. In Part II of this thesis we show that the transpulmonary thermodilution (TPTD) 
method is a reliable method of CO measurement under various conditions of critical 
illness and its use in children can be advised. The second option, CO trend monitoring, 
can be applied with less accurate methods with advantages of being less invasive and 
easy to apply.[19-22] In critically ill patients the first approach may be preferred above 
the latter as an accurate estimation of the CO may give a better insight of the etiology of 
the circulatory failure. High CO values in combination of inadequate oxygenation may 
indicate hyperdynamic shock and should be treated differently from a low CO state. In 
this context it is also important to realize which optimal values should be targeted.
CO should be integrated into therapeutic guidelines as an end-point in critically 
ill children. Furthermore, separate estimations of one or more determinants of CO 
(heart rate, preload, afterload and contractility) may help to direct medical decisions 
to improve specifically these variables. Examples are fluid responsiveness (preload) to 
guide fluid administration and systemic vascular resistance index (afterload) to institute 
vasodilators.
Fluid status related end-points
The relation between CO and preload is reflected by the Frank-Starling curve (Figure 
3). The steep part of the curve demonstrates fluid responsiveness. Estimating fluid 
responsiveness is often used as an indicator of preload. Dynamic indices of fluid 
responsiveness can be obtained by tracking changes in stroke volume and blood 
pressure continuously, making use of the heart-lung interaction.[23, 24] These functional 
hemodynamic parameters, like pulse pressure variation and stroke volume variation, 
can be provided by various advanced hemodynamic monitoring devices, estimating 
variations in arterial pulse pressure, systolic pressure, stroke volume and changes in 
central venous pressure, aortic flow and variability of plethysmographic measurements.
[25] However, these parameters are limited in their use because the patients require 
positive pressure ventilation under strictly defined conditions.[26, 27] Several studies 
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in children have evaluated these parameters.[28-39] It may reduce the amount of 
inappropriate fluid administration and may potentially improve outcome from critical 
illness, but further research is needed to validate these indices. At present, they cannot 
be used as therapeutic end-points yet.
 
Figure 3
Frank Starling curve
Instead, monitoring extravascular lung water (EVLW) may help to diagnose fluid overload. 
This parameter quantifies pulmonary edema and can be measured at the bedside by the 
TPTD technique. In chapter 7 we describe a validation study of measuring EVLW over a 
wide range of pulmonary edema. Changes over time are reliably estimated. However, 
this parameter seems to be related to growth and development and age related normal 
values are lacking. In chapter 8 we present age categorized normal EVLWI values for 
clinical use. We also suggest an even more practical age-independent EVLW indexed-to-
height value. Targeting EVLWI end-points may prevent overzealous fluid administrating 
and may be used in titrating fluid and diuretic therapy.[40]
 
Algorithm
Having summarized various potential therapeutic end-points to be targeted in critically 
ill children, the next step should be a practical advice for clinical use. The proposed flow 
diagram is similar to the treatment algorithm in chapter 2, supplemented with end-
point targets.
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 Figure 4
Algorithm of end-points hemodynamic monitoring.
BE base excess, = normal value, ScvO2 central venous oxygen concentration, OER oxygen 
extraction ratio, CI cardiac index, EVLWI extravascular lung water index, Hb hemoglobin 
concentration, SaO2 arterial oxygen saturation, VO2 oxygen consumption, R-L shunt right-
to-left shunt. 
Signs of
hemodynamic failure
i/=BE, h/=lactate
ScvO2 < 65%
OER < 30%
CI > 3 L/min/m2
Optimize Hb
Optimize SaO2
iVO2spill 
(sedation)
CI < 3 L/min/m2
Normal hemodynamic
variables normal
bloodgas and lactate
ScvO2 > 70%
OER < 30%
CI > 3 L/min/m2
Evaluate 
presence
R-L shunt
CI > 3 L/min/m2
vasopressors
Indication
observation
or re-assessment?
Normal hemodynamic
variables
lacticacidosis
ScvO2 < 65%
OER > 40%
CI < 3 L/min/m2
hEVLWI
Inotropic
drugs
normal
EVLWI
Fluid
challenge
Metabolic disorder
Impaired lactate 
clearance
hEVLWI
Inotropic drugs
normal EVLWI
Fluid challenge
Physical examination
Routine hemodynamicmonitoring
Bloodgas, lactate
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CO and the other measurements are not mandatory for every child admitted to the PICU. 
So the first step in the flow diagram (figure 4) should discriminate these children, using 
physical examination, routine hemodynamic monitoring and blood gas analysis and 
serum lactate concentration.
In the flow diagram target values are suggested. But normal values are not always 
optimal endpoints and moreover, target values need adjustments over time and have to 
be interpreted in relation to the underlying pathophysiologic process. 
Timing of applying advanced hemodynamic monitoring is important. Should we wait 
until all other measures have failed to start monitoring cardiac output? Looking at the 
sepsis algorithm of the stepwise management of hemodynamic support in infants 
and children, cardiac output monitoring is only suggested in persistent catecholamine 
refractory shock.[4] Of course, inserting catheters or applying special monitoring 
equipment can be time consuming and inconvenient in the very first minutes of 
resuscitation. But waiting until fluid administration seems to be ineffective, risking 
overzealous fluid administration with detrimental effects on morbidity and mortality, 
may be the other extreme.
Conclusion
In conclusion, advanced hemodynamic monitoring can provide essential information of 
the hemodynamic status of a patient in order to ensure adequate tissue oxygenation. 
Today, various devices are available, also in children, to estimate cardiac output and 
other hemodynamic parameters using different techniques. We have validated CO 
and EVLW measurements using the TPTD method in various critically ill conditions in 
pediatric animal models. This relatively invasive technique is able to estimate CO and 
EVLW reliably even in extreme conditions, although there are also limitations.
However, simply measuring advanced hemodynamic parameters will not change patient 
outcome unless it is coupled with therapies, that by itself are associated with improved 
patient outcomes. A treatment algorithm for clinical practice is suggested using end-
point targets like CI and EVLWI to guide medical decisions. 
 
Future perspectives
The next step to be taken are prospective clinical studies in critically ill children, to study 
the following research questions: 9
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- Do we need different treatment protocols during the acute and chronic phases 
of critical illness in children? In the acute phase of septic shock most patients will 
be treated aggressively with fluid administration. Targeting the same end-points 
values in the chronic phase, fluid administration could be detrimental. Maybe by 
that time fluid restriction and vasoactive drugs or even diuretics could be beneficial, 
which is often instituted with delay. A more patient- and disease-course-tailored 
approach may be needed.
- Because overzealous fluid administration appears to be detrimental, can we 
define an optimal point on the Starling curve where we should stop further fluid 
administration even though the patient appears to be fluid responsive? Being 
fluid responsive surely doesn’t mean fluids should be administered if clear signs of 
aerobic metabolism are present.
- Can we use less invasive methods to obtain CO, EVLW and ScvO2? At present, 
EVLW can only be measured invasively using dilution techniques. It would be 
very useful to quantify pulmonary lung edema in a non-invasive way, for example 
by using ultrasound techniques. Continuous non-invasive measurement of 
ScvO2 may be possible by pulse oximetry in pulmonary tissue.[41] Validation 
studies of non-invasive CO measurement techniques in children are needed, 
using standardized reference methods. Special attention should be paid to the 
underlying algorithms which should be adapted to children. The different body 
proportions in children should be taken into account formulating normal values 
and indexing parameters. 
- More research is warranted to explore the microcirculation. Assessment of the 
adequacy of oxygen balance by markers like ScvO2, OER and lactate reflect the 
global body oxygen balance, yet may not recognize regional mismatch. Indices of 
tissue perfusion may be used as early indicators of impaired tissue oxygenation. We 
may even go one step further, looking at the cellular level. Most of the body’s oxygen 
consumption is used by mitochondria. Mitochondrial function monitoring may be 
ultimately the optimal method monitoring the adequacy of organ perfusion.
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Summary 
Chapter 2 reviews the clinical assessment of various hemodynamic variables in 
pediatric critical care. The goal of monitoring is to guide clinicians in their management 
and anticipate on hemodynamic changes. The relationships between specific 
hemodynamic variables are complex and only a thorough understanding of the (patho)
physiology will help interpreting the values in making clinical decisions. There is no 
one single variable on which medical decisions can be based, but a combination of 
clinical assessment and (advanced) hemodynamic monitoring parameters is probably 
the most reliable. 
As long as we do not routinely estimate the oxygen balance on cellular or tissue 
level (monitoring microcirculation), we have to rely on variables derived from the 
macrocirculation. Cardiac output measurement quantifies systemic blood flow, which 
can be estimated by the transpulmonary thermodilution technique, which is considered 
as one of the gold standards in pediatric patients. The use of the central venous oxygen 
saturation is hampered by different normal values under specific patient conditions. 
The presence of a right-to-left shunt for example, makes a great difference in the 
absolute value, but shouldn’t influence the oxygen extraction ratio. Several tests and 
measurement parameters are suggested to evaluate fluid responsiveness, although the 
application of functional hemodynamic monitoring in pediatric patients is only scarcely 
studied. Relatively unknown is the estimation of extravascular lung water in children to 
guide fluid or diuretic therapy. Further pediatric studies need to be done to evaluate the 
potential beneficial impact on outcome in critically ill children and how to index these 
values and estimate normal values for infants and children. 
In chapter 3 an overview is provided of the available cardiac output monitoring systems 
that can be used in infants and children. The systems are reviewed listed in order of 
degree of invasiveness, from the invasive dilution techniques to the completely non-
invasive bioreactance/bioimpedance technique, continuous finger cardiac output 
monitoring and ultrasound. Pediatric (animal) studies are used to provide scientific 
evidence to support their application in infants and children. Comparing all these 
systems is difficult as several different reference standards are applied instead of using 
one valid gold standard.
Choosing the right monitoring system out of all the available monitoring devices is 
difficult as the ideal hemodynamic monitoring system doesn’t exist (yet). Furthermore, 
none of the devices can be generally applied to all individuals, as patients and their 
underlying disease processes are very heterogeneous. It is more appropriate to employ an 
individualized approach and select the system most suitable for each individual patient 
and for each type of problem. For a patient-tailored monitoring it is however essential to 
be familiar with the available technologies with all its advantages and limitations. Even 
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more important is the understanding and interpretation of the measurement results. 
In general, a more invasive technique produces a more reliable absolute estimation of 
cardiac output. The same applies to a system that needs calibration. 
 
Validation studies are needed before an advanced hemodynamic monitoring system can 
be applied into clinical practice. The transpulmonary thermodilution (TPTD) technique is 
considered to be a pediatric clinical gold standard in normal conditions and hypovolemic 
shock.[42, 43]
In chapter 4 we have validated the TPTD technique in the presence of a left-to-right 
shunt. Overall, a left-to-right shunt is more frequently seen in infants than in adults. 
Shunts can be present in patients born with congenital heart and/or vascular diseases 
or with a persistent ductus arteriosus. The manifestation of a left-to-right shunt can 
be associated with (cardiogenic) shock, depending on the seriousness of the defect. 
Frequently these patients will be admitted to an intensive care for stabilization and pre-/
postoperative monitoring
In our study we demonstrated that the transpulmonary thermodilution cardiac output 
measurement is feasible in the presence of a significant left-to-right shunt. A left-to-
right shunt prolongs the indicator pathway by recirculation and distorts the dilution 
curve. The longer passage time of the thermal indicator in the extra circuit causes loss 
of indicator by diffusion into the surrounding tissue, resulting in some overestimation 
of the CO. The distortion of the TPTD curve can also be quantified by calculating the 
mean transit time (MTt) and down slope time (DSt). Both may be useful for quantifying 
the magnitude of the shunt. The presence of a shunt also effects the measurement 
of the global end diastolic volume (GEDV) and extravascular lung water (EVLW), both 
becoming inaccurate.
Most of congenital shunt anomalies are corrected by the time of adolescence, which 
make (intra)cardiac shunts rare in adults. Sometimes acquired or congenital shunts are 
found in adults, detected by coincidence e.g. a different shape of the TPTD curves. In 
chapter 5 we comment on two adult case-reports by Giraud et al., both having a left-to-
right shunt diagnosed by an abnormal TPTD curve. We tried to explain what influence 
the presence of a shunt has on the various TPTD derived parameters extracted from the 
dilution curve, focusing on cardiac output, extravascular lung water and global end-
diastolic volume. We concluded that a left-to-right shunt induces an increase in DSt and, 
to a lesser extend MTt as a consequence of delayed delivery of indicator to the systemic 
circulation, due to the presence of an extra circuit. This phenomenon should not be 
confused with true recirculation.
Another critically ill condition in which we have validated the transpulmonary 
thermodilution technique is acute lung injury. Respiratory insufficiency based 
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primarily on injured lungs is often associated with a compromised circulation, either 
directly caused by lung edema or indirectly induced by positive pressure ventilation. 
Especially patients with capillary leakage and acute lung injury require tight fluid 
management avoiding overzealous fluid administration while maintaining a 
sufficient intravascular volume status. These patients may benefit from advanced 
hemodynamic monitoring 
Chapter 6 describes a validation study of the TPTD technique in a surfactant wash-out 
model to induce acute lung injury (ALI). Although the TPTD technique measures cardiac 
output reliably, it slightly overestimates the true CO value, both in adults and children. 
This may be explained by loss of the thermal indicator during the passage through the 
heart, lungs and great vessels. Presence of pulmonary edema may cause even more 
loss as a thermal indicator diffuses much more easily through water than through air. 
Since infants and young children have a much higher EVLW indexed to body weight 
(EVLWI) than adults, the impact of these increased amounts of lung edema may be more 
pronounced. 
Our study showed however that the TPTD method remained accurate in measuring CO 
in the presence of severe pulmonary edema (increase over 125%). The results showed 
no important influence of the amount of extravascular lung water on the reliability of 
CO measurements. These findings suggest, that in the presence of severe pulmonary 
edema, other factors compensate for the possible loss of the thermal indicator, like the 
velocity of diffusion of the cold indicator, the surface area for exchange, the volume of 
the interstitial fluid into which cold diffuses, and the blood flow, which determines the 
time during which temperature exchange must occur.
Chapter 7 describes a validation study of extravascular lung water (EVLW) measurements 
using TPTD in a pediatric animal model. The measurement of EVLW enables the bedside 
quantification of pulmonary edema and is increasingly used as a parameter for diagnosis, 
treatment and optimized fluid management of critically ill adults with acute lung 
injury (ALI). It is a relatively new parameter, not yet integrated in pediatric therapeutic 
guidelines, and only a few studies have investigated the value of EVLW measurement 
in children. Interestingly, these reports show consistently higher normal EVLW values, 
indexed to bodyweight, specifically in young children. Among the clinical methods 
estimating EVLW, the most frequently used at the bedside is the TPTD technique. 
However, the reliability of this technique may be influenced by the amount of EVLW 
itself. The TPTD measurement of EVLW hasn’t been validated yet in critically ill children 
with extremely high amounts of lung water. The purpose of our study was to validate 
the EVLW measurements by TPTD against two gold standards, the gravimetric method 
and the transpulmonary double indicator dilution (TPDD) technique, using ice-cold 
indocyanin green (ICG). 
We used eleven lambs in which pulmonary edema was induced using a surfactant 
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washout model. Indexed EVLW by TPTD correlated significantly with both reference 
measurements. The percentage errors with gravimetry and TPDD were 41% and 
14%, respectively. A significant overestimation was demonstrated comparing EVLW 
measurements by TPTD and gravimetry, specifically in the higher lung water range. 
Secondly, changes in EVLWITPTD were closely related to changes in EVLWITPDD, which 
makes EVLWITPTD suitable for trend monitoring of pulmonary edema.
In chapter 8 an international multi-centre study is presented in which EVLW 
measurements, reflecting the amount of pulmonary edema, were collected from children 
admitted to a PICU after resolution of their illness. These data reflect near ‘normal’ values 
in children. Lack of age related normal values makes the interpretation and clinical use of 
this parameter impracticable in critically ill children. The obtained values were measured 
at the bedside, using the transpulmonary thermodilution method. They were indexed 
to predicted body weight and to height and subsequently related to age. The unusual 
high body weight indexed EVLW (EVLWI) compared to adults seems to be related to 
growth and development. Goal of this study was to define ‘near normal’ values of EVLWI 
in children. 58 children with heterogeneous PICU admission diagnoses were included 
in this study. EVLW indexed to predicted body weight correlated with age (r2 = 0.7) and 
could be categorized in three age groups with significantly different median EVLWI 
values (5-95 percentile) < 1 year 10-35 ml/kg, 1-5 year 7-22 ml/kg and 5-17 year 6-12 ml/
kg. EVLW indexed to height did not correlate to age and resulted in an age-independent 
“near normal” value of < 315 ml/m.
In conclusion, younger children have higher “near normal” values of EVLW indexed to 
predicted body weight and age categorized normal EVLWI values are presented for 
clinical use. Additionally, we suggest to index EVLW to height, which seems to be age-
independent.
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Samenvatting, conclusie en toekomst perspectieven 
voor niet ingewijden
Inleiding 
Op een kinder intensive care (PICU) worden onder anderen de ademhaling en de 
bloedsomloop van patiënten bewaakt. De focus van dit proefschrift ligt op het monitoren 
van de bloedsomloop bij kinderen, ook wel het hartminuutvolume of circulatie (Engels: 
cardiac output) genoemd. Het hartminuutvolume is afhankelijk van de hartfunctie 
(contractiliteit), hartfrequentie, de bloedvaten (afterload) en de vullingstatus (preload) 
van de patiënt. Het hartminuutvolume zorgt ervoor dat alle lichaamscellen, al naar 
gelang de behoefte, van voldoende bloed met zuurstof en voedingsstoffen worden 
voorzien. Bij een verminderde bloedsomloop kan zuurstoftekort in de cellen ontstaan, 
dat uiteindelijk zal leiden tot orgaanschade. 
Het doel van het monitoren van de bloedsomloop is drieledig: in de eerste plaats om 
gealarmeerd te worden van een achteruitgang van de circulatie, ten tweede om de 
juiste therapeutische keuzes te maken ter voorkoming van (verdere) orgaanschade. 
Tenslotte om het effect van de ingezette therapie te evalueren en te sturen richting een 
bepaalde streefwaarde van een parameter, de zogenaamde doelgerichte therapeutische 
benadering.
Parameters die gebruikt worden in de praktijk om een indruk te krijgen van de kwaliteit 
van de bloedsomloop zijn bijvoorbeeld bloeddruk, hartfrequentie, bewustzijn en 
kenmerken van de huid (temperatuur verschil op verschillende plaatsen in het lichaam 
(Δ temp) en doorbloeding van de huid (capillary refill time)). Bovendien wordt extra 
informatie verkregen uit aanvullend bloedonderzoek. Ondanks de vanzelfsprekendheid 
waarmee dit allemaal wordt gedaan, blijkt de waarde die er aan gehecht kan worden 
voor het inschatten van de bloedsomloop slechts zeer beperkt. Dit heeft voor een groot 
deel te maken met het feit dat deze parameters slechts indirect afgeleide waarden 
zijn van het hartminuutvolume en beïnvloed kunnen worden door compensatie 
mechanismen van de circulatie en externe factoren, die niets met de bloedsomloop te 
maken hebben. Bij een zieke patiënt bijvoorbeeld kan aanvankelijk de bloeddruk hoog 
zijn door angst en koorts, terwijl tegelijkertijd de bloedsomloop al ernstig tekort schiet. 
In dit geval maskeert een goede bloeddruk een slechte circulatie. Andersom kan ook: 
als de omgevingstemperatuur koud is, is de huid vaak ook koud en bleek en zal de 
doorbloeding slecht zijn. Dat betekent echter nog niet, dat de patiënt in shock is.
Concluderend: er is behoefte aan parameters, die de bloedsomloop en de zuurstofbalans 
in het lichaam betrouwbaar weergeven, zodat een circulatoire achteruitgang eerder 
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wordt opgemerkt en orgaanschade mogelijk kan worden voorkomen. In de afgelopen 
decennia zijn er daarom geavanceerde hemodynamische monitoring technieken 
ontwikkeld, die het hartminuutvolume direct kunnen bepalen en daarnaast nog 
aanvullende waarden van bloed volumina en zuurstof saturaties kunnen weergeven. 
Het is belangrijk om de fysiologische achtergrond van de circulatie goed te begrijpen 
voor een juiste interpretatie van deze geavanceerde parameters. Centraal staat hierin de 
balans van zuurstof aanbod en zuurstof verbruik in het lichaam.
Bij volwassen intensive care patiënten zijn deze geavanceerde monitoren inmiddels 
uitgebreid bestudeerd en worden al ruimschoots toegepast. De ervaringen die hiermee 
zijn opgedaan zijn helaas niet 1 op 1 te extrapoleren naar kinderen aangezien zij geen 
kleine volwassen zijn. Zij verschillen van volwassenen op basis van hun anatomie, 
lichaamsverhoudingen en (patho)fysiologie met andere compensatie mechanismen en 
response op therapieën. 
Geavanceerde hemodynamische monitoren worden bij kinderen nog niet routinematig 
in de praktijk gebruikt. Dit kan onder anderen worden verklaard door onbekendheid 
met de technieken, ongeschiktheid van de apparatuur voor kinderen (grootte van 
probes en katheters) en gebrek aan validatie studies en normaalwaarden bij kinderen. 
Daarnaast is er ook nog geen wetenschappelijk bewijs, dat de toepassing van 
geavanceerde hemodynamische monitoring ook uiteindelijk een positief effect heeft op 
het ziektebeloop en de mortaliteit van kritisch zieke kinderen.
Doel van het onderzoek
Het onderzoek beschreven in dit proefschrift is gericht op het valideren van 
hartminuutvolume metingen middels de transpulmonale thermodilutie techniek 
(TPTD) bij kinderen in aanwezigheid van diverse ziektebeelden. Er is hierbij gebruik 
gemaakt van diermodellen als surrogaat voor kinderen. De TPTD techniek wordt 
beschouwd als een goud standaard bij kinderen onder normale omstandigheden. Het 
eerste diermodel simuleert een links-rechts shuntcirculatie, waarbij een aangeboren 
hartafwijking is nagebootst met een extra omleiding van de bloedsomloop tussen 
de grote lichaamsslagader (aorta) en de longslagader. In het tweede diermodel zijn 
de longen ziek gemaakt, waardoor zich een grote hoeveelheid vocht ophoopte in de 
longen.
Het tweede deel van het onderzoek is gericht op de bepaling van een relatief nieuwe 
parameter, die de hoeveelheid vocht in de longen kan kwantificeren: longwater of 
longoedeem of extravasculair longwater (EVLW). De mate van longoedeem wordt bij 
volwassen patiënten gebruikt als voorspeller van overvulling. Het is een potentieel 
bruikbare maat voor het titreren van het vochtbeleid bij patiënten. Er zijn echter nog 
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veel onduidelijkheden, voordat deze parameter in de klinische praktijk bij kinderen 
kan worden toegepast. Gebruik makend van het tweede diermodel met ziek gemaakte 
longen en grote hoeveelheden longoedeem, zijn EVLW metingen middels de TPTD 
techniek gevalideerd. Ten slotte is middels een klinische studie getracht, indexeringen 
en normaalwaarden voor EVLW te definiëren voor kinderen.
Samenvattingen van de studies
Hoofdstuk 2 geeft een overzicht van de fysiologische achtergronden en gebruik van 
hemodynamische parameters voor de beoordeling van de circulatie bij kinderen. Er wordt 
ingegaan op de eventuele toegevoegde waarde van geavanceerde hemodynamische 
monitoring. Aan de orde komen het meten van hartminuutvolume, het voorspellen 
van positieve reactie van het hartminuutvolume op extra vocht toediening (fluid 
responsiveness), het berekenen van zuurstof aanbod in relatie tot zuurstof verbruik in 
het lichaam en het kwantificeren van vocht in de longen. De specifieke fysiologische 
verschillen tussen kinderen en volwassenen worden toegelicht.
Het meten van cardiac output is technisch inmiddels betrouwbaar mogelijk, ook 
bij kinderen. Het kan een belangrijke bijdrage leveren in het beoordelen van de 
hemodynamische status van een patiënt. Dit geldt ook voor het bepalen van de centraal 
veneuze saturatie, al moet bij de interpretatie van de absolute uitslag altijd rekening 
worden gehouden met eventuele congenitale hartafwijkingen, zoals een shuntcirculatie. 
Met de opkomst van nieuwe technologieën, worden ook nieuwe volumetrische en 
dynamische parameters verkregen. Volumetrische parameters zoals GEDV, ITBV en EVLW 
zijn potentiële waarden, die een inschatting kunnen geven van de mate van onder- en 
overvulling van de patiënt. Dynamische parameters zijn afgeleid van variaties tijdens 
de ademhalingscyclus die ontstaan in de bloeddruk en slagvolume van het hart. Deze 
parameters worden gebruikt voor het voorspellen van fluid responsiveness.
Ondanks de verschillende mogelijkheden voor geavanceerde hemodynamische 
monitoring bij kinderen, zullen toekomstige studies moeten aantonen of dit uiteindelijk 
ook een verbetering zal geven op de morbiditeit en mortaliteit. Naast validatie studies 
zullen in de toekomst studies moeten worden verricht, waarin cardiac output en andere 
geavanceerde parameters geïntegreerd zijn in behandelingsprotocollen. 
Hoofdstuk 3 geeft een overzicht van alle klinisch beschikbare methoden om 
het hartminuutvolume bij kinderen te kunnen meten. Helaas bestaat de ideale 
hemodynamische cardiac output monitor vooralsnog niet. De meest invasieve methoden 
zijn de transpulmonale dilutie technieken. Deze geven het meest betrouwbaar het 
hartminuutvolume weer. Minder en niet-invasieve methoden zijn pulse contour analyse 
technieken, echocardiografie en echo doppler, bioreactance/bioimpedance technieken 
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en continue vinger cardiac output monitoring. Ongekalibreerde technieken zijn 
onbetrouwbaarder dan gekalibreerde technieken, maar zijn vaak wel makkelijker en 
sneller toe te passen. De keuze van de methode wordt meestal bepaald door de klinische 
situatie van de individuele patiënt. Tevens zou men zich kunnen afvragen 1. Is een 
betrouwbare meting noodzakelijk of is het volgen van cardiac output (trendmonitoring) 
voldoende, 2. Zijn invasieve metingen haalbaar of moet voornamelijk niet invasief 
worden gemeten 3. Zijn ook andere hemodynamische metingen gewenst (zoals EVLW, 
GEDV)? Bij deze keuzes dient men bekend te zijn met de eigenschappen en beperkingen 
van de verschillende hemodynamische monitoren om de uitslagen goed te kunnen 
interpreteren. 
De transpulmonale thermodilutie techniek wordt beschouwd als een goud standaard 
voor cardiac output metingen bij kinderen. Deze is gevalideerd voor normale 
omstandigheden en bij hypovolemische shock. 
In hoofdstuk 4 hebben we een validatie studie uitgevoerd naar de cardiac output 
metingen in de aanwezigheid van een links-rechts shuntcirculatie. De studie is uitgevoerd 
in een pediatrisch diermodel, waarbij een artificiële shunt is aangelegd tussen de aorta 
en de longslagader. Dit diermodel simuleert een links-rechts shuntcirculatie zoals in de 
praktijk gezien wordt bij een persisterende open ductus Botalli of diverse aangeboren 
hartafwijkingen. Aangezien een dergelijke shunt hemodynamisch belangrijke 
consequenties kan hebben, kan het van groot belang zijn, de circulatie betrouwbaar te 
monitoren bij deze kinderen.
Onze studie toont aan dat het meten van het hartminuutvolume mogelijk is in 
aanwezigheid van een belangrijke links-rechts shunt. Hoewel de circulatietijd van de 
indicator verlengd wordt met veranderingen van de vorm van de dilutie curve tot gevolg, 
blijven de cardiac output waarden acceptabel in vergelijking met de referentie methode 
(ultrasound flow probe). Er ontstaat enige overschatting van het hartminuutvolume bij 
toename van de shuntgrootte. De verandering van de vorm van de dilutie curve heeft 
wel invloed op de bepalingen van GEDV en EVLW. Deze worden hierdoor onbetrouwbaar 
en niet interpreteerbaar.
Hoofdstuk 5 is een commentaar op een gepubliseerd artikel van Giraud, waarin twee 
case reports worden besproken van volwassen patiënten met een links-rechts shunt. 
Door de afwijkende vorm van de TPTD dilutie curve en onlogische uitslagen van de 
cardiac output, werden de artsen getriggerd om aan de aanwezigheid van een shunt te 
denken. Deze toevalsbevinding werd middels aanvullende diagnostiek in beide gevallen 
bevestigd. Wij hebben aan de hand van de gepresenteerde data een logische verklaring 
gegeven voor de sterk afwijkende CO, EVLW en GEDV uitslagen. Deze case reports 
illustreren fraai het belang van het goed interpreteren van data die door de monitor 
gegeven worden. Het is belangrijk de vorm van de dilutie curve steeds te controleren en 
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niet te berusten in afwijkende uitslagen, maar actief op zoek te gaan naar een plausibele 
verklaring.
Een veel voorkomend ziektebeeld bij kritisch zieke patiënten is ALI (acute lung injury), 
waarbij patiënten respiratoir insufficiënt worden en afhankelijk zijn van mechanische 
beademing. Meestal zijn deze patiënten tevens circulatoir instabiel en moeten 
hemodynamisch bewaakt worden.
Hoofdstuk 6 beschrijft een validatie studie van cardiac output metingen middels 
TPTD in een pediatrisch diermodel, waarbij in de longen een ALI wordt geïnduceerd 
door middel van longspoelingen. Tijdens deze experimenten ontstaat een toename 
van longoedeem, bepaald aan de hand van EVLW metingen. De betrouwbaarheid van 
de cardiac output metingen met de thermodilutie techniek zou theoretisch beïnvloed 
kunnen worden door de hoeveelheid vocht in de longen. Temperatuurverlies treedt 
namelijk makkelijker op in water dan in lucht, waardoor meer verlies van de thermo-
indicator zou optreden in longen met grote hoeveelheden longoedeem. Deze studie 
resultaten zijn vooral van belang voor kinderen, aangezien met name zieke jonge 
kinderen veel hogere geïndexeerde EVLW waarden hebben dan volwassenen. 
De resultaten van onze studie toonden echter geen grote invloed van de hoeveelheid 
EVLW op de betrouwbaarheid van de cardiac output metingen. Mogelijk zijn er andere 
factoren, die het eventuele verlies van de thermo-indicator compenseren. Theoretisch 
zijn dit de invloed van de snelheid van diffusie van de thermo-indicator, de grootte 
van het oppervlak van uitwisseling, het volume van het interstitiele vocht waarin 
gediffundeerd kan worden en de bloeddoorstroming in de longen.
Hoofdstuk 7 beschrijft een validatie studie van EVLW metingen middels de TPTD 
techniek in hetzelfde pediatrische diermodel als de studie in hoofdstuk 6. EVLW is een 
relatief nieuwe parameter, die gebruikt kan worden voor het kwantificeren van vocht 
in de longen en een richting kan geven aan het vochtbeleid bij patiënten. Kritisch 
zieke kinderen kunnen extreem grote hoeveelheden longoedeem hebben. In deze 
omstandigheden zouden de EVLW bepalingen middels TPTD onbetrouwbaarder kunnen 
worden, maar dit is echter nooit eerder onderzocht.
In het diermodel werd het beeld van acute lung injury (ALI) middels longspoelingen 
geïnduceerd, waardoor een forse toename van het EVLW ontstond. De TPTD techniek 
werd vergeleken met twee goud standaarden voor EVLW metingen: de postmortale 
gravimetrie methode en de transpulmonale double indicator dilution (TPDD) techniek. 
Ondanks een goede correlatie van de EVLW metingen middels TPTD (EVLWTPTD) met beide 
referentie methoden, ontstond er wel een trend van overschatting van het EVLWTPTD 
vergeleken met de gravimetrie tijdens de toename van het longoedeem. Aangezien het 
tevens klinisch van belang is, om het EVLW in de tijd te vervolgen, hebben we in onze 
studie ook nog gekeken naar de veranderingen van EVLW gedurende het beloop van 
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het experiment. De veranderingen in EVLWTPTD metingen blijken betrouwbaar als trend 
monitoring vergeleken met de veranderingen in EVLWTPDD metingen. 
Hoofdstuk 8 beschrijft een internationale klinische studie bij kinderen, opgenomen op 
de PICU met een medische indicatie voor een PiCCO katheter, waarmee TPTD metingen 
van cardiac output en EVLW kunnen worden verricht. Prospectief zijn EVLW metingen 
verzameld op het moment, dat de kinderen vrijwel helemaal opgeknapt waren van hun 
opname diagnose. We hebben deze waarden als ‘bijna’ normaal beschouwd, aangezien 
in de inclusie criteria stabiele respiratoire en hemodynamische voorwaarden werden 
gesteld. De klinische toepassing van EVLW bij kinderen is nog niet goed onderzocht. Dit 
komt mede door het gebrek aan normaalwaarden en onduidelijkheid rondom optimale 
indexering.
Kinderen hebben opvallend hoge EVLW waarden geïndexeerd naar lichaamsgewicht 
vergeleken met volwassenen. Dit werd bevestigd met onze studie. Dit heeft naar alle 
waarschijnlijkheid te maken met groei en ontwikkeling. Uit de metingen van in totaal 
58 kinderen hebben we normaalwaarden voor 3 leeftijd-categorieën gecreëerd, met 
mediane EVLWI (5-95 percentile) waarden die onderling significant van elkaar verschillen: 
< 1 jaar 10-35 ml/kg, 1-5 jaar 7-22 ml/kg en 5-17 jaar 6-12 ml/kg. EVLW geïndexeerd naar 
lengte blijkt een leeftijd onafhankelijke maat te zijn, met een normaalwaarde van < 200 
ml/m.
Circulatoir falen is een levensbedreigende situatie die gepaard gaat met zuurstoftekort 
in de cellen en geassocieerd is met orgaan uitval. Geavanceerde hemodynamische 
bewaking kan een toegevoegde waarde hebben voor het starten en sturen van therapie 
bij ernstig zieke kinderen. De parameters die middels geavanceerde hemodynamische 
monitoring worden verkregen, kunnen vervolgens gebruikt worden als streefwaarden 
in een doelgericht therapie algoritme (zie hoofdstuk 9, figuur 4). Hiervoor komen in 
aanmerking: centraal veneuze zuurstofsaturatie (ScvO2), zuurstof extractie ratio (OER), 
serum lactaat concentratie, base excess (BE), hartminuutvolume (CO) en extra vasculair 
longwater (EVLW). Een advies voor de meest optimale monitor voor het verkrijgen van 
deze hemodynamische parameters bij kinderen kan vooralsnog niet worden gegeven.
Het beoordelen van de circulatie is een dynamisch proces, waarbij niet op een enkele 
parameter of een enkele meting gevaren kan worden. Het lijkt het meest betrouwbaar om 
regelmatig een combinatie van bovengenoemde parameters gedurende verschillende 
fasen van het ziekteproces te interpreteren. Hierbij kan het effect worden gemeten van 
therapie en een trend worden vervolgd van het ziekteproces. De streefwaarden zullen 
gaandeweg mogelijk moeten worden aangepast afhankelijk van het ziektebeloop. 
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Conclusies en toekomstperspectieven
Geavanceerde hemodynamische monitoring kan essentiële informatie geven over de 
circulatoire conditie van de patiënt en is toenemend ook beschikbaar voor kinderen. 
Met onze studies hebben we een bijdrage willen leveren aan het valideren van CO en 
EVLW metingen bij kinderen. De transpulmonale thermodilutie methode lijkt onder 
verschillende condities betrouwbaar, maar er zijn ook beperkingen. 
Toekomstig onderzoek zal zich met name richten op prospectieve klinische studies bij 
kinderen met de volgende onderzoeksvragen:
- Kunnen we toekomstige behandelingsprotocollen van hemodynamisch instabiele 
patiënten nog meer individualiseren en rekening houden met het stadium van het 
ziekteproces?
- Kunnen we een optimaal eindpunt definiëren voor het toedienen van vaatvulling 
ter preventie van overvulling?
- Welke minder invasieve meetmethoden kunnen (betrouwbaar) gebruikt worden 
bij kinderen voor het beoordelen van de circulatie? Mogelijk door uitbreiding 
van validatie studies bij kinderen van reeds bestaande technieken, mogelijk door 
nieuw te ontwikkelen meetmethoden.
- Welke methoden en parameters kunnen worden gebruikt voor onderzoek 
naar de microcirculatie. Mogelijk geeft onderzoek op weefsel, cellulair of zelfs 
mitochondrieel niveau een betrouwbaardere weergave van de zuurstofbalans.
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Dankwoord 
Terwijl Nederland momenteel gebukt gaat onder een hittegolf, begin ik aan de laatste 
tekstregels van dit proefschrift. De afgelopen 4 jaar hebben in het teken gestaan van 
hemodynamisch onderzoek, al moesten daarnaast de klinische werkzaamheden ook 
gewoon doorgaan. Ik heb me steeds erg gesteund gevoeld door het thuisfront en mijn 
collega’s, waardoor de combinatie uiteindelijk toch mogelijk was. Ik voel me dan ook 
een bevoorrecht mens: dat ik deze kans heb gekregen en dat het uiteindelijk tot dit 
proefschrift heeft mogen komen.
In de afgelopen jaren heb ik mezelf verder kunnen ontplooien en heb veel geleerd 
over het opzetten van onderzoek, analyseren van resultaten, statistiek, schrijven van 
wetenschappelijke artikelen en presenteren. Aangezien ik nog lang niet uitgeleerd 
ben, zal het hierna dan ook niet ophouden. Ik hoop in de komende jaren betrokken 
te blijven bij het onderzoek op de kinder intensive care (PICU). Daarnaast wachten 
er nieuwe uitdagingen op het gebied van onderwijs, waarvoor ik me met evenveel 
enthousiasme zal inzetten.
Professor van der Hoeven, beste Hans, initiatiefnemer van dit promotietraject, ik 
ben je veel dank verschuldigd. Jij hebt me 4 jaar geleden deze kans geboden en het 
vertrouwen uitgesproken dat ik het zou kunnen. Ik was toen nog niet zo overtuigd, 
dat het me zou lukken, maar jouw stimulerende woorden hebben me zelfvertrouwen 
gegeven. Je kritische commentaren op de artikelen waren steeds heel waardevol 
evenals je visie op de richting van de onderzoekslijn. Tot op het laatst heb je de 
kwaliteit van het manuscript bewaakt en ervoor gezorgd, dat de lat hoog bleef liggen. 
Je bent voor mij en veel anderen een voorbeeld. Ik ben trots dat jij mijn promotor bent. 
Dr. Lemson, beste Joris, jij bent 4 jaar lang de allerbelangrijkste spil geweest in mijn 
promotietraject en bovenal mijn onderzoeksmaatje. Bij jou zeg ik de enige keer in 
dit dankwoord: ‘zonder jou was het niet gelukt!’. Hans had geen betere keuze kunnen 
maken door mij aan jou te koppelen, je hebt je taak als co-promotor meer dan waar 
gemaakt. In de eerste fase heb je me intensief begeleid en daarna geleidelijk steeds 
meer los gelaten, waardoor ik steeds zelfstandiger werd. Een mooi proces, waarvan 
ik veel geleerd heb. Je doorzettingsvermogen is bewonderenswaardig en door je 
bevlogenheid met het onderwerp weet je de hemodynamische onderzoekslijn steeds 
verder uit te breiden.
Dr. de Boode, beste Willem, je enthousiasme en liefde voor het onderzoek werken 
aanstekelijk. Het is inmiddels overduidelijk dat een samenwerkingsverband tussen de 
kinder intensive care en de neonatologie zijn vruchten afwerpt. Het grondige voorwerk 
en je begeleiding van de dierexperimenten waren essentieel voor het welslagen ervan. 
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Samen met Sabine Vrancken hebben we dankbaar gebruik gemaakt van je handigheid 
en expertise. 
Beste Sabine, mijn ‘mede-promovendus’ van de neonatologie. Heerlijk om iemand 
naast me te hebben gehad, die zich met dezelfde onervarenheid in het onderzoek 
heeft gestort. Ook mooi om te zien, hoe we allebei zijn gegroeid en ons werk langzaam 
zichtbaar werd in wetenschappelijke artikelen. Dat je door overmacht nu wat achterop 
bent geraakt, zal je uiteindelijke promotie niet in de weg zitten. Alles is relatief en 
gezondheid gaat boven alles, dat zul jij als geen ander kunnen beamen. Ik kijk uit naar 
je promotie, volgend jaar?
Beste leden van de manuscript commissie, prof. dr. Gert Jan Scheffer, prof. dr. Menko 
Jan de Boer en prof. dr. Bert Bos, hartelijk dank voor het beoordelen van dit proefschrift.
Heel belangrijk is de steun geweest van mijn collega’s: Louis van ’t Hek (boegbeeld van 
de PICU Nijmegen), Chris Neeleman (diplomaat bij uitstek), Ronald Petru (vraagbaak 
op alle vlakken), Ruud Eijk (recht door zee), Luc Frijns (welkome vreemde eend in de 
bijt), Joris Lemson (de manager), Carin Verlaat (veel dank dat je me zo ontlast hebt 
bij de allerlaatste loodjes), Twiggy Walk (altijd een luisterend oor), Anique Hemelaar 
(efficiënter kan niet) en Chantal Liebrand (na jouw vertrek mogen we eindelijk weer eens 
zelf intuberen en oplijnen). Het rooster is altijd aangepast aan de dierexperimenten en 
waar mogelijk werd er rekening gehouden met extra studietijd. Samen met de fellows, 
Jopje Ruskamp en Rinske Brohm, hebben we een geweldig team en ik prijs mezelf 
gelukkig daar deelgenoot van te mogen zijn. 
Dat geldt overigens ook voor het hele PICU-team: verpleegkundigen, arts-assistenten, 
afdelingssecretaresses, etc. Dank voor jullie niet aflatende interesse en bemoedigende 
woorden. Het is fantastisch om te merken dat hemodynamische monitoring leeft 
op de afdeling en dat jullie het belang van het onderzoek inzien. Ik ben me er al te 
zeer van bewust, dat het niet altijd even goed uitkwam als er eerst weer een PiCCO 
katheter moest worden ingebracht, ijswater moest worden gehaald, regelmatig een 
onderzoekstoren naast een patiëntenbed werd geplaatst en data extra moesten 
worden opgeslagen. Heel veel dank voor jullie geduld en medewerking, waarvan we 
ook in de toekomst hopelijk nog dankbaar gebruik zullen maken.
De IC-research groep, IC staf en het stafsecretariaat: dank voor jullie betrokkenheid en 
interesse in mijn onderzoek.
Veel waardering gaat uit naar de medewerkers op het centraal dierenlaboratorium 
met speciale dank aan Alex, Wilma en Jeroen. Dankzij jullie inzet en expertise verliepen 
de proefdierexperimenten veelal voorspoedig. Ik bewonder jullie flexibiliteit en 
bereidheid altijd weer naar een oplossing te zoeken bij onverwachte problemen. 
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Veel dank ook aan Jan Menssen en Jeroen Hopman voor de data acquisitie en 
technische ondersteuning van de experimenten en Sandeep Singh en Paul Schoof 
voor het aanleggen van de aortopulmonale shunts.
Nynke Menger, lieve Nynke, en in dezelfde adem lieve Frank. Jullie zijn een van onze 
dierbaarste vrienden. In de lange tijd dat we elkaar kennen, zijn we bij elkaar getuige 
geweest van vele hoogtepunten en veranderingen in het leven. Het voelt daarom ook 
zo vertrouwd dat jij Nynke als paranimf naast mij staat op de dag van de promotie. 
Dank voor jullie vriendschap!
Eric de Groot, lieve Eric, en ook hier in dezelfde adem lieve Leonieke. Jullie zijn onze 
eerste ‘Beekse vrienden’ en mede daarom heel speciaal. Ik ken weinig mensen, die 
zo gastvrij zijn en altijd klaar staan voor hulp. Eric, ik weet dat je naast paranimf het 
liefst op de valreep ook mijn derde co-promoter had willen zijn, maar dat blijft een 
onderonsje. Als een ware chef-kok heb je me steeds weer van de nodige brandstof 
voorzien. Je kookkunsten zullen we nooit overtreffen met pakjes, maar daar doen we 
overigens ook niet ons best voor: we blijven graag een vorkje meeprikken tijdens jullie 
gezellige etentjes. Het groepje ‘Beekse vrienden’ is inmiddels uitgebreid met Ben & 
Pauline en Ben & Saskia. Jullie vriendschap is mij erg dierbaar. De etentjes, feestjes, 
Sinterklaasgedichten, muzikale optredens, wintersportvakanties, etc. waren steeds 
een welkom tegenwicht voor mijn onderzoek en werk. Ben van Nugteren, ondanks 
het feit dat je je werkzame leven aan het afronden bent, is het een eer dat jij mijn 
boekje uitgeeft.
Lanny, onze steun en toeverlaat voor het thuisfront. Als oppasmoeder run jij ons 
huishouden en geef je mij de ruimte iedere dag weer zorgeloos naar het werk te 
kunnen gaan. Heel veel dank voor alles wat je voor ons doet!
Mijn ouders, dank voor jullie goede zorgen en de mogelijkheden die ik van jullie heb 
gekregen me te ontplooien. Elisabeth, de afstand is helaas te groot om elkaar vaker te 
zien. Je betekent veel voor me. Ik ben blij je zo gelukkig te zien met Geert en de kleine 
Linde.
Lieve vrienden en familie, iedereen die ik nog niet bij naam heb opgenoemd: dank 
voor jullie interesse, steun en medeleven, maar vooral ook dank voor jullie vriendschap 
en afleiding. Ik hoop jullie allemaal persoonlijk te mogen bedanken als jullie op mijn 
feestje komen. 
Tenslotte, lieve Gert, Ruben en Maurits, dé mannen in mijn leven. Dankzij jullie 
kon ik regelmatig de nodige afstand nemen en genieten van de andere mooie 
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dingen in het leven. Gert, dank voor je geduld en interesse en bovenal je humor en 
relativeringsvermogen. We hebben het goed met elkaar, dat realiseer ik me maar al te 
goed. Je suggestie voor de titel van dit proefschrift ‘Silence of the lambs’ zegt genoeg 
over je bereidheid je in deze materie te verdiepen. Ruben en Maurits, ik ben zo trots op 
jullie en hou zielsveel van jullie!
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